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ABSTRACT  
 
Throughout the world the population is aging and the burden of chronic diseases and 
co- morbidity is growing. While the appropriate use of medicines help to decrease 
morbidity and mortality from chronic diseases, research consistently demonstrates that 
preventable medication-related problems cause unplanned hospitalisation and 
morbidity. The elderly and those consuming multiple medicines are at greatest risk. 
Pharmacist-provided medication management services aim to prevent and resolve 
medication-related problems for those consumers who have been identified as being 
at increased risk. This thesis deals with consumers' participation in pharmacist-
provided medication management services with a particular focus on Australia's Home 
Medicines Review (HMR). HMR has been shown to improve health outcomes across a 
variety of research settings. The rationale for the thesis was that some consumers who 
have been identified as being at risk have declined the offer to use HMR. 
Many potential consumers of HMR are cared for by informal caregivers such as 
spouses or other family members (caregivers). Caregivers therefore necessarily have 
a key role in enhancing consumer participation in medication management services. 
Therefore, the aim of this thesis was to investigate consumers' and caregivers' 
awareness, expectations and willingness to use HMR. In order to address the aim, the 
thesis used cross sectional studies with mixed-methods. Studies included qualitative 
methods using focus group discussions and quantitative methods using surveys. 
Given the preliminary nature of the research, survey data was obtained from three 
different samples in order to validate the measurement scales and to test and re-test 
hypotheses. Such an approach strengthens the key findings of the thesis.  
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Chapter One provides the background to the study. The literature review identified that 
consumers' most salient expectations of pharmacist-provided medication management 
services are those centred on the interpersonal interaction with the pharmacist during 
the patient-pharmacist interview. While it is acknowledged that these services improve 
medication safety through for example; enhanced inter-professional communication, 
goal setting, and optimised therapies, consumers tend to focus on the benefit of 
receiving personalised medicines information. Given the lack of previous research 
using behavioural theory to study the factors which influence willingness to use 
medication management services, a new framework was developed. The research 
was therefore guided by a conceptual model which was grounded in theories of 
medication information seeking behaviour. 
Chapter Two reports a cross-sectional survey which was distributed to patients by 264 
pharmacists throughout Australia. A total of 1893 questionnaires for HMR recipients 
were sent to pharmacists of which 595 (31%) were returned by patients. A total of 
1829 questionnaires for consumers who were eligible to use HMR (eligible non-
recipients) were sent to pharmacists of which 293 (16%) were returned and met the 
inclusion criteria. The results showed that most recipients of HMR were very satisfied 
with the service, had few barriers to using it and were very willing to re-use it. Eligible 
non-recipients were provided with a description of HMR in the survey and 
encouragingly, a majority reported that they would be willing to ask for an HMR, if they 
had concerns about their medicines. Overall however, they were less willing to use 
HMR than recipients. Having prior awareness of HMR increased eligible non-
recipients' willingness to use it. 
The research reported in Chapter Three used structural equation modelling to analyse 
the data from a subset of eligible non-recipient consumers (n=286) from Chapter Two 
who were using multiple medicines (taking more than 5 medicines daily or more than 
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12 doses daily). Results showed that consumers' willingness to use HMR was most 
strongly influenced by their  positive  outcome  expectancy  -  expectations  that  HMR  
would  provide  them  with increased medicines knowledge, help them to manage their 
medicines and reduce their medicine concerns (β = 0.56, P < .001). Importantly 
however, overall respondents recorded neutral rather than positive or negative scores 
on the positive outcome expectancy scale. 
Having determined that consumers' positive outcome expectancy had a strong 
influence on their willingness to use it, the thesis then focussed on a deeper 
understanding of the factors which may influence their positive outcome expectancy 
and willingness to use HMR. The theoretical framework suggested that consumers' 
worries about experiencing medication- related problems may increase their positive 
outcome expectancy. Chapter Four reports a qualitative study which was used to 
explore consumers' expectations of and motivation to use HMR. For this study, 12 
focus groups were held using the English language, two in Mandarin and one in 
Arabic. The data pertaining to recipient (n=28) and non-recipient (n=52) consumers 
were thematically analysed with the conceptual framework of the study. A key theme 
was that consumers experienced worries about their medicines. Medicines were 
considered to be innately harmful and consumers could also experience harm from 
making mistakes themselves. While some lacked information about their medicines, 
others believed that medicines information could be confronting. Another theme was 
that consumers expected that HMR would be useful because they expressed a clear 
preference to learn about their medicines during interpersonal interactions with 
pharmacists, rather than from written sources. Consumers' thoughts and feelings 
appeared to be more focussed on the positive outcomes of HMR when they were 
worried about medication-related problems. 
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Having demonstrated qualitative support for the hypothesis that increased medication- 
problem worry would increase positive outcome expectancy and willingness, Chapter 
Five aimed to test this hypothesis using quantitative methods. In addition, this study 
aimed to quantify the extent to which willingness was affected by the social influence 
of the GP - consumers' perceptions of what the GP thinks of HMR. For this study, 
eligible non-recipient consumers were recruited by postal survey of 1600 members of 
Council of the Ageing, NSW (COTA, NSW). Surveys received from 390 respondents 
(24.3%) who were taking multiple medicines were analysed.  Similar to the  results  of  
Chapter  Three,  overall  respondents recorded neutral rather than positive or negative 
scores on the positive outcome expectancy scale. Structural equation modelling 
revealed that consumers' medication-problem worry increased their positive outcome 
expectancy (β  =  0.66,  P  <  .05)  and  indirectly  increased their willingness to use 
HMR (β = 0.22, P < .05). The effect of the social influence of the GP was to act directly 
on consumers' willingness to use HMR (β = 0.27, P < .05). The social influence of the 
GP did not increase positive outcome expectancy. In other words, this social influence 
was effective, even though it had no bearing over whether consumers thought that the 
HMR was personally beneficial. 
Having examined some of the factors influencing consumers' willingness to use HMR, 
Chapter Six turned to the case of caregivers. The background to Chapter Six identified 
that caregivers may experience knowledge hassles - daily stressors experienced whilst 
dealing with tasks which require knowledge about the safety and effectiveness of the 
care-recipients' medicines. Similar to the effect that medication-problem worry had on 
consumers' willingness, it was predicted that knowledge hassles would increase 
caregivers' positive outcome expectancy for HMR and their willingness to assist their 
care-recipient to use HMR. For this study, a cross sectional postal survey was 
conducted among members of 2350 Carers (NSW, Australia). Respondents were 
included in the study if they were involved in medication-related tasks for their care-
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recipient and were not paid as caregivers. Also, their care-recipient needed to be using 
multiple medicines and had not yet experienced HMR. There were 324 useable 
surveys which yielded a response rate of 14%. Structural equation modelling revealed 
that the higher the level of caregivers' knowledge hassles, the higher their  positive  
outcome  expectancy  (β  =  0.40,  P  <  .05)  and  since  positive  outcome expectancy 
increased willingness (β = 0.55, P < .05), knowledge hassles indirectly increased 
willingness  (β  =  0.19,  P  <  .05).  Similar  to  research  conducted  with  consumers  
(Chapters Three  and  Five),  overall  caregivers'  positive  outcome  expectancy  was  
neutral. 
Conclusion 
The central aim of this thesis was to investigate the factors which influence consumers' 
and caregivers' willingness to use HMR, before they have experienced the service. 
One of the most important findings of the research was that if eligible consumers were 
informed of HMR they would be willing to ask for it, under the right circumstances. This 
indicates that consumers have an important role in driving participation in medication 
management services. Knowledge of the factors which influence willingness to use 
these services may therefore be used to improve the design and delivery of them with 
a view to improving consumer acceptance and engagement. 
In this research, it was demonstrated that a strong influence on consumers' and 
caregivers' willingness to use HMR was the extent to which they believed that HMR 
would benefit them personally. In other words a very important influence on willingness 
was consumers' and caregivers' expectations that during the pharmacist-patient 
interview they would learn about their medicines, feel reassured, and be more capable 
managing their medicines. The fact that these expectations were not high yet very 
influential indicates that there is significant scope for increasing consumers' willingness 
 
xvii 
  
to use HMR by building these expectations. While this research focussed on 
willingness as the dependent variable, future research could  use  intervention  studies  
to  determine  whether   increasing   consumers' expectations  increases consumer 
participation. 
Expectations about the benefits of participating in HMR appear to be highest if the 
consumer is worried about experiencing medication problems and when a caregiver is 
stressed about dealing with the knowledge required to manage their care-recipients 
medicines. Promotional programs for HMR could use this finding to appeal to 
consumers and caregivers who   are worried   or   stressed   about   using   medicines. 
As expected, consumers' medication- problem worry (Chapter Five) and caregivers' 
knowledge stress (Chapter Six) was highest during the three months after the 
medicine-user had experienced a change in the medication regimen. At these times 
medicine-users are at greater risk and their and their caregivers' emotional response 
to medicine changes may increase expectations and demand for HMR. This indicates 
that, as suggested in available service information sources (Appendix Two), HMR 
should  ideally be offered within three months after a  change in medication regimen. 
The research also showed that efforts should be made to make the process of asking 
for an arranging HMR as transparent and easy as possible for eligible consumers and  
their informal caregivers. There are a variety of ways with which this could be  
addressed. Possibly the most influential would be to have community pharmacists 
initiate conversations with eligible non-recipients using consumer-directed promotional 
materials. They could explain how the HMR process works and offer to assist 
consumers overcome communication barriers. 
Finally, this research showed that consumers will need to believe that their GP has 
positive attitudes towards HMR if service participation is to be consumer-driven. It is 
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likely that some form of GP endorsement of HMR such as promotional messages 
within GPs surgeries would increase consumers' intentions to ask their GP about the 
service. This could be achieved with  posters  or  brochures  about  the  service,  or  
perhaps  on  GP  network  television commercials. 
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CHAPTER ONE - BACKGROUND 
CHAPTER ONE 
BACKGROUND  
1.1 Preamble 
 
Throughout Europe (Uijen and van de Lisdonk 2008; Junius-Walker, Voigt et al. 2010), 
North America (Fortin, Bravo et al. 2005) and Australia (Britt, Harrison et al. 2008) the 
population is ageing and the burden of chronic disease and co-morbidity is growing. In 
Australia, the proportion of those aged 65 years and older with two or more concurrent 
chronic health problems is 65% (Gilbert, Caughey et al. 2011). Multiple medicines are 
often used to manage common chronic diseases (Vitry and Zhang 2008), resulting in 
complex medication regimens (Moen, Antonov et al. 2009). Adverse events related to 
the consumption of medicines are a leading cause of morbidity in the Australian 
community (Miller, Britt et al. 2006). These adverse events are estimated to result in 
over 190,000 hospital admissions each year, approximately half of which are 
preventable (Roughead and Semple 2009). In 2007, the United States Institute of 
Medicine (IOM) report on preventing medication errors highlighted the urgent need for 
strategies to improve medication safety (Committee on Identifying and Preventing 
Medication Errors 2007). One of the key recommendations of the IOM report 
(Recommendation 2) was that regulatory agencies should provide consumers with 
increased access to medication information and medication self-management support 
(Committee on Identifying and Preventing Medication Errors 2007).  
Medication management services provided by pharmacists are indicated for persons 
who consume multiple medicines (Moen, Antonov et al. 2009) and are at elevated risk 
of experiencing medication-related problems (Pit, Byles et al. 2008). These services 
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have been shown to be effective in reducing preventable medication-related problems 
(Roberts, Stokes et al. 2001; Sorensen, Stokes et al. 2004; Sorensen, Stokes et al. 
2005; Castelino, Bajorek et al. 2009; Castelino, Bajorek et al. 2010; Castelino, Bajorek 
et al. 2010; Castelino, Hilmer et al. 2010; Ellitt, Engblom et al. 2010; Nishtala, 
McLachlan et al. 2011). Various models of outpatient services provided by pharmacists 
exist internationally, for example; the USA’s Medication Therapy Management (MTM) 
services (American Pharmacists Association 2011), the UK’s medicines management 
services (United Kingdom Department of Health), New Zealand’s Comprehensive 
Pharmaceutical Care (CPC) (Bryant, Coster et al. 2011) and Australia’s Home 
Medicine Review (HMR) service (Australian Government Depart of Heath and Ageing). 
While the models of service provided in various countries have unique elements, there 
are significant similarities between them. Medication management services utilise the 
pharmacists’ expertise in the area of pharmacotherapy in order to prepare a 
medication history and optimise treatment for the patient. Depending on the service, 
there may be collaboration between the prescriber and the pharmacist. Of particular 
interest to this thesis is that these services generally include an interview between the 
patient and the pharmacist about the patient’s medicines.   
Research into consumers’ perceptions of pharmacist-provided medication 
management services is critically important because studies conducted within the 
United Kingdom (UK), Australia and the United States of America (USA) demonstrate 
that some eligible consumers are reluctant to use medication management services 
and decline an offer to participate (Kyle and Nissen 2006; Law, Okamoto et al. 2008; 
Ponniah, Shakib et al. 2008; Latif, Pollock et al. 2010). Since these services resolve 
medication-related problems which can in turn improve health outcomes (Roberts, 
Stokes et al. 2001; Naunton and Peterson 2003; Roughead, Semple et al. 2003; 
Peterson, Fitzmaurice et al. 2004; Roughead, Barratt et al. 2004; Sorensen, Stokes et 
al. 2004; Roughead, Semple et al. 2005; Sorensen, Stokes et al. 2005; Sorensen, 
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Stokes et al. 2006; Tenni, Stafford et al. 2007; Castelino, Bajorek et al. 2009; 
Roughead, Barratt et al. 2009; Stafford, Tenni et al. 2009; Castelino, Bajorek et al. 
2010; Castelino, Bajorek et al. 2010; Castelino, Hilmer et al. 2010; Ellitt, Engblom et al. 
2010; Nishtala, McLachlan et al. 2011; Roughead, Barratt et al. 2011), a lack of 
consumer participation is a quality use of medicines issue. In addition, a lack of 
consumer willingness may limit the future viability of these services.  
Many medicine consumers who have vision impairment, dementia, or severe mental 
illness and those who are frail and elderly depend on informal caregivers to assist 
them to participate in health services. These informal caregivers share the burden of 
chronic disease and associated stress. The more complex a care-recipient’s 
medication regimen, the more stress a caregiver experiences (Travis, McAuley et al. 
2007). Furthermore, better caregiver access to medication information may lower their 
stress and could help them avoid medication problems (Britten 2009). Yet, these 
informal caregivers tend not to use many of the services available to them and further 
work is needed to understand how to encourage participation (Lucke, Russell et al. 
2008; Stockwell-Smith, Kellett et al. 2010).  Therefore, this thesis also deals with the 
perceptions of informal caregivers of consumers who are eligible to use medication 
management services. This thesis explores both consumers’ and informal caregivers’ 
perceptions of Australia’s Home Medicines Review service and their willingness to use 
it.  
 
The remaining parts of this background chapter include six sections. The first section 
describes Home Medicines Review. The second section describes the research 
setting. The third section provides a literature review of what is known about the 
perceptions of eligible non-recipients (and their informal caregivers) towards 
pharmacist-provided medication management services. The fourth section describes 
the theoretical framework for the study. The fifth section sets out the aims and 
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objectives of the thesis. The final section provides an overview of the layout of the 
thesis.   
1.2 Home Medicines Review (HMR) 
 
Home Medicines Review (HMR) (Australian Government Department of Human 
Services 2011) is a quality use of medicines intervention which aims to prevent and 
resolve medication-related problems and improve health outcomes for those at 
greatest risk of medicine related problems (Peterson, Fitzmaurice et al. 2004; 
Roughead, Barratt et al. 2009; Stafford, Tenni et al. 2009; Castelino, Bajorek et al. 
2010; Ellitt, Engblom et al. 2010; Nishtala, McLachlan et al. 2011; Roughead, Barratt 
et al. 2011). HMR also aims to increase consumer and caregiver knowledge of 
medicines. HMR is provided collaboratively by general practitioners (GPs) and 
pharmacists. The providers claim for the full cost of service provision from the 
Australian government.  An HMR is initiated with a referral from the consumer’s GP. 
The process for referral allows for the consumer to choose the accredited pharmacist. 
Therefore, the referral may be sent the consumers’ preferred community pharmacy or 
may be sent directly to an independent accredited pharmacist.  The pharmacist 
generally visits the consumer and caregiver(s) in their home, for an extended interview 
regarding medication management issues where some medication-related problems 
are resolved. The pharmacist prepares a comprehensive medication history using 
information obtained from the GP, the community pharmacy (including the dispensing 
history) and the patient interview. Following the visit, the pharmacist sends a written 
report documenting medication review findings and recommendations to the GP, who 
then formulates a medication management plan with the consumer (Australian 
Government Department of Human Services 2011). 
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The HMR program was introduced to the Medical Benefits Schedule in 2001. Two 
successive evaluations of the HMR program in 2005 (Schwartzkoff 2005) and 2008 
(Campbell Research and Consulting 2008) identified that uptake of the HMR program 
had been slower than expected. Each of these evaluations highlighted that if 
consumers were to derive the positive outcomes of HMR, they needed to be willing to 
participate. Yet each of these evaluations reported that consumers’ awareness of the 
program was low and more research was needed to understand consumers’ 
perspectives towards the program (Schwartzkoff 2005; Campbell Research and 
Consulting 2008). In particular, the perspectives of informal caregivers needed to be 
understood since they have a crucial role in ensuring the participation of many 
consumers who have vision impairment, dementia, or severe mental illness and those 
who are frail and elderly (Campbell Research and Consulting 2008). 
1.3 Research Setting 
 
The impetus for this doctoral research stemmed from a funded project as part of the 
Fourth Community Pharmacy Agreement Research & Development Program managed 
by the Pharmacy Guild of Australia. The funded project was headed by Professor 
Lesley White and was titled: Increasing patient demand for Home Medicines Reviews: 
a marketing plan (White and Clarke 2010). Approval for the project was given by The 
University of Sydney Human Ethics Committee. While the student (SRC) was not 
involved in the grant application for the study, he was involved in all subsequent 
phases of the research. This included obtaining ethical approval for the project, setting 
the research questions, recruitment of study sample, writing interview guides for focus 
groups, facilitating focus groups, developing questionnaires for the quantitative study, 
and analysing results.  
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The funded study dealt with the perceptions of consumers who had received HMR 
(recipients) and non-recipient consumers who would be eligible to receive HMR based 
on program guidelines (eligible non-recipients) (Australian Government Department of 
Human Services 2011). In addition the perceptions of informal caregivers of recipients 
and eligible non-recipients were examined. Due to resource and time constraints that 
limit the scope of this thesis, some prioritisation was necessary. The main focus of the 
thesis was on the perceptions of eligible non-recipients and their informal caregivers. 
The research presented in this thesis therefore represents a secondary analysis of 
selected data from the funded study.   
The next section of this chapter (Section 1.4, page 6) provides a literature review of 
what is known about the perceptions of eligible non-recipients (and their informal 
caregivers) towards HMR and other pharmacist-provided medication management 
services. The literature review informed the theoretical framework which was used to 
guide the research. The development of the conceptual model is described in greater 
detail in Section 1.5 (page 43).  
1.4 The perceptions of eligible non-recipients (and their informal 
caregivers) towards medication management services 
 
1.4.1 Scope of the review 
 
This literature review aimed to identify and evaluate studies which specifically explored 
consumers’ and informal caregivers’ expectations of and willingness to use 
pharmacist-provided medication management services prior to service provision.  In 
particular only those services which were provided within community pharmacy, within 
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an out-patient hospital service, within medical practices or within the patients’ home or 
care home were eligible. Articles were not eligible if the article reported the views of 
consumers towards traditional community pharmacy services which focussed on 
medication supply and/or patient counselling but did not report on extended or 
“cognitive” pharmaceutical services. Table 1 (page 8) provides a summary of the 
articles. Within this table, the name of the country where the study was conducted and 
the terminology used to describe the service is provided. Articles are arranged 
chronologically from earliest to latest. 
The next section of the literature review outlines the terms used to describe medication 
management services and the historical context in which the terminology has evolved. 
The terminology used within each of the manuscripts is systematically identified. 
While the search for literature and evaluation of the studies was completed prior to 
2009, it has been continuously updated since that time.  This literature review 
therefore includes all published studies up till September 2012, with the exception of 
studies published as a result of this research project. 
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Table 1 Studies identified which explored consumers’ perception of and willingness to use medication management services 
Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
Volume, Farris 
et al. (2001) 
 
Canada -
Pharmaceutical 
care 
To compare patients' 
adherence to therapy, 
expectations, satisfaction 
with pharmacy services, 
and health-related quality of 
life (HRQOL) after the 
provision of pharmaceutical 
care with those of patients 
who received traditional 
pharmacy care 
Respondents had higher expectations of care 
related to dispensing medicines in a timely 
manner and providing advice, and lower 
expectations of communicating in depth, 
collaborating with prescribers or medicines 
management. 
Nichols-
English (2002)  
 
USA-
Pharmaceutical 
care 
To explore attitudes, 
perceptions, and awareness 
of the pharmaceutical care 
concept and the role that 
pharmacists play in the 
provision of primary patient 
care. 
Lay participants and participating health care 
professionals overall were satisfied with current 
pharmacy services in the community. None of the 
lay people was aware of the concept of 
pharmaceutical care. There was a lack of social 
demand for pharmaceutical care services 
Larson, Rovers 
et al. (2002) 
 
USA -
Pharmaceutical 
care 
 
To explore the dimensional 
structure of a satisfaction 
survey in patients who have 
not yet received 
pharmaceutical care 
services.  
There were two dimensions of performance 
evaluation of receiving pharmaceutical care 
services; Friendly Explanation and Managing 
Therapy. Respondents had lower expectations on 
items on the Managing Therapy scale lower than 
they did items on the Friendly Explanation scale.  
Tootelian, 
Rolston et al. 
USA – 
Pharmaceutical 
services not 
To examine consumer 
perceptions of the future of 
healthcare delivery for 
Consumers would be receptive to seeking advice 
relative to specific medications, however they 
would be less receptive to other possible services 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
(2005) 
 
related to the 
provision of 
medicines 
prescription drugs and their 
interest in receiving medical 
services from pharmacists, 
which they traditionally have 
received from other 
healthcare providers 
that pharmacists could provide. Overall, fewer 
than two in five respondents said they are 
somewhat or very willing to personally pay 
pharmacists for these services. Approximately 
half of the respondents indicated they are 
somewhat or very unwilling to pay. Furthermore, 
when respondents were asked what they would 
be willing to pay for, more than half indicated 
“nothing.” 
Assa-Eley and 
Kimberlin 
(2005) 
 
USA-
Pharmaceutical 
care  
To compare pharmacists’ 
and patients’ perspectives 
of the benefits of 
pharmaceutical care.  
Patients valued the items regarding the provision 
of information as the most beneficial. Items 
related to the preparation of care-plans and 
monitoring were rated as less beneficial.  
 
Hill and Dowse 
(2007) 
 
South Africa - 
Pharmaceutical 
care 
To examine willingness to 
pay for pharmaceutical care 
46% said that they were willing to pay 
pharmacists for providing professional cognitive 
services. It is not clear from the manuscript about 
how the term cognitive service was defined. 
Although pharmacists were significantly more 
likely to provide participants with their prescription 
medicines, they compared unfavourably with 
doctors in terms of healthcare provider 
accessibility and in providing patients with health-
related information and medication counselling. 
While the majority of participants surveyed 
classified their relationships with their 
pharmacists as good, just under half were willing 
to pay pharmacists for providing professional 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
pharmacy services. 
Doucette, 
Witry et 
al.(2007) 
 
USA - 
Medication 
therapy 
management 
(MTM) 
To assess consumers’ 
attitudes towards activities 
considered to be core 
elements of MTM. 
Consumers held more positive attitudes towards 
MTM activities related to patient counseling than 
other MTM activities such as setting goals or 
monitoring follow-up. Consumers who had 
recently visited their doctor about an adverse 
drug event were more positive than others. 
Consumers who recognized their need for 
medicines held more positive attitudes towards 
MTM activities.  
Tinelli, Bond et 
al. (2007) 
  
United 
Kingdom - 
Community 
Pharmacy 
Medicines 
Management 
Project  
To determine whether the 
intervention causes a 
change in patient 
satisfaction with, attitudes 
towards, and expectations 
of, or experience with 
community pharmacy in 
general.   
Many of the outcomes expected of the service 
related to the opportunity to learn about the 
patient’s medicines by communicating with a 
pharmacist. Other outcomes related to 
collaborating with the doctor or providing a wider 
advisory health-related role. Those items which 
related to expectations about learning about 
medicines were rated more highly than items 
related to a wider advisory health-related role. 
Franic, Tucker  
et al. (2008) 
 
USA -
Pharmaceutical 
care 
To evaluate patients' 
awareness and 
understanding of pharmacy 
practice, pharmacy 
services, and 
pharmaceutical care. 
The practice of pharmaceutical care is not widely 
understood by patients. Furthermore, many 
patients were unaware of the cognitive and 
clinical services that pharmacists provide.  
Law, Okamoto USA - MTM To explore the awareness 
of Medicare Part D 
Awareness of MTM was low (93% unaware). 
Trust in the pharmacist centred on dispensing 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
et al. (2008) 
 
enrollees regarding MTM 
and to examine their 
expectations and 
perceptions of pharmacists 
in providing MTM. 
prescriptions. Expectation of pharmacists also 
revolved around supply of products. 
Approximately 70% of respondents did not 
believe they needed MTM; however, 58% 
believed pharmacists were good candidates to 
provide MTM. Willingness to pay for MTM 
services was low (31%).  
Schuh and 
Droege (2008) 
 
USA - MTM To examine willingness to 
pay for MTM services.  
85% were willing to use MTM services if 
insurance paid 100% of the cost. Of those willing 
to use MTM at all, 47% of the sample was willing 
to pay 100% out-of-pocket expenses.  
 
Kassam, 
Collins et al. 
(2009) 
 
USA -
Pharmaceutical 
care activities 
provided within 
community 
pharmacies 
To develop and validate a 
patient satisfaction survey 
There were three dimensions of expectations of 
ANY pharmacy. 1) monitoring outcomes, 2) 
information and education, and 3) personalized, 
collaborative and preventive care. Mean factor 
score of expectations were factor 3 (4.51 +/ 0.49), 
factor 2 (4.11 +/ 0.67) and factor 1 (3.71 +/ 0.78).    
Truong, 
Layson-Wolf et 
al. (2009)  
 
USA - MTM  To determine patients' 
perceptions and 
expectations about MTM 
services and to develop 
educational strategies and 
outreach programs aimed at 
increasing patients' 
knowledge of MTM services 
and the expanded role of 
Patients had very limited knowledge of the core 
elements of an MTM service in the community 
pharmacy setting. 49 of 81 patients (60%) had 
never heard of MTM services. A total of 65 
patients (80%) had never had or received a 
medication therapy review. Patients reported that 
pharmacist provision of MTM services was 
important, but they were concerned about privacy 
and pharmacists' time. Patients were supportive 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
pharmacists in the 
community pharmacy 
setting. 
of and believe that MTM services can improve 
communication and relationship with their 
pharmacist and improve medication use. Patients 
appeared to prefer receiving brochures and 
talking to pharmacists to learn more about MTM 
services.  
Garcia, Snyder 
et al. (2009)  
 
USA - MTM To identify effective 
strategies for marketing 
pharmacist-provided MTM 
services to patients in a 
self-insured employer 
setting 
Participants generally felt positively toward 
pharmacists. Some participants questioned 
pharmacists' education and qualifications for this 
enhanced role in patient care. Perceived benefits 
of MTM noted by participants included the 
opportunity to obtain personalized information 
about their medications and the potential for 
improved communication among their health 
providers. Barriers to patient participation were 
out-of-pocket costs and lack of time for MTM 
visits. Participants suggested use of alternative 
words to describe MTM and marketing 
approaches that involve personal contact.  
Friedrich, 
Zgarrick et al. 
(2010) 
  
USA - MTM To determine patients' 
willingness to receive and 
self-pay for MTM services 
and to examine factors that 
may influence willingness to 
pay. 
The majority of patients felt that pharmacists 
should provide MTM services. No correlation was 
found between complexity of the medication 
regimen and willingness to pay. Presence of 
certain chronic conditions and insurance status 
appeared to have a correlation with willingness to 
pay. 
Kassam, 
Collins  et al. 
USA - 
Pharmaceutical 
care activities 
To compare patients' 
expectations and 
experiences at pharmacies 
The results of factor analysis revealed three 
dimensions of expectations of pharmacy. The 
results were very similar to the results of the 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
(2010) 
 
provided within 
community 
pharmacies 
offering traditional APPE 
learning opportunities (for 
pharmacy student 
placements) with those 
offering enhanced APPEs 
that incorporate 
pharmaceutical care 
activities. 
previous study.(Kassam, Collins et al. 2009)  
Montgomery, 
Kälvemark 
Sporrong et al. 
(2010) 
Sweden – 
Pharmaceutical 
care provided 
within 
community 
pharmacies 
To describe and compare 
patients who had previously 
received a voluntary 
pharmaceutical care service 
and patients who had 
received standard service 
with regard to their 
perceptions of medicine use 
and the pharmacy 
encounter. 
Respondents with the perception of greater need 
for medicines and greater concern about 
medicines were more likely to use the service 
than those who did not. Patients who used the 
service were more likely to have had; difficulties 
opening container (40.7% vs 29.0%, P<.01), 
worries about side effects (44.7% vs 30.0%, 
P<.001), experiences of side effects (52.9% vs 
26.9%, P<.001), worries about drug-drug 
interaction (27.0% vs 18.6%, P<.05), inadequate 
treatment effects (16.8% vs 8.7%, P<.05). Those 
who were interested in learning more about their 
medicines were also more likely to have 
volunteered to use the service.  
Linton, Bacon  
et al. (2010)  
 
USA - 
Medication 
reviews 
performed by 
physicians or 
pharmacists 
To determine if beneficiaries 
will respond to a mailed 
request to pursue a 
medication review; and to 
identify where veterans had 
chosen to have medication 
reviews and outcomes from 
The finding relevant to the present study was that 
the overall uptake of pharmacist provided 
medication review was low. 4000 beneficiaries 
were offered free medication review and 606 
consented to be surveyed. Among the 373 who 
completed the survey, just 190 (50.9%) received 
reviews in a physician's office; 103 (27.6%) 
received reviews in a pharmacy; 60 (16.1%) 
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Reference Country - type 
of service 
Focus of the study Main findings relevant to present study  
the patient perspective. received reviews in both locations; and 20 (5.4%) 
reported a different location or no location.  
Hong, Liu et al. 
(2011)  
 
USA- MTM To identify attributes of 
MTM valued by Medicare 
beneficiaries and to 
determine patient 
preferences and willingness 
to pay for MTM attributes. 
 
Study participants viewed cost (relative 
importance 32.2%) as the most important 
attribute of MTM, followed by service setting 
(24.2%), provider experience in overall practice 
(19.5%), and provider experience in geriatrics 
(16.6%). Community pharmacies (beta = 0.146, P 
= 0.007) were the most preferred environment for 
MTM services, followed by clinics, whereas 
telephone consultation was the least preferred 
environment (beta = -0.349, P < 0.001).  
Renberg, 
Wichman 
Törnqvist et al. 
(2011) 
Sweden - 
Services 
provided by 
community 
pharmacy  
To explore pharmacy 
clients’ expectations of 
services provided by an 
ideal community pharmacy 
Consumers’ expectations of medication 
management services were not highly prevalent. 
In general, pharmacy did not present as a health-
care destination. The authors concluded that this 
might be a challenge for promoting or 
implementing cognitive services. 
Lee, George et 
al. (2012) 
Australia – 
Home 
Medicines 
Review 
To explore stakeholder 
perspectives on a 
government-subsidised 
Home Medicines Review 
(HMR) service and factors 
affecting the uptake of 
HMRs for older residents of 
retirement villages 
These residents thought the service could be 
useful and beneficial in improving their 
understanding about medicines, assuring them 
that their medicines were appropriate, or 
simplifying their medication regimen. Some 
residents perceived a lack of need for the service 
at present but thought they might need it in the 
future. 
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1.4.2 Terminology and medication management services  
 
The majority of research into consumers’ perceptions of medication management 
services has occurred within the United States of America. In that country, a federal 
program, Medicare Part D provides subsidies for medication costs for beneficiaries. 
The Medicare Modernization Act of 2003 requires that Medicare Part D insurers 
provide Medication Therapy Management (MTM) services to selected beneficiaries, 
with the goals of providing education, improving adherence, or detecting adverse drug 
events and medication misuse (Pellegrino, Martin et al. 2009).  
 
Prior to and including 2007, the provision of medication management services had 
been referred to as pharmaceutical care (Volume, Farris et al. 2001; Larson, Rovers et 
al. 2002; Nichols-English 2002; Assa-Eley and Kimberlin 2005; Hill and Dowse 2007) 
or as non-traditional roles for community pharmacists (Tootelian, Rolston et al. 2005). 
Since 2007, research conducted within the USA into consumer perceptions of 
medication management services has tended to use the term MTM (Doucette, Witry et 
al. 2007; Law, Okamoto et al. 2008; Schuh and Droege 2008; Garcia, Snyder et al. 
2009; Truong, Layson-Wolf et al. 2009; Friedrich, Zgarrick et al. 2010; Hong, Liu et al. 
2011). Research into consumer perceptions of pharmaceutical care in the USA 
however, continues to appear (Franic, Tucker et al. 2008; Kassam, Collins et al. 2009; 
Kassam, Collins et al. 2010). A recent study in the USA investigated consumer uptake 
of medication review after a mailed promotion. The study compared the uptake of 
pharmacist versus general practitioner review yet no reference was made to 
pharmaceutical care or MTM (Linton, Bacon et al. 2010). 
 
Different terms for medication review are used in Europe and the United Kingdom.  A 
study within Sweden referred to medication management services supplied in 
community pharmacies as pharmaceutical care in 2010 (Montgomery, Kälvemark 
 
16 
CHAPTER ONE - BACKGROUND 
Sporrong et al. 2010). Another study within Sweden examining consumers’ 
expectations of the types of services that community pharmacy should provide did not 
refer to a particular service by name (Renberg, Wichman Törnqvist et al. 2011). Within 
the United Kingdom a study published in 2007 referred to a medication management 
service as Community Pharmacy Medicines Management Project.  
 
Only one study, which was published in 2012, dealt with consumer perceptions of 
Australia’s Home Medicines Review (Lee, George et al. 2012).  
1.4.3 Methodological issues 
 
There are a number of methodological considerations when conducting research into 
consumers’ perceptions of medication management services. Three categories of 
methodological considerations have been identified from the literature review.  It is 
considered important that studies obtain the views of consumers who would be eligible 
to receive medication management services and their informal caregivers. Given the 
difficulty of identifying respondents who would be eligible to receive these services, the 
first methodological consideration deals with the recruitment strategy used to recruit 
respondents. The second methodological consideration deals with the issue of 
whether respondents were consumers who were using multiple medicines or their 
caregiver. The third methodological consideration covers the issue of how medication 
management services were described to study participants. This is considered 
important because at the time the research was conducted respondents were yet to 
experience the service.  
 
1.4.3.1 Recruitment strategies  
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A variety of strategies were employed to facilitate recruitment. Many studies had 
pharmacists or their staff approach clients/patients of community pharmacies (Franic, 
Tucker et al. 2008; Kassam, Collins et al. 2009; Truong, Layson-Wolf et al. 2009; 
Friedrich, Zgarrick et al. 2010; Kassam, Collins et al. 2010; Renberg, Wichman 
Törnqvist et al. 2011). In one study, physicians working at a specialist medical clinic 
asked their patients to participate (Tinelli, Bond et al. 2007). Other personal methods 
included approaching people on the street (Schuh and Droege 2008) within a senior 
citizen centre (Hong, Liu et al. 2011) and in a medical centre (Nichols-English 2002). 
In the study of Lee, George et al. (2012), residents of retirement villages were 
identified by using expression of interest (EOI) forms and posters distributed by the 
support staff of the retirement villages   
 
In order to overcome selection bias which affects convenience sampling, some studies 
used methods such as post, telephone or online sampling (Larson, Rovers et al. 2002; 
Assa-Eley and Kimberlin 2005; Doucette, Witry et al. 2007; Hill and Dowse 2007; Law, 
Okamoto et al. 2008; Linton, Bacon et al. 2010). A mixed method of recruitment was 
used by  the study of Garcia et al (2009). In that case, flyers were used to recruit 
people at the workplace but this was supplemented by telephoning known contacts.  
 
The recruitment strategy for each study is summarised in Table 2 (Page 19). 
Consistent with Table 1 studies are arranged chronologically, beginning with those 
published first.  
 
1.4.3.2 Use of medicines among study participants  
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Medication management services are ideally suited to persons who use multiple 
medicines. Several studies have attempted to obtain the views of participants who 
were likely to be using multiple medicines while others did not attempt to target such 
participants. Studies did not always report the number of medicines used by 
participants making it difficult to infer the proportion of respondents who were using 
multiple medicines. Since increasing age is associated with increasing incidence of 
multiple medicine use (Moen, Antonov et al. 2009), it is likely that those studies which 
included a high proportion of respondents who were older also had a large proportion 
using multiple medicines. Table 2 (Page 19) provides an indication of the proportion of 
respondents who were using multiple medicines and some representative statistics to 
indicate the proportion of respondents who were of advanced age.  
 
Finally, Table 2 identifies those studies in which there was a substantial proportion (or 
it was likely that there was a substantial proportion) of respondents who used multiple 
medicines as well as those studies in which there was a low proportion (or it was likely 
that there was a low proportion). 
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Table 2 Characteristics of respondents 
Reference Sample and recruitment strategy 
Indication of 
the proportion 
of 
respondents 
who were of 
advanced age 
Use of medicines by 
participants 
Volume, Farris 
et al. (2001) a 
 
Convenience sample 
of prescription 
customers of 
community 
pharmacies using 
three or more 
medicines aged over 
65 years. 
Mean age was 
73 +/- 6 years. 
All participants were 
using three or more 
medications according 
to pharmacy profiles. 
No data on medicine 
use was reported. 
Nichols-
English (2002) 
b 
 
Convenience sample 
of patients of a 
medical service. 
27-74 years No data on medicine 
use was reported 
Larson, 
Rovers et al. 
(2002) a 
 
Convenience sample 
of prescription 
customers of 
community 
pharmacies using one 
or more medicines for 
chronic disease. 
67% were 60 
years old or 
more. 
77% had used three 
or more medicines 
within the last 4 
weeks. 
Tootelian, 
Rolston et al. 
(2005) b 
 
Random sample of 
homes within using a 
telephone survey. 
23% were 65 
years or older. 
No data on medicine 
use was reported. 
Assa-Eley and 
Kimberlin 
(2005) b 
 
Random sample of 
homes using a 
telephone survey. 
Included only those 
who had received one 
prescription 
medication within the 
previous six months. 
24% were older 
than 60 years. 
All respondents had 
used at least one 
prescription within the 
previous six months 
but no data on 
medicine was 
reported. 
Hill and Dowse 
(2007) b 
Purposive sample of 
the customers of 
community 
pharmacies. 
14% were older 
than 65 years. 
No data on medicine 
use was reported. 
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Reference Sample and recruitment strategy 
Indication of 
the proportion 
of 
respondents 
who were of 
advanced age 
Use of medicines by 
participants 
 
Doucette, 
Witry et al. 
(2007) a 
 
Sample obtained from 
a private database 
(Harris Interactive). 
Purposive sample of 
Medicare beneficiaries 
who were 65 years or 
older. 
Mean age was 
73 years. 
45% used more than 
4 medicines daily  
Tinelli, Bond et 
al. (2007)a 
  
Convenience sample 
of clinic patients with 
established coronary 
artery disease 
recruited during 
attendance at the 
clinic. 
76% were older 
than 65 years. 
No data on medicine 
use was reported. 
Franic, Tucker  
et al. (2008) b 
 
Convenience sample 
of customers of 
different types of 
community 
pharmacies.  
Depending on 
the type of 
pharmacy the 
mean age of 
participants 
varied between 
36 +/- 13 and 
48 +/- 18  
Depending on the 
type of pharmacy, the 
mean number of 
medicines taken by 
participant varied 
between 2.3 +/- 2.4 
and 3.9 +/- 3.6. 
Law, Okamoto 
et al. (2008) a 
 
Sample obtained from 
a private database 
(Harris Interactive). 
Purposive sample of 
Medicare 
beneficiaries. 
Mean age was 
72 +/- 5 years. 
The median number 
of daily medicines was 
4.0 [range 0 - 15]. 
Schuh and 
Droege (2008) 
b 
 
Random sample of 
general population 
using postal survey. 
27% were aged 
60 years or 
older. 
67% were taking 
medicines. 
Kassam, 
Collins et al. 
(2009) b 
Convenience sample 
of customers of 
community pharmacy 
presenting with 
prescription for 
39% were older 
than 60 years. 
No data on medicine 
use was reported. 
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Reference Sample and recruitment strategy 
Indication of 
the proportion 
of 
respondents 
who were of 
advanced age 
Use of medicines by 
participants 
 asthma medicines. 
Truong, 
Layson-Wolf et 
al. (2009) a 
 
Convenience sample 
of customers of 
community 
pharmacies. 
28% were aged 
65 years or 
older. 
48% were taking five 
or more regular 
medicines. 
Garcia, Snyder 
et al. (2009) a  
 
Purposive sample of 
university employees 
who had a least one 
chronic diseases. 
Mean age was 
58 years. 
81% were taking three 
or more regular 
medicines. 47% were 
taking five or more 
regular medicines. 
Friedrich, 
Zgarrick et al. 
(2010) a  
  
Convenience sample 
of adult customers of 
community 
pharmacies. 
29% were 65 
years or older. 
48% were taking three 
or more medicines 
daily. 15% were taking 
five or more 
medicines daily. 
Kassam, 
Collins  et al. 
(2010) b 
 
Convenience sample 
of customers of 
community pharmacy 
presenting with 
prescription for 
asthma medicines. 
39% were older 
than 60 years. 
No data on medicine 
use was reported. 
Montgomery, 
Kälvemark 
Sporrong et al. 
(2010) a 
Convenience sample 
of customers of 
community 
pharmacies who were 
older than 60 years 
and were taking five 
or more medicines 
daily. 
Mean age was 
74 +/- 8 years. 
All participants used 
medicines. 64% used 
more than 5 
medicines daily. 10% 
used 11 medicines 
daily or more.  
Linton, Bacon  
et al. (2010) a  
 
Postal invitation using 
purposive sampling of 
Medicare beneficiaries 
who used more than 
ten medications within 
the previous three 
months.  
78% were aged 
65 years or 
older. 
Average number of 
maintenance 
medications was 12.3 
+/- 2.0. 
Hong, Liu et A purposive sample of 100% of No data on medicine 
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Reference Sample and recruitment strategy 
Indication of 
the proportion 
of 
respondents 
who were of 
advanced age 
Use of medicines by 
participants 
al. (2011) a   
 
Medicare beneficiaries 
who were recruited at 
senior citizen centres. 
participants 
were older than 
65 years. 
use was reported. 
Renberg, 
Wichman 
Törnqvist et al. 
(2011) a 
Convenience sample 
of the customers of 
community pharmacy 
with at least condition 
requiring treatment for 
more than three 
months. 
The mean age 
was 61 years. 
No data on medicine 
use was reported. 
Lee, George et 
al. (2012) a 
A purposive sample of 
the residents of 
retirement villages. 
53% were aged 
65-79 and 47% 
were aged 80-
86. 
All participants were 
using three or more 
medicines. 
a There was a substantial proportion (or it was likely that there was a substantial proportion) of 
respondents who used multiple medicines in these studies.                                                                                                           
b There was a low proportion (or it was likely that there was a low proportion) of respondents who 
used multiple medicines in these studies.  
    
1.4.3.3 Descriptions of medication management services 
 
Since participants in these studies had not yet experienced medication management 
services it is important to report how the concept of the service or service elements 
were described to participants during the study. There is a dearth of literature about 
the details of how a particular medication management service was described to 
participants. There were several studies where MTM was explained to study 
participants but the explanation was not provided in the manuscript (Law, Okamoto et 
al. 2008; Garcia, Snyder et al. 2009; Truong, Layson-Wolf et al. 2009). In two studies 
the description provided in the manuscript was very brief. These descriptions were: “A 
45 minute appointment-based service which was held within a private area of the 
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community pharmacy.” (Friedrich, Zgarrick et al. 2010) and “The new Medicare drug 
benefit will include a service to help some Medicare beneficiaries manage their 
medicines (Doucette, Witry et al. 2007). In one study the description of MTM provided 
to participants was apparently very detailed (although not provided in the manuscript) 
and defined terms such as medication therapy review, personal medication record and 
medication action plan (Truong, Layson-Wolf et al. 2009). Hong, Liu et al. (2011) 
performed a discrete choice experiment to evaluate preferences for seven various 
service elements of MTM such as service setting, experience of the pharmacist, years 
of practice and cost among other attributes, but it is unclear from the manuscript what 
participants were told or understood about the provision of MTM. Only one study 
provided a rationale for the description provided (Garcia, Snyder et al. 2009). In that 
case, the rationale was the researchers’ wish to probe five elements of MTM as 
defined by the professional bodies representing pharmacists in the United States 
(American Pharmacists Association and the National Association of Chain Drug Stores 
Foundation 2008). 
 
In an attempt to determine the effect of promoting medication reviews (whether 
provided by a physician or pharmacist) to United States’ veterans who used multiple 
medicines, Linton, Bacon et al. (2010) mailed veterans directly. The manuscript did not 
describe the concept of medication review.   
 
In the one study published regarding HMR, it is not clear from the manuscript how 
Home Medicines Review was described to participants (Lee, George et al. 2012).   
 
Having explained methodological considerations, the next section examines 
consumers’ overall willingness to use medication management services.  
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1.4.4 Consumers’ overall willingness to use medication management services  
 
There were two main categories of research methods investigating consumers’ 
willingness to use medication management services.  
 
The first category of research methods dealt with observing the rate at which 
consumers used the services and describing the characteristics of consumers who did 
and/or did not use the services. There were two studies which used this method. In 
one of these studies the willingness to use pharmacist-provided medication review was 
investigated in a study of US veterans who were using more than ten medicines daily 
(Linton, Bacon et al. 2010). Of 4000 patients who were invited to participate in a study 
offering free medication review, only 123 actually received medication reviews by 
pharmacists. This was a disappointing result for the authors of the study. They 
concluded that more intensive interventions may be required to ensure that medication 
regimens are being actively managed among those who use a large number of 
prescription medications. While this study did not explore the perceptions of 
participants, it was included in this review because the results provide some 
information about the willingness of consumers to use medication management 
services. The second study compared the characteristics of consumers who chose to 
use a Swedish pharmaceutical care intervention with those who did not (Montgomery, 
Kälvemark Sporrong et al. 2010).  
 
The second category of research used cross sectional methods to explore consumers’ 
perceptions of medication management services and their willingness to use them. In 
these studies, qualitative and quantitative methods were used to enquire as to 
consumers’ willingness to use the services and the factors which influence willingness. 
Using these methods, consumers’ willingness to use the services varied widely. In one 
study, after receiving a description of MTM only 18% of participants were willing to use 
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MTM (Law, Okamoto et al. 2008). The question posed to consumers in that case did 
not explain whether they had to pay for the service. Interestingly, the next question 
posed to respondents was how much they would be willing to pay for a service and 
32% responded that that they would be willing to pay a median of $10US. This result 
may be compared with that of another study where 85% were willing to use “cognitive 
services” if insurance paid 100% of the cost (Schuh and Droege 2008). Willingness to 
receive MTM was investigated by Friedrich, Zgarrick et al. (2010). In that study, it was 
reported that a surrogate measure for willingness to receive MTM was used. The 
surrogate measure was whether MTM was “a good idea”. It should be noted that 
consumers’ belief that something is a good idea is not the same as willingness to use 
the service. Of the sample, 94% stated that the MTM service would be a “very good 
idea” or “somewhat a good idea” (Friedrich, Zgarrick et al. 2010).  
 
In  summary  there  is  a  lack  of  information  regarding  consumers'  willingness  to  
use medication management services. The few studies which have examined this 
issue indicate considerable variation in willingness.  The next section examines factors 
which may be expected to influence this willingness.    
 
1.4.5 Factors which may influence consumers’ willingness to use medication 
management services 
 
Several studies investigated the factors which may influence consumers’ willingness to 
use medication management services. These factors included: awareness and 
understanding of the service; perceptions of receiving benefits; perceptions of the role 
of the pharmacist to perform medication management services; psycho-social factors; 
and other factors.   
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1.4.5.1 Awareness and understanding of medication management services  
 
Since demand for health services is influenced by consumer knowledge and 
understanding of the service (Ensor and Cooper 2004), it is possible that prior 
awareness of a medication management service may influence willingness to use it. 
Importantly, prior awareness appears to be low among relevant populations.  
 
There were two studies which investigated awareness of MTM. In the study of Truong, 
Layson-Wolf et al. (2009) 60% of participants had never heard of MTM. Similarly, in 
the study of Law, Okamoto et al. (2008) 93% were unfamiliar with the term Medication 
Therapy Management or MTM.  Furthermore, in a qualitative study participants were 
unsure about the suitability of the name MTM and suggested alternative words to 
describe MTM (Truong, Layson-Wolf et al. 2009). Participants felt that alternative 
terms such as “medication management” or “medication checkup” would be less 
confusing and have a more “personal” feel (Garcia, Snyder et al. 2009). Lee, George 
et al. (2012) concluded that residents’ lack of awareness of HMR was a barrier to them 
using it  Many residents reported they had not heard of the service, and were unaware 
that the service is government subsidised (Lee, George et al. 2012). 
 
It remains unclear whether a lack of awareness or understanding of a medication 
management service influences consumers’ willingness to use it because no studies 
have used quantitative methods to address this issue.  
 
Having  dealt  with  what  is  known  about  awareness,  the  following  section  
explores  how consumers' perception of the benefits of  medication management 
services influences their willingness to use the service. It is important to explore 
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consumers’ benefit perceptions because consumers who believe that a service would 
be personally beneficial would be more willing to use it (Rosenstock 1974; Ajzen 
1991). 
 
1.4.5.2 The influence of benefit perceptions on willingness to use medication 
management services 
 
The relationship between consumers’ benefit perceptions and willingness was 
explored in a study performed in the United States (Friedrich, Zgarrick et al. 2010). It 
was shown that participants’ willingness to receive MTM correlated highly with their 
beliefs that MTM would be helpful to them (Friedrich, Zgarrick et al. 2010). Closely 
related to whether consumers perceive medication management services to be 
beneficial is whether they believe that they need the service. A qualitative study has 
reported that residents’ lack of perceived need for HMR is a barrier to them using the 
service (Lee, George et al. 2012). In a quantitative study, it has been reported  that  
just 7% of the cohort believed that they “fall into the category of need” for MTM and  
21% believed that they would benefit, despite the fact that participants were taking a 
median of 4 medicines per day (Law, Okamoto et al. 2008).  
 
In summary, there is some evidence that consumers’ benefit perceptions positively 
influence their willingness to use medication management services.  It is also 
important to note that in neither of the two quantitative studies mentioned above were 
participants surveyed about how they were likely to benefit (Law, Okamoto et al. 2008; 
Friedrich, Zgarrick et al. 2010).  
 
The next two sections therefore explore how consumers may benefit from medication 
management services. As described in Section 1.4.3.3 (page 22), it is relevant 
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whether consumers had received a description of the medication management service 
as part of research design. Therefore, the next section explores consumers’ 
perceptions in studies where the service had been described to them whereas the 
section following that explores consumers’ perceptions in studies where the service 
had not been described. 
 
1.4.5.3 Exploring consumers’ perceptions of the benefit of medication management 
services – after the service had been described 
 
In these studies respondents were provided with or it is assumed that they were 
provided with some definition of the medication management services of interest. In 
the only qualitative study regarding MTM activities, it was reported that the perceived 
benefits were the opportunity to obtain information about their medicines, to provide 
reassurance about their medicine concerns and receive the expert opinion of the 
pharmacist (Garcia, Snyder et al. 2009).  Similar qualitative findings were reported in 
relation to HMR (Lee, George et al. 2012). The authors of that study added that 
residents believed that HMR could assist them to simplify their medication regimen 
(Lee, George et al. 2012).  
 
In quantitative studies, a variety of methods have been employed to determine 
consumers’ expectations of particular elements of medication management services 
and pharmaceutical care in general. The study of Doucette, Witry et al. (2007) 
assessed consumers’ attitudes towards those activities considered to be core 
elements of MTM. Attitudes were defined as consumers’ expectations that community 
pharmacy should provide certain activities as part of their Medicare Part D prescription 
drug benefit. In that study, the researchers used the same seven variables which were 
intended to tap aspects of pharmaceutical care, as previously defined (Assa-Eley and 
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Kimberlin 2005). While factor analysis was not used to group the variables, they were 
grouped according to the notions of the researchers about the benefits of 
pharmaceutical care. Three of the items were intended to relate to the benefit of 
learning about medicines through counselling and four items for MTM specific activities 
such as carrying out plans to solve or prevent problems with medicines. Those items 
which related to counseling activities were rated with higher expectations than for 
items relating to MTM specific activities (Doucette, Witry et al. 2007). 
 
In another study participants were asked to rate the importance (to themselves) of a 
list of benefits of MTM (Truong, Layson-Wolf et al. 2009). The list of benefits included 
items such as; follow-up with physician, making recommendations about medication 
regimen, and providing medication review.  Unlike other studies, participants were 
provided with detailed descriptions of each of these items. The survey also provided 
items related to more general benefits such as; improving overall health, improving 
medication use, and improving communication with health providers. There were no 
items related specifically to the benefit of communicating with a pharmacist about 
medicines. Interestingly, participants rated the highest level of importance to making 
recommendations about medication regimen.  
 
1.4.5.4 Exploring consumers’ perceptions of the benefit of medication management 
services – where the service had not been described 
 
In these studies, few detailed definitions of particular services were provided for 
participants. Participants were asked a variety of questions regarding their perceptions 
of the concept of pharmacists providing services related to medication management.  
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Franic, Tucker et al. (2008) used qualitative methods to explore underlying perceptions 
of pharmaceutical care activities   In their introduction, the authors defined 
pharmaceutical care as the “responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improves the patient’s quality of life.” The researchers 
asked participants to describe what they knew about the term “pharmaceutical care”. 
Content analysis of open-ended responses was used to explore underlying themes. 
Whereas the proportion of respondents who provided usable responses to other items 
approached 100%, the researchers noted a high level of non-response when 
participants were asked to define the term pharmaceutical care (just 97/175 
participants provided usable answers). In addition they reported that around only half 
the responses that were provided could be categorised into themes which 
corresponded with the researchers’ definition of pharmaceutical care. Other responses 
tended to describe supply functions or so-called early clinical functions. They 
concluded that “overall, study participants were not knowledgeable or did not have an 
articulated preconceived viewpoint of pharmaceutical care.” They also suggested that 
the profession needs to increase consumers’ expectations of pharmaceutical care 
services (Franic, Tucker et al. 2008). 
 
The following studies used quantitative methods to explore consumers’ perception of 
receiving benefits. 
 
Volume, Farris et al. (2001) explored patients’ expectations that their pharmacist would 
perform various elements of pharmaceutical care. In general, respondents had higher 
expectations of care related to dispensing medicines in a timely manner and providing 
advice, and lower expectations of communicating in depth or collaborating with 
prescribers. In another study, participants rated the perceived benefit of 
pharmaceutical care (Assa-Eley and Kimberlin 2005).  In that study, the tasks provided 
were those related to pharmaceutical care as originally defined by Hepler and Strand 
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(1990). Items related to receiving information about medicines were rated higher than 
items related to discussing general health matters. The study of Tootelian, Rolston et 
al. (2005) explored consumers’ perception of the value of community pharmacists 
providing various services. This was achieved by providing participants with a list of 
service elements and asking them to rate the value of each element. It should be 
noted that the research question did not ask how valuable the service element was to 
themselves, it simply asked how valuable each element was. Items related to receiving 
information about vitamins and reducing the cost and number of medicines were rated 
higher than working with other health providers and managing medications for specific 
disease states.  
 
Similarly, Tinelli, Bond et al. (2007) assessed patient expectations that a community 
pharmacy-led medication management service should provide certain elements. Many 
of the elements provided to respondents related to the opportunity to learn about the 
patient’s medicines by communicating with a pharmacist. Other elements related to 
collaborating with the doctor or providing a wider advisory health-related role. Those 
items which related to expectations about learning about medicines were rated higher 
than items related to a wider advisory health-related role. 
 
The following studies add an extra dimension to the studies above by grouping 
different elements of pharmaceutical care activities into overarching themes of 
consumer interest.  
The first study in this section reported consumers’ performance evaluation of various 
service tasks related to pharmaceutical care as part of the development of a 
“satisfaction with pharmaceutical care” questionnaire (Larson, Rovers et al. 2002). 
These assessments were measured prior to the introduction of formal pharmaceutical 
care activities in the pharmacy. The responses were factor analysed in order to 
determine underlying dimensions of patient perspectives of pharmaceutical care. 
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There were two dimensions: Friendly Explanation (including items related to 
friendliness of care, the setting of care, and medication counselling); and Managing 
Therapy (items dealing with the concept of pharmaceutical care — managing drug 
therapy and solving therapy problems). Participants reported lower scores for items on 
the Managing Therapy scale than items on the Friendly Explanation scale (Larson, 
Rovers et al. 2002). 
 
Three studies explored participants’ expectations of pharmaceutical care provided by 
pharmacies (Kassam, Collins et al. 2009; Kassam, Collins et al. 2010; Montgomery, 
Kälvemark Sporrong et al. 2010).  Participants were provided with a list of services and 
were asked as to whether they expected the services would be provided by any 
pharmacy.  Responses to these statements were factor analysed. In each study, there 
were three dimensions of expectations: 1) monitoring outcomes; 2) information and 
education; and 3) personalized, collaborative and preventive care (Kassam, Collins et 
al. 2009; Kassam, Collins et al. 2010). In the first of these studies, mean factor score 
of expectations were factor 3 (4.51 +/ 0.49), factor 2 (4.11 +/ 0.67) and factor 1 (3.71 
+/ 0.78) (Kassam, Collins et al. 2009). This indicates that participants held more 
positive expectations of activities related to patient counseling than other MTM 
activities such as setting goals or monitoring follow-up. In regard to these 
expectations, the results of the second study were very similar (Kassam, Collins et al. 
2010).   In the third study which examined consumers’ expectations, Renberg 
Wichman Törnqvist et al. (2011) explored consumers’ normative expectations of 
community pharmacy encounters. Respondents were provided with a list of 54 items 
describing services which may be provided by community pharmacies. Using items on 
this list, respondents were asked to describe “an ideal community pharmacy 
encounter”. Participants acknowledged that medicines were central to pharmacy 
services, but did not particularly emphasise pharmacists acting in medication 
management roles “as a central desired concept”.  
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Overall consumers have well developed expectations that pharmacists generally 
provide them with medicines information and advice which may help them to manage 
their medicines. Consumers generally do not have highly developed expectations that 
pharmacists perform other technical functions such as making recommendations to 
prescribers or reviewing the medication for appropriateness. Truong and colleagues 
demonstrated that it is possible to create and measure expectations about these 
technical functions by providing detailed descriptions of them within a survey (Truong, 
Layson-Wolf et al. 2009). However in the absence of such detailed descriptions, 
qualitative and quantitative studies suggest that consumers’ most salient expectations 
about the benefit of medication management services relate to their participation in a 
discussion with a pharmacist. Consumers tend to expect that these discussions could 
provide them with information and reassurance that could help them manage their 
medicine regimen. While there is some evidence that these expectations increase 
consumers’ willingness, the evidence is not strong and further work is needed to clarify 
this issue.    
 
Having explored the influence of awareness and benefit perceptions, the following 
section describes how consumers' perception of the role of the pharmacist to perform 
medication management services may influence their willingness to use the services. 
 
1.4.5.5 Role orientation  
 
Evidence for this proposition that consumers’ perceptions of the role of the pharmacist 
to provide medication management services may influence their willingness to use it 
arises from several studies.  
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 In a qualitative study of consumer attitudes towards MTM, participants generally felt 
positively toward pharmacists and the concept of MTM (Garcia, Snyder et al. 2009). 
However, some participants questioned pharmacists' education and qualifications for 
this enhanced role in patient care. Elsewhere, it was reported that only 54% of 
participants believed that pharmacists were good candidates to provide MTM (Law, 
Okamoto et al. 2008). In that study, the more frequently the participant interacted with 
a community pharmacist, the more likely they were to: be aware of MTM; believe that 
pharmacists can help with providing medication information; and believe that they 
would personally benefit from MTM. In previous research, Assa-Eley and Kimberlin 
(2005) explained that role orientation could be positively influenced by pharmacists 
providing a higher level of counseling in the store. They found that patients who 
reported that their usual pharmacist asked if they were having problems, saw 
pharmaceutical care services as more beneficial than patients whose pharmacist did 
not (Assa-Eley and Kimberlin 2005). This is consistent with another study where it was 
shown that participants’ perceptions of the benefit of MTM were higher among the 
patrons of pharmacies where more patient counselling may be expected to be 
provided (such as independent and clinic pharmacies) compared with the patrons of 
grocery and mass-merchandise pharmacies (Doucette, Witry et al. 2007). 
 
Having described how awareness, benefit perceptions and role orientation may 
influence consumers' willingness to use medication management services, the next 
two sections explore the influence of psycho-social factors and other factors 
respectively. 
 
1.4.5.6 Psycho-social factors  
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It is possible that consumers’ beliefs about the harmfulness of their medicines 
influence their willingness to use medication management services. This section 
describes two studies which examined this possibility. Montgomery et al. explored the 
relationship between consumers’ beliefs about medicines and their voluntary use of a 
pharmaceutical care service (Montgomery, Kälvemark Sporrong et al. 2010). Using the 
Beliefs about Medications Questionnaire (Horne, Weinman et al. 1999), they found 
that respondents with the perception of greater need for medicines and greater 
concern about the harmfulness of medicines were more likely to use the service than 
those who did not. This study also explored whether consumers who experienced 
medication-related problems were more likely to use the service.  Compared with 
patients who had not used the service, those who had used the service were more 
likely to have had; difficulties opening containers (40.7% vs 29.0%, P < .01), worries 
about side effects (44.7% vs 30.0%, P < .001), experiences of side effects (52.9% vs 
26.9%, P < .001), worries about drug-drug interactions (27.0% vs 18.6%, P < .05), and 
inadequate treatment effects (16.8% vs 8.7%, P < .05) (Montgomery, Kälvemark 
Sporrong et al. 2010).  This study also showed that those who were interested in 
learning more about their medicines were also more likely to have volunteered to use 
the service (Montgomery, Kälvemark Sporrong et al. 2010).  
 
One study explored the relationship between patients’ beliefs about medicines and 
their perception of obtaining personal benefit from two dimensions of MTM activities: 
patient counseling activities; and setting goals or monitoring follow-up (Doucette, Witry 
et al. 2007). Using the Beliefs about Medications Questionnaire (Horne, Weinman et 
al. 1999) they found that patients with the perception of greater need for medicines 
perceived greater benefit from MTM activities related to setting goals or monitoring 
follow-up. Greater need for medicines was not associated with greater perceptions of 
benefit from patient counselling. Having greater concerns about medicines was not 
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associated with perceptions of benefit from patient counseling activities or other MTM 
activities (Doucette, Witry et al. 2007). 
 
1.4.5.7 Other factors  
 
Three studies explored the possibility that consumers may experience certain barriers 
to using medication management services. In one qualitative study, barriers identified 
were out-of-pocket costs and lack of time for MTM visits (Garcia, Snyder et al. 2009). 
A qualitative study identified that lack of time was a barrier to the use of HMR among 
residents of retirement villages (Lee, George et al. 2012). Residents reported that they 
were already overloaded with various medical appointments. In addition, another 
category of barrier was that residents thought that HMR could potentially compromise 
the relationship with their doctor (Lee, George et al. 2012). 
 
In another study participants were encouraged to list any barriers which would prevent 
them from using MTM (Truong, Layson-Wolf et al. 2009).  Of 81 participants surveyed, 
confidentiality and privacy was mentioned 12 times, and lack of time was listed 7 
times.   
No study was designed to determine whether perceived barriers influenced 
consumers’ willingness to use MTM.  
 
The discrete choice experiment of willingness to pay for MTM (Friedrich, Zgarrick et al. 
2010) was included in this review because it evaluated consumers’ preferences for 
various service elements.  It was shown that the preferred service setting for the 
service was the community pharmacy rather than the consumers’ home, medical clinic 
or telephone. Participants preferred pharmacists who provided MTM service to have 
greater experience and particularly geriatric pharmacy experience. Willingness did not 
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vary according to whether the patient had multiple chronic diseases or was taking 
multiple medicines (Friedrich, Zgarrick et al. 2010). 
 
1.4.6 Discussion of literature 
 
An analysis of the available peer-reviewed literature has been conducted. Studies 
were identified and evaluated which explored consumers’ expectations of and 
willingness to use pharmacist provided medication management services prior to 
service provision. Results indicate that prior to experiencing medication management 
services consumers are largely unaware that pharmacists provide these services.  
Once introduced to the concept, consumers hold cautiously positive views. Overall 
however, there remains considerable doubt as to whether a majority of consumers are 
personally willing to use these services. This was evidenced by a low uptake among 
US veterans who were promoted medication review by post. In the only study where 
consumers were actually asked whether they were personally willing to use a specific 
service (the United States’ MTM program), only a small minority were willing (Law, 
Okamoto et al. 2008). This low willingness was recorded despite the fact many 
participants in the study would have been legitimate candidates for MTM because they 
were taking multiple medicines. In that study, few believed that they needed MTM or 
believed that they would benefit.  
 
At present, it is unknown whether consumers’ awareness of the benefits of HMR would 
drive participation. Nevertheless, since consumers’ awareness  of  (Ensor and Cooper 
2004) and expectations of the benefits of (Boulding, Kalra et al. 1993) drive demand 
generally, it is worthwhile to conduct research into understanding consumers’ 
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perceptions of HMR. The following section summarises what consumers are likely to 
perceive of the benefits of HMR.  
 
1.4.6.1 Summary of benefit perceptions  
 
Overwhelmingly, consumers appear to perceive that the major benefits to themselves 
of receiving specific medication management services or pharmaceutical care in 
general are those benefits related to receiving information about their own medication 
regimen. This finding is evident regardless of whether the studies were qualitative or 
quantitative and regardless of whether the study participants were provided a detailed 
definition of a particular service.  A review of the descriptive statistics of quantitative 
studies reveals that items related to patient counselling are rated higher than items 
related to managing drug therapy and solving therapy problems. This is evident 
whether the target variable is consumer expectations (Volume, Farris et al. 2001; 
Doucette, Witry et al. 2007; Law, Okamoto et al. 2008; Kassam, Collins et al. 2009; 
Kassam, Collins et al. 2010), perceived benefit (Assa-Eley and Kimberlin 2005), 
perceived value (Tootelian, Rolston et al. 2005) or performance evaluation of current 
pharmacy (Larson 2000; Larson, Rovers et al. 2002).  
 
This review demonstrates that consumers may find the technical aspects of medication 
management services relatively intangible. These technical aspects may include 
identifying medication-related problems, identifying the appropriateness of therapies 
and making recommendations to prescribers. Perhaps related to this finding is that 
several studies identify that some consumers question the pharmacist’s role in 
medication management. As a result of these issues, prior to service provision 
consumers appear to formulate a limited breadth and depth of expectations about the 
benefit of using medication management services. Since satisfaction depends on 
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meeting or exceeding expectations, the limited benefit expectations are consistent with 
the high level of satisfaction with pharmacists services generally (Panvelkar, Armour et 
al. 2010). However, these low expectations may limit consumers’ evaluation of 
personal need for medication management services and may moderate willingness to 
use the services.  
 
1.4.6.2 Gaps in the literature  
 
This review identifies some important gaps in the literature. Possibly the most 
important methodological problem facing research in this area is recruitment of the 
relevant consumer.  Research should be directed at obtaining the views of consumers 
(or their informal caregivers) that are eligible to receive a particular medication 
management service but have not yet experienced it. Medication management 
services are often intended to benefit consumers who use multiple medicines and in 
particular those who are at risk of experiencing medication-related problems. Many of 
the studies reviewed have relied on the views of patients who were not taking multiple 
medicines. Furthermore, apart from identifying various disease states, most studies 
which explored consumers’ perceptions in detail have not attempted to identify 
whether participants had risk factors for medication misadventure. The one exception 
to this was that the qualitative study conducted regarding consumers’ views of 
Australia’s HMR did report these and this adds to the value of the manuscript (Lee, 
George et al. 2012). However, that study was not designed to determine whether 
experiencing these risk factors influenced consumers’ views. Therefore, it is not known 
whether experiencing these risk factors may influence willingness to use medication 
management services. Only one study included the views of caregivers and these 
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views were included in the results of other participants.  Overall, many of the studies 
may lack generalisablity to the relevant population. 
 
The generalisablity of some studies may also be limited by selection bias. Many 
studies have used convenience sampling of patients who attend pharmacies, clinics 
and medical practices. It is possible that subjects may be ‘hand-picked’ who are known 
to have favourable attitudes towards pharmacists.  
 
It is clear that a study designed to explore consumer (and caregiver) perceptions of 
and willingness to use HMR should have a process to systematically identify eligible 
participants. This identification process could occur during the recruitment phase or 
during the data screening phase. Ideally, the recruitment of the study sample should 
occur using a number of strategies in order to minimise selection bias and improve 
generalisablity. In this way, the findings obtained using a particular strategy could be 
cross-validated with the findings of another study.  
 
While some studies have attempted to identify consumers’ expectations of receiving 
benefit from medication management services, there is a lack of knowledge as to 
whether these expectations actually influence willingness. Other than cost, which is 
not relevant to Australia’s HMR program as there is no direct cost to consumers, there 
remains a relative deficiency of investigation of barriers towards participation. The 
main barrier cited is a lack of perceived personal benefit but other barriers such as lack 
of trust in the pharmacist and lack of time may exist.  One study suggests that 
consumers may not use Australia’s HMR program because they were unsure of what 
the GP would think of the service (Lee, George et al. 2012). No study has been 
designed to determine whether barriers influenced willingness to use medication 
management services.   
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The review highlights a relative absence of studies which use a theoretical framework 
to investigate the psycho-social factors affecting willingness to use the services. Only 
two such studies were identified (Doucette, Witry et al. 2007; Montgomery, Kälvemark 
Sporrong et al. 2010). Those studies, using constructs derived from self-regulation 
theory (Horne and Weinman 1999), showed that consumers’ beliefs about medicines 
influenced either their perceptions of the value of MTM (Doucette, Witry et al. 2007) or 
whether they had already volunteered to use a pharmaceutical care service 
(Montgomery, Kälvemark Sporrong et al. 2010). One study showed that patients who 
had recently visited their doctor about an adverse drug event were more likely to value 
MTM (Doucette, Witry et al. 2007). Another showed that those who experienced or 
were worried about experiencing medication-related problems were more likely to have 
volunteered to use the service (Montgomery, Kälvemark Sporrong et al. 2010). 
Furthermore, those who were interested in learning more about their medicines were 
also more likely to have volunteered to use the service (Montgomery, Kälvemark 
Sporrong et al. 2010). 
 
These finding suggest that consumers’ perceptions of themselves being at risk (of 
experiencing medication-related problems) may increase their willingness to use a 
medication management service. This is an important issue because as explained 
earlier, eligibility for the program is premised on being at risk of experiencing 
medication-related problems.  
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1.4.7 Conclusion of the literature review  
 
 
This literature review identified and evaluated studies which specifically explored 
consumers’ and informal caregivers’ expectations of and willingness to use 
pharmacist-provided medication management services prior to service provision.  In 
order to further explore the factors which may influence such willingness, two 
important issues were identified. First, research methods are needed to systematically 
identify those consumers who would be eligible or their informal caregivers. Second, 
there is a need to develop a theoretical framework which links a consumer’s thoughts 
and feelings about the experiencing medication-related problems and their willingness 
to use Home Medicines Reviews. Therefore, the next section of this chapter sets out a 
theoretical framework which was developed to study some of the psycho-social factors 
affecting consumers’ willingness to use the services and informal caregivers’ 
willingness to assist their care-recipient to use HMR.   
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1.5 Theoretical framework  
 
This section sets out the theoretical framework which was used to study the psycho-
social factors affecting consumers’ willingness to use HMR and informal caregivers’ 
willingness to assist their care-recipient to use HMR. 
1.5.1 Home Medicines Review as an information source  
 
Demand for health services is influenced by expectations about the benefit to be 
derived (Boulding, Kalra et al. 1993; Catrine, Ekman et al. 2008). Therefore, 
willingness to use Home Medicines Reviews is likely to be influenced by expectations 
about the benefit that would be derived by participating. Given that past experience is 
a key determinant of a person’s expectations about a service (Zeithaml, Berry et al. 
1993), eligible non-recipients expectations about medication management services 
would likely reflect their past experience of pharmacists acting in more familiar roles. 
The literature review presented in this chapter suggests that consumers’ most salient 
expectations of medication management services are those centred in receiving 
medication advice. Such expectations are probably derived whilst consumers are 
having their medicines dispensed. Consumers expect pharmacists to provide 
medication advice, although the lack of privacy in community pharmacy setting is 
considered to limit patient demand for such advice (Anderson, Blenkinsopp et al. 
2004).  It is well known that consumers prefer to learn about their medicines from 
interpersonal sources, such as medical practitioners and pharmacists (Raynor, 
Blenkinsopp et al. 2007). Written information is viewed as a supplement, rather than a 
replacement for contact with health professionals (Raynor, Blenkinsopp et al. 2007). It 
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is reported that 36% of consumers found written information difficult to read (Svarstad, 
Mount et al. 2005). 
The literature review suggests that consumers formulate relatively higher levels of 
expectations of those aspects of medication management service which relate to 
information-seeking rather than those aspects related to other technical qualities 
(Section 1.4.5.4, page 29).  The technical qualities include managing drug therapy, 
solving therapy problems and making recommendations to prescribers. Since 
consumers have low expectations of the technical benefit of medication management 
services, it is questionable whether receiving these benefits would drive participation. 
Whereas, the desire to search for health information is a basic step in the process of 
choosing and participating in medical services (Lenz 1984). The theoretical foundation 
of this thesis is therefore centred on the proposition that eligible non-recipients’ 
willingness to use medication management services is driven by their expectation that 
these services would provide medication information tailored to their individual needs.  
1.5.2 Theories of health information seeking behaviour.  
 
This section introduces several models of information-seeking behaviour from within 
the health psychology and health communication literature. Lambert and Loiselle 
(2007) suggest that in the context of health, information-seeking is often framed as a 
coping strategy which attempts to reduce the cognitive stress and emotional arousal 
arising from health-related uncertainty. Each of the following models theorise that 
thoughts and feelings about experiencing health problems have a central role in 
stimulating a person to seek health-related information. These theoretical models are: 
the Comprehensive Model of cancer-related Information Seeking (CMIS) (Johnson and 
Meischke 1993); the Theory of Motivated Information Management (TMIM) (Afifi and 
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Weiner 2004); the Risk Information Seeking and Processing (RISP) model (Griffin, 
Dunwoody et al. 1999); and the Planned Risk Information Seeking Model (PRISM) 
(Kahlor 2010). These models are different to the Health Belief Model (HBM) which is 
purely a cognitive model (Becker 1974; Rosenstock 1974). In the Health Belief Model, 
emotional arousal does not have a role. 
At their core, these models share similarities in that they draw relationships between 
experiencing cognitive stress and emotional arousal about a health-related topic and 
the act of seeking information about the topic. Within each model, there is an 
interpretation phase in which cognitive stress and emotional arousal occurs. There is 
an evaluation phase, in which a person considers the outcomes and processes 
involved in information seeking. These phases are followed by intention which is in-
turn followed by action (see  Figure 1, page 45).  
 
  Figure 1 Phases in the information-seeking process 
 
However, these models differ markedly in the interpretation phase. In this phase, the 
cognitive stress and emotional arousal which drive the process are conceived 
differently. In Comprehensive Model of cancer-related Information Seeking, 
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experiencing particularly salient beliefs about personal risk are instrumental. In the 
Theory of Motivated Information Management, experiencing unwanted uncertainty 
which induces anxiety is the driver. In the Risk Information Seeking and Processing 
model and Planned Risk Information Seeking Model, risk perception and worry cause 
a person to focus on how much information is actually needed, which can act to drive 
information seeking intent.  
The models are also different in that the conceptual framework which links the 
interpretation phase with the evaluation and/or intention phases is unique to each 
model. For example: the Comprehensive Model of cancer-related Information Seeking 
model has expectancy-value elements which underpin the Heath Belief Model 
(Rosenstock 1974); the Theory of Motivated Information Management uses a 
framework adapted from both Bandura’s (1997) Social Cognitive Theory  and Maddux 
and Rogers’ (1983) Protection Motivation Theory (PMT) while the Risk Information 
Seeking and Processing model and the Planned Risk Information Seeking Model use 
the Theory of Planned Behavior framework (Ajzen 1991).                                     
1.5.3 The conceptual model  
 
Prior to conducting this research, no theoretical framework existed for studying 
consumers' willingness to use HMR. In particular no framework existed which linked a 
consumer's thoughts and feelings about experiencing medication-related problems, 
their expectations of HMR, the social influences to participate in HMR, and their 
willingness to use the service. Therefore for the purpose of this research, a conceptual 
model was developed which synthesises various elements from each of the theories 
mentioned in section 1.5.2 (page 44).  
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The broad conceptual model is presented in Figure 2. The framework for the model 
sets out four phases in the decision-making process regarding consumers’ willingness 
to use HMR: 1) an interpretation phase, where individuals’ thoughts and feelings about 
medication-related problems are influential; 2) an evaluation phase, where individuals’ 
expectations about the outcomes and processes of HMR are influential; 3) an intention 
phase, where an individual decides whether they are willing to use HMR; and 4) an 
action phase where an individual uses HMR. 
 
Figure 2 The conceptual model 
The next part of the Background section describes how the relationships between the 
interpretation, evaluation and intention phases were explored. In terms of how the 
research was conducted, qualitative research was initially conducted, followed by the 
quantitative research.  
1.5.4 Intention phase  
 
Outside the 
scope of the 
thesis  
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The first step taken in developing the conceptual model was to define the construct for 
the intention phase. Most of the research conducted with social cognitive theory places 
behavioural intention as the antecedent variable to actual behaviour. In general terms 
therefore, the conceptual model includes variables related to intention. However, 
Gibbons and colleagues (2009) argue that willingness to perform a behaviour, that is 
intention conditioned on certain premises, may explain more variation in actual 
behaviour than intention alone. Willingness may capture irrational and reactive 
influences (Gibbons, Houlihan et al. 2009). Based on qualitative research (White, 
Carter et al. 2011) it was hypothesised that respondents may be willing to use HMR if 
the GP suggested it to them and/or if they were concerned about their medicines.  
Therefore, within the present model, Willingness (W), that is intention conditioned on 
these 2 premises formed the dependent variable. In the case of caregivers, willingness 
refers to the willingness of an informal caregiver to arrange an HMR for their care-
recipient. 
1.5.5 Evaluation phase  
 
The next step of model development included defining the evaluation phase. Two of 
the three broad categories of constructs for the evaluation phase are most closely 
aligned with that of the Theory of Motivated Information (Figure 3, page 49)  (Afifi and 
Weiner 2004). The Theory of Motivated Information Management is specifically 
designed to explain a person’s motivation to seek information from an interpersonal 
source. Therefore a majority of the conceptual model is based on this theory with 
some notable exceptions.   
As in the Theory of Motivated Information Management, the conceptual model 
suggests that outcome expectancy and communication efficacy have direct effects on 
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Willingness (W). The following two sub-sections provide descriptions of the outcome 
expectancy and communication efficacy constructs and how they relate to willingness, 
respectively.  At this stage, the Theory of Motivated Information Management has not 
fully explored how social normative influence may affect information seeking.  
Therefore, the conceptual model differs from that theory and a separate sub-section is 
provided in section 1.5.5.3 (page 51). This section describes the hypothesised 
relationship between Willingness (W) and the social normative influence of the 
consumer’s GP.  The conceptual model differs from the Theory of Motivated 
Information Management in the interpretation phase and the key differences are 
described in section 1.5.6 (page 52). 
 
Figure 3 The theory of motivated information management. Adapted from (Afifi 
and Weiner 2004) 
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1.5.5.1 Outcome expectancy  
 
The first category of beliefs deals with an individual’s focus on outcomes expectancies. 
These may be further divided into positive expectancies and negative expectancies. 
This evaluation broadly follows a benefit versus cost trade-off. In identifying potential 
positive outcome expectancies for HMR, consistent with TMIM (Afifi and Weiner 2004) 
the  literature suggests that patients expect to receive medication information which 
would assist medicines management, and that they would feel reassured by receiving 
this information (Tinelli, Bond et al. 2007; Bissell, Blenkinsopp et al. 2008; Latif, 
Pollock et al. 2010). It is therefore hypothesised that positive outcome expectancies, 
centred on these observations, would have a direct and positive effect on willingness 
to use HMR. 
Consistent with TMIM, willingness to use HMR would depend on the patient 
overcoming negative process-based outcome expectancies. The HMR service is free 
to the patient therefore, any potential costs (to patients) are non-financial.  A 
qualitative study in the UK concluded that patients who were unwilling and had 
declined to use medication management “hid” complex reasons for declining to 
participate (Latif, Pollock et al. 2010). It is unclear at the present, what these negative 
feelings represent and whether they would impact on willingness to use. Within the 
HMR model, the patient interview is performed by a pharmacist whom the patient may 
or may not know. Patients have the option of having the interview in their home. 
However studies conducted by the present study group (White, Carter et al. 2011; 
Carter, Chen et al. 2012) and another’s (Campbell Research and Consulting 2008) 
indicate that some patients express negativity, such as feeling a loss of privacy and 
independence. Therefore, it is hypothesised that process-based negative outcome 
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expectancies, related to the potential discomfort of being visited at home, would have 
a direct and negative effect on willingness to use HMR. 
1.5.5.2 Communication efficacy 
 
The second broad category of beliefs is assessments about an individual’s ability to 
perform the information seeking action, self-efficacy  (Bandura 1997). In the present 
context, self-efficacy evaluations most closely follow those of TMIM’s construct known 
as communication efficacy (Afifi and Weiner 2004). These evaluations centre on a 
patient’s perception of their ability to overcome potential barriers in the communication 
process such as: making time for; organising; and if required, asking the patient’s 
doctor for the HMR.  In a qualitative study it was mentioned that some individuals 
appeared to lack the capability or confidence to address these potential barriers 
(White, Carter et al. 2011). It was apparent that some patients expressed difficulty 
asking the doctor for an HMR, if they thought the doctor would interpret the request as 
an indication that they lacked confidence in the doctor  (White, Carter et al. 2011). 
Therefore, it is hypothesised that communication efficacy would have a direct and 
positive effect on willingness.  
Having dealt with outcome expectancies and communication efficacy, the following 
sub-section explores how social pressure may influence willingness.   
1.5.5.3 Subjective norms of the GP 
 
In a qualitative study it was found that some participants who thought HMR would be 
beneficial were not willing to use a pharmacist-provided service because they could 
not be sure that their general practitioner (GP) approved of the service (White, Carter 
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et al. 2011).  Within social cognitive theory, social persuasion is a recognised 
antecedent to both outcome expectancy and self-efficacy (Bandura 1997).  Subjective 
norms, derived from the Theory of Planned Behavior (Ajzen 1991) is a related 
construct.  Within the context of information-seeking, subjective norms operate such 
that if the subject thinks that someone close to themselves, such as a family member, 
friend or carer, would approve of the utilisation of the information resource; and if the 
subject has motivation to comply with the wishes of the close person then the subject 
is more likely to seek information (Griffin, Dunwoody et al. 1999). Subjective norms 
have been integrated into the Risk Information Seeking and Processing model (Griffin, 
Dunwoody et al. 1999) and the Planned Risk Information Seeking Model (Kahlor 2010) 
and they have been shown to be one of the strongest predictors of health information-
seeking intent (Kahlor 2010). Given the strong relationship between a consumer and 
their GP, subjective norms of the GP could have a potentially powerful and direct 
influence over medication behaviours. For example, subjective norms of the GP has 
increased the likelihood of patient persistence with antidepressant medicines (Van 
Geffen, Heerdink et al. 2010).  In the context of the current study therefore, subjective 
norms of the GP was defined as the perceived social pressure (of the consumer’s GP), 
to use HMR. It was hypothesised that subjective norms of the GP would have a direct 
and indirect positive effect on willingness.  
Having dealt with the evaluation phase of the decision process, the following section 
explores constructs within the interpretation phase of the conceptual model.  
1.5.6 Interpretation phase  
 
In the framework selected for this thesis, the interpretation phase includes process in-
which a subject becomes aware of the need to seek-information. Consistent with the 
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Comprehensive Model of cancer-related Information Seeking, the Theory of Motivated 
Information Management, Risk Information Seeking and Processing model, and 
Planned Risk Information Seeking Model, the conceptual model draws relationships 
between cognitive stress and emotional arousal about a health-related topic and the 
act of seeking information about the topic. The conceptual model proposes that 
thoughts and feelings about experiencing medication-related problems form the broad 
category of cognitive and emotional drivers for information seeking by using HMR 
(Figure 2, page 47).  
In Chapter Four of this thesis, a qualitative study based on the conceptual model is 
presented. That study investigated the cognitive and emotional processes surrounding 
consumer’s medication information seeking behaviour. Using the Theory of Motivated 
Information Management as a framework for analysis, Chapter Four explores 
consumers’ uncertainties and worries about the health problems resulting from taking 
medicines and their motivations to seek information about medicines from a variety of 
sources including HMR.  
In the Theory of Motivated Information Management, the motivating force for 
information-seeking about a topic is unwanted uncertainty about the topic and the 
ensuing anxiety. It is considered that the act of information-seeking assists a person to 
manage their anxiety. Thoughts about unwanted uncertainty occur first, but it is the 
negative affect - anxiety, which is the proximal antecedent variable to the evaluation 
phase.  This conceptualisation is similar to that of the Risk Information Seeking and 
Processing model and the Planned Risk Information Seeking Model, in that cognition 
occurs first, followed by worry.  
At the time the quantitative study was conducted (2008-2009), Theory of Motivated 
Information Management was a very new theory. It had been applied in predicting 
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health behaviours in few studies (Afifi and Weiner 2006).  Furthermore, the unwanted 
uncertainty is defined as uncertainty discrepancy. In order to probe unwanted 
uncertainty in a survey, rather complicated questions are needed. For example, in 
terms of the current context, uncertainty discrepancy could be measured by asking 
“How much information do you have about the problems which could arise from taking 
your medicines? ’’ [1 = more than I want to 7 = less than I want]. The ensuing anxiety 
could be measured with “The size of the similarity/difference between how much I 
know and how much I’d like to know about the problems which could arise from taking 
your medicines is 1 = extremely comforting through to 7 = anxiety-producing’’. It was 
felt that many of the elderly participants would have less difficulty with framing 
thoughts and feelings about medicine-problems in terms of risk and worry. Therefore in 
this thesis, the primary motivating force for consumers’ information seeking is more 
similar to Risk Information Seeking and Processing model and the Planned Risk 
Information Seeking Model.  It was proposed that risk perception induces worry which 
acts to motivate information seeking. In the present context, risk perception was 
defined as a person’s perception of the likelihood of them experiencing problems as a 
result of taking their medicines. Worry was defined as the specific (and mild) anxiety 
state which arises in tandem with this risk perception. 
1.5.6.1 Medication-problem worry (MPW)  
 
For many consumers who use multiple medicines, the possibility of experiencing 
health problems as a result of taking their medicines can be worrisome. Elderly 
consumers who use multiple medicines have many concerns especially about side 
effects and their management (Gordon, Smith et al. 2007). In that study, consumers 
reported that they lacked information or understanding about their medicines and 
having problems with access to support services.  
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In this thesis, medication-problem worry was identified as the frequency with which a 
person worries about the health problems resulting from taking medicines. It was 
measured with a single 5-point semantic differential scale with available responses 
ranging from 1= “never” to 5= “always”. 
Similar to the Theory of Motivated Information Management, the conceptual model 
suggests that experiencing emotional arousal (negative affect) about a topic causes a 
person to focus on their expectations of outcomes to be derived from information 
seeking and the communication tasks processes involved. That is, it is assumed that 
negative affect influences a person’s evaluations about the information source. This 
model differs from that of Risk Information Seeking and Processing model and the 
Planned Risk Information Seeking Model in that those models assume that negative 
affect does not influence evaluations (or attitudes) about the information source. In 
Risk Information Seeking and Processing model and the Planned Risk Information 
Seeking Model, negative affect influences intention to seek information independently. 
It is hypothesised that worry increases consumers’ positive outcome expectancy. The 
net effect of worry on willingness is unknown, since it is possible that heightened levels 
could diminish a person’s capacity to undertake the communication tasks necessary to 
participate in an HMR.  In short, negative affect could reduce communication efficacy.  
1.5.6.2 Medication risk factors  
 
The Risk Information Seeking and Processing model (Griffin, Dunwoody et al. 1999) 
and the Planned Risk Information Seeking Model (Kahlor 2010) place various 
demographic and situational factors as antecedents to risk perception and worry. 
Chapter Five focussed on the potential impact of three different situations facing a 
multiple medicine user which could induce risk perception and medication-problem 
 
56 
CHAPTER ONE - BACKGROUND 
worry: a) whilst a person adjusts to changes to the medication regimen. During this 
time the person undergoes a period of “self-monitoring” to detect any physiological 
response to the change. Prescribers, pharmacists and nurses often encourage such 
self-monitoring in order to avoid preventable adverse effects; b) whilst a person adjusts 
to changes in their overall health after hospitalisation; and c) when a person is 
required to implement the instructions of multiple regular prescribers, which could at 
times be conflicting (Carpenter, DeVellis et al. 2010). Each of the situations mentioned 
above: a) having a change in the regimen within the past three months, b) having been 
hospitalised within the past month, and c) having multiple regular prescribers, place an 
individual at increased risk of experiencing medication-related problems (Pit, Byles et 
al. 2007; Pit, Byles et al. 2008). These risk factors may also be used to identify 
consumers who may benefit from HMR (Australian Government Department of Human 
Services 2011) and it was hypothesised that these risk factors would increase 
medication-problem worry. 
1.5.6.3 Knowledge hassles  
 
It was an intention of the thesis to explore the willingness of an informal caregiver (of a 
person who uses multiple medicines) to use HMR for their care-recipient. In section 
1.5.6.1 (Page 54), the relationship between a form of negative affect (medication-
problem worry) and willingness to use HMR was explored. The present section 
explores the possibility that informal caregivers experience another form of negative 
affect which increases their positive outcomes expectancy of using HMR.  It is known 
that caregivers experience daily hassles as a result of performing tasks related to 
managing their care-recipients’ medicines (Travis, Bethea et al. 2000; Travis, Bernard 
et al. 2003).  
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Daily hassles are the “irritating, frustrating, distressing demands that to some degree 
characterise everyday transactions with the environment” (DeLongis, Coyne et al. 
1982). Experiencing hassles can represent an on-going and insidious threat to health. 
For example, the frequency and severity of daily hassles is a better predictor of 
psychological distress and somatic disease than major life events such as death in a 
relative, marital changes and serious financial problems (DeLongis, Coyne et al. 
1982). Past research has shown that experiencing daily hassles with friends, family, 
environment, and life’s practicalities, is associated with negative affect (Russell and 
Davey 1993). Furthermore, experiencing daily hassles is associated with the tendency 
to interpret events as threatening and with the tendency to seek out threat-relevant 
information (known as “monitoring”) (Russell and Davey 1993).  It is proposed that 
when the caregiver experiences daily hassles, specifically related to knowledge 
processing, they are motivated to consider outcome expectancy of information-seeking 
and expectations about their capacity to undertake the communication tasks involved. 
Experiencing knowledge hassles could increase informal caregivers’ positive outcome 
expectancy. The net effect of knowledge hassles on willingness was however 
unknown, since it was possible that heightened levels of knowledge hassles and other 
hassles could diminish a person’s capacity to undertake the communication tasks 
necessary to participate in an HMR.  In short, negative affect could reduce 
communication efficacy. 
In Section 1.5.6.2, it was hypothesised that medication risk factors would increase 
consumers’ medication-related worry which would in-turn increase their positive 
outcome expectancy. Since there is a similarity between worry and stress, it was 
hypothesised that the same risk factors would increase the need for caregivers to 
process specialised medication information thereby increasing knowledge hassles; a) 
having a change in the regimen within the past three months, b) having been 
hospitalised within the last month, and c) having multiple regular prescribers.  
 
58 
CHAPTER ONE - BACKGROUND 
1.6 Aims and objectives of the thesis 
 
The overall aim of this thesis was to determine the factors which influence consumers’ 
willingness to use HMR and caregivers’ willingness to assist their care-recipient to use 
HMR, prior to service provision.  
The specific objectives of the research were: 
I. To compare the perceptions of patients who have experienced 
HMR with those who have not yet experienced it. Further, the 
study aimed to determine the effect of having experienced HMR 
on patients’ willingness to use HMR and the effect of having prior 
awareness on their willingness to use HMR (Chapter Two). 
II. To test the capacity for the conceptual model to predict the 
willingness of eligible non-recipient patients to use HMR. 
Specifically, this study aimed to determine the influence of 
patients’ positive and negative outcome expectancies and 
communication efficacy over their willingness to use HMR 
(Chapter Three). 
III. To investigate psychosocial factors which may motivate patients 
who are at risk of experiencing medication-related problems to 
use HMR (Chapter Four). 
IV. To test the capacity for the conceptual model to predict the 
willingness of eligible non-recipient consumers to use HMR.  
Specifically, this study aimed to determine the effects of 
consumers’ medication-related worry and the social influence of 
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the consumer’s general practitioner over their willingness to use 
HMR (Chapter Five). 
V. To test the capacity for the conceptual model to predict the 
willingness of informal caregivers to assist their care-recipient to 
use HMR.  Specifically, this study aimed to determine the effects 
of caregivers’ knowledge hassles - daily stressors experienced 
whilst dealing with tasks which require knowledge about the 
safety and effectiveness of the care-recipients’ medicines over 
their willingness to assist their care-recipient to use HMR 
(Chapter Six).  
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1.7 Thesis overview 
 
The thesis is presented in three main parts; Part A - Background, Part B – Qualitative 
and quantitative studies, and Part C – Discussion and Conclusion. 
Part B  
Part B of this thesis (Chapters Two to Six) reports the research which used qualitative 
and quantitative studies.  
In Chapter Two, a quantitative study is presented which compared the perceptions of 
recipients of HMR with those of eligible non-recipients. Among eligible non-recipients, 
the effect of having prior awareness on their willingness to use HMR was investigated. 
A background is provided which briefly sets out what was known about the perceptions 
of consumers towards HMR. The methods section describes how recipients and non-
recipients of HMR were recruited by community pharmacists. There is a description of 
the development of the survey and how it was pilot-tested. The results of the survey 
are presented using descriptive statistics and chi-square tests.  In this study there 
were 595 recipients of HMR (31% response rate) and 293 eligible non-recipients (16% 
response rate). The results are discussed and compared with published literature. 
While the influence of having prior awareness of HMR on eligible non-recipients’ 
willingness to use HMR was discussed, the study recommended that future research 
should investigate the influence of other factors.  
Chapter Three reports a quantitative study which explored the factors influencing 
consumers’ willingness to use HMR. In terms of how this study relates to the 
conceptual model, Chapter Three examined the evaluation phase and the intention 
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phase of the decision-making process (Figure 2, page 47). The background to this 
chapter provides a detailed presentation of the theoretical framework for the 
investigation. Using constructs adapted from Social Cognitive Theory (Bandura 1997) 
and the Theory of Motivated Information Management  (Afifi and Weiner 2004), the 
study aimed to determine the influence of patients’ positive and negative outcome 
expectancies and communication efficacy over their willingness to use HMR.  
The study sample was a subset of eligible non-recipients from Chapter Two who were 
using multiple medicines (n=286). Exploratory and confirmatory factor analysis was 
used to develop measurement scales. Structural equation modelling was used to test 
hypotheses.  The results are discussed in terms of assisting health practitioners to 
present the benefits of HMR to consumers and in terms of optimising the content of 
consumer-directed promotional material. The study acknowledged that the findings 
may lack generalisablity because of selection bias and recommended that study be 
repeating using a sample of consumers who were not recruited by community 
pharmacists.  
Chapter Four reports a study which used qualitative methods to investigate the 
psychosocial factors which may motivate consumers who are at risk of experiencing 
medication-related problems to use HMR. Chapter Four builds on the study reported in 
Chapter Three by examining the interpretation phase of the conceptual model (Figure 
2, page 47). The methods section describes the recruitment of the study sample, the 
development of the interview guide and how the focus groups were conducted. 
Thematic analysis was used to analyse the data obtained from 14 focus groups 
comprising 88 participants. The discussion of the results centred on consumers’ 
perceptions of being at risk of experiencing medication-related problems, their worry 
about these problems and how these factors influenced their willingness to use HMR.  
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Chapter Five reports a quantitative study of the willingness of eligible non-recipient 
consumers to use HMR.  Chapter Five builds on previous chapters by undertaking a 
quantitative examination of the effect of variables in the interpretation phase and 
another variable from the interpretation phase. Specifically, this study aimed to 
determine the effects of consumers’ medication-related worry and the social influence 
of the consumer’s general practitioner over their willingness to use HMR. The study 
sample was obtained by postal invitation to members of a community organisation, 
Council on the Ageing (COTA NSW). Structural equation modelling was used to test 
the model. The discussion focussed on the relationship between consumers’ worry 
about medication-related problems and their motivation to use HMR. In addition, the 
importance of understanding what consumers believe their GP thinks about HMR was 
discussed.   
Chapter Six extends the research of the previous chapters by reporting a quantitative 
study of the willingness of informal caregivers to assist their care-recipient to use 
HMR. This research was considered important because many older persons and those 
with disabilities rely on informal caregivers to participate in health services. The 
background to this chapter provides a detailed description of how the conceptual 
model was applied to this situation. The study sample was obtained by postal invitation 
to members of a community organisation, Carers NSW. Exploratory and confirmatory 
factor analysis was used to develop measurement scales. Structural equation 
modelling was used to test hypotheses. The discussion highlighted the important role 
of informal caregivers in providing medication management services to vulnerable 
persons.  
 
 
 
63 
 CHAPTER ONE - BACKGROUND 
 
Part C   
Part C of this thesis includes a general discussion of all the studies conducted with 
conclusions and directions for future research in this field.  
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Abstract
Objective There is a lack of knowledge regarding recipients’ experiences with,
perceptions of, and willingness to reuse the Home Medicines Review (HMR) pro-
gramme in Australia. In addition, little is known about eligible non-recipients’
awareness of and willingness to use the HMR service. The aim of the study was there-
fore to explore perceptions of, and willingness to use, HMRs.
Methods A cross-sectional questionnaire was conducted with recipients and
eligible non-recipients of HMRs. Eligible non-recipients were defined as those who
had not had an HMR and were at risk of medication misadventure. The question-
naire was distributed by 264 practising pharmacists throughout Australia.
Results A total of 595 out of 1893 (31%) HMR recipients and 293 out of 1829
(16%) eligible non-recipients completed the questionnaires. Overall, 91% of recipi-
ents were satisfied with the service. Compared with eligible non-recipients, recipi-
ents were more willing to have an HMR if their general practitioner (GP) suggested it
(91% versus 71%,P < 0.001) and more willing to ask for an HMR if they were having
concerns about their medicines (82% versus 63%, P < 0.001). Among eligible non-
recipients, 23% were aware of HMRs. Predominantly pharmacists (68%) and GPs
(36%) provided awareness of HMRs, which was associated with increased willing-
ness to have an HMR if their GP suggested it (83% versus 67%, P < 0.014).
Conclusions An overwhelming majority of patients were satisfied with the HMR
programme. Experience with HMR, and to a lesser extent, prior awareness, increased
willingness to use HMR. Therefore, pharmacists and GPs who introduce HMR to
eligible non-recipients may increase their willingness to use this service.
Introduction
Throughout Europe,[1,2] North America[3] and Australia[4] the
population is ageing and the burden of chronic disease and
co-morbidity is growing. Multiple medicines are often used
to manage common chronic diseases,[5] resulting in complex
medication regimens.[6] Adverse events related to the con-
sumption of medicines are a leading cause of morbidity in the
Australian community.[7] These adverse events result in over
190 000 hospital admissions each year, approximately half of
which are preventable.[8] Pharmacist-provided medication
management services including medication review have been
shown to be effective in reducing preventable medication-
related problems.[9–14] Little is known about patients’ per-
ceptions of these services or their willingness to use them.
However, theory suggests that expectations created through
awareness and/or prior experience influence willingness to
use services.[15]
Various models of outpatient services provided by phar-
macists exist internationally, for example: the USA’s Medica-
tion Therapy Management (MTM) programme,[16] the UK’s
medicines management services,[17] New Zealand’s Compre-
hensive Pharmaceutical Care (CPC),[18] and Australia’s Home
Medicines Review (HMR) service.[19] Each of these service
models varies in procedural aspects but typically they include
an interview between the patient and the pharmacist about
the patient’s medicines. The pharmacist reviews the appro-
priateness of treatment, including pharmacotherapeutic and
lifestyle factors and provides advice to the patient. The phar-
macist then writes a report to the general practitioner (GP)
with suggestions for improving medicines management.
The Australian model of HMR is a collaborative
process involving the patient, their GP and pharmacist. It
is a Commonwealth-funded service which comprises the
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following steps: (1) GP referral of a patient to the patient’s
preferred community pharmacy based on standard criteria,
e.g. the patient taking five or more medicines or a medicine
with a narrow therapeutic index; (2) the pharmacist conducts
an interview (usually) in the patient’s home to ascertain
a comprehensive medication profile; (3) the pharmacist’s
written report documenting HMR findings and recommen-
dations is sent to the GP; and (4) the GP and patient agree on
a medication management plan based on the HMR report.[19]
Thus, HMR aims to be a collaborative process, although some
argue that aspects of the communication processes between
health professionals could be improved.[20]
Internationally, lack of awareness of pharmacist-provided
medication management services is recognised as a signifi-
cant patient barrier to participation.[21] Qualitative studies
show that overall, patients are unaware of HMRs.[22,23] Fur-
thermore, there are anecdotal reports where patient’s refusal
to have an HMR was attributed to a lack of awareness.[22,24] To
date, no large scale quantitative studies designed to investi-
gate the overall awareness of HMRs have been published. Spe-
cifically, none have investigated whether patients’ willingness
to use HMRs is influenced by their lack of awareness.
Theory suggests that patient’s willingness to use health
services is driven by their expectations of receiving personal
benefit.[25,26] With regard to medication management services,
recipients have reported several benefits derived from parti-
cipating in the extended patient interview. These benefits
include: increased general medicines knowledge,[23,27,28]
improved understanding of the purpose and need for the
medicines,[23,27,28] and reassurance about medication con-
cerns.[23,27,29,30] Yet one unresolved issue is whether recipients
believe that HMR improves their ability to manage their
complex medicine regimens confidently.[23]
There is a lack of data concerning the range of benefits
that eligible non-recipients would expect to receive if they
had an HMR. A quantitative study of consumer attitudes
towards MTM activities in the USA suggests that eligible non-
recipients who were informed of the service held positive
attitudes toward receiving information during the patient
interview.[31] However, an Australian qualitative study
reported that eligible non-recipients of HMRs did not gener-
ally expect to receive any additional medicines information
than had already been provided by their GPs and/or commu-
nity pharmacists.[23]
Within the HMR model, the patient interview is per-
formed by a pharmacist whom the patient may or may not
know. Patients have the option of having the interview in
their home; however, some patients express negativity, such
as feeling a loss of privacy and independence.[23] Despite these
barriers, the GP/patient relationship is important. Patients’
willingness to have an HMR if it was suggested by the GP may
be facilitated by the social pressure to comply with the GP’s
wishes. Such social influence has, for example, been shown
to increase the likelihood of patient persistence with antide-
pressant medicines.[32]
Theoretically, the HMR process could be initiated in two
ways: the GP suggests it, or the patient asks for it. However,
patients may be inhibited from asking for an HMR due to
behavioural controls. Patients have difficulty in seeking
medicines information from GPs.[33] Overall, there is a lack of
quantitative data from which to draw robust conclusions
regarding patient perceptions of HMRs.
The aim of the study was therefore to explore patient
perceptions of HMRs. The objectives of the study were to:
(1) report on key elements of the HMR service experience
including patient satisfaction; (2) examine and compare the
perceived benefits reported by recipients with the expected
benefits of eligible non-recipients; (3) examine recipients’
barriers, facilitators and willingness to use HMRs and
compare these with those of eligible non-recipients; and
(4) explore eligible non-recipients’ awareness of HMRs and
determine its effect on their willingness to use the service.
Methods
Approval for the project was given by The University of
Sydney Human Ethics Committee, Australia.
Questionnaires
Two purpose-designed questionnaires were developed to
meet the specific objectives of this study, one for recipients
of HMRs and the other for eligible non-recipients. The first
and final sections of both questionnaires included questions
on patients’ characteristics including demographics. In the
first section there were six questions regarding the presence
of risk factors for medication misadventure which had a
response format of yes, no or not sure. Also included was the
Medication Adherence Report Scale (MARS).[34–36] Within
the first section of the questionnaire for recipients, there
were three questions about HMR service provision; how
long ago they had their HMR interview, who first suggested
the HMR, and how many HMRs they had participated in.
In the first section of the questionnaire for eligible non-
recipients, respondents were asked about their awareness of
‘Home Medicines Reviews or HMR’ with a response format
of yes/no/not sure. Those who answered yes were provided
with four options regarding the source of awareness. These
respondents were also asked ‘How do you recall the Home
Medicines Review being mentioned?’ with a response format
being a five-point scale ranging from very negative to very
positive.
The second sections of the questionnaires contained
attitudinal items concerning HMR. Respondents in both
questionnaires were asked to record their level of agreement
with each statement on a five-point Likert scale, with
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responses ranging from strongly disagree to strongly agree.
For eligible non-recipients, a short explanation of the HMR
service[37] was included (Box 1). Respondents were asked two
questions regarding their willingness to use (or reuse in the
case of recipients) HMRs. The first question probed whether
respondents would agree to have an HMR (or another HMR)
if their GP suggested it. The second question probed whether
they would ask their GP for an HMR (or another HMR) if
they had concerns about their medicines. Recipients were also
asked about their overall satisfaction and whether they would
recommend the service to others. Both recipients and eligible
non-recipients were asked about potential benefits, barriers
and facilitators to participation (or re-participation). Items
were formulated from a review of the literature and the results
of focus groups.[38]
In the questionnaire for recipients, the wording of state-
ments regarding benefits of HMRs were formulated on the
basis of service performance evaluation.[39] For example:
As a result of the Home Medicines Review, managing my
medicines is easier. In the questionnaire for eligible non-
recipients, the wording used predictive expectations.[40] For
example: ‘If I had an HMR, managing my medicines would
be easier.’
The questionnaires were tested for face validity by a panel
of seven expert community pharmacists, consultant pharma-
cists and academic pharmacists. They were pretested with
10 HMR recipients and 15 eligible non-recipients, which
resulted in the rewording of some questions and reducing the
number of variables. In the final questionnaire there were 33
attitudinal items for recipients and 28 for non-recipients.
This paper reports the results only for those items which
directly address the stated aims.
Study respondents
Respondents were recruited throughoutAustralia by pharma-
cistswhowerepractisingwithincommunitypharmacyand/or
practising as HMR consultant pharmacists. Of the 898 phar-
macists contacted, 264 (29%) agreed to participate. Pharma-
cists were provided with a study materials kit containing
a participant information statement, a questionnaire and a
reply-paid envelope for each respondent.Follow-up calls were
made to the pharmacists five working days and 28 days
after dispatching the study materials, in order to facilitate
maximum distribution. Questionnaires were distributed to
pharmacists from November 2008 through to May 2009.
Pharmacists were asked to recruit five respondents who had
received an HMR within the previous 6 months and/or five
eligible non-recipients. Pharmacists could choose to recruit
morerespondents if desired.Sinceeligibility for theHMRpro-
gramme is premised on the patient being at risk of medication
misadventure,[19] pharmacists were instructed to recruit non-
recipients who had at least one of six risk factors: taking more
than five regular medicines daily; taking more than 12 doses
daily; taking medicines which need particular monitoring
(warfarin, lithium or digoxin);having experienced a change in
medication regimen within the past 3 months; experiencing
hospitalisation within the past 1 month; and having multiple
regularprescribers.Theserisk factorswereselectedfromapre-
vious study which found that patients could reliably self-
report them,[41] and because community pharmacists could
also be aware of them during their day-to-day interactions
with patients. In order to ensure that the study only analysed
the results of eligible non-recipients,those questionnaires that
did not record the presence of any risk factors were excluded.
Data analysis
Descriptive statistics were computed. Non-parametric tests
were used to test for differences in categorical data. The c2 test
was used for binary variables whereas the Mann–Whitney
U-test was used for ordinal variables. Responses to the Likert
scales were dichotomised into: (1) agree and strongly agree
(agree) and (2) a combined group of neither agree nor dis-
agree, disagree and strongly disagree (not agree). Consistent
with the treatment of Mårdby et al.[35] the MARS results were
dichotomised into adherent and non-adherent individuals.
Non-adherent respondents were those who answered some-
times, often or always to any of the five MARS questions.
Adherent respondents were those who answered never or
rarely to all five MARS questions.
The level of significance was preset at P < 0.05.
Results
A total of 1893 questionnaires for HMR recipients was sent
to pharmacists of which 595 (31%) were returned. A total of
Box 1 Description of a Home Medicines Review
service provided to eligible non-recipients,
adapted from an Australian Government
consumer brochure[37]
A Home Medicines Review, a free service funded by
Medicare, provided jointly by your General Practitioner
(GP) and pharmacist, is particularly useful for people who
take multiple medicines each day, or who have recently
spent time in hospital or who are concerned or uncertain
about their medicines. After being referred by a GP, the
pharmacist usually visits the patient in their own home
at a mutually agreed time. The pharmacist will look at all
medicines that the patient has, discuss any difficulties or
concerns the patient may have with using their medicines
and write a report to the GP. The GP will then discuss the
results of the Home Medicines Review with the patient.
Home Medicines Reviews help patients and carers to
understand better how to use their medicines.
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1829 questionnaires for eligible non-recipients was sent to
pharmacists of which 320 were returned and, of these, 293
(16%) met the inclusion criteria. The researchers were unable
to determine the number of questionnaires that pharmacists
handed to patients. Therefore, the percentages of question-
naires returned should not be interpreted as true response
rates and probably underestimate the true response rates.
Characteristics of respondents
The demographic characteristics of respondents are reported
in Table 1. Responses were obtained from an approximately
even number of male and female respondents. The majority
of respondents were aged over 65 years which reflects the dis-
tribution of multiple-medicine users within the commu-
nity.[6] Respondents had a range of educational backgrounds
and were predominantly located in metropolitan areas.
Recipients were more likely to be older and have a lower level
of education than eligible non-recipients. There was no dif-
ference in other demographic characteristics.
Risk factors for medication misadventure also are reported
in Table 1. The most commonly reported risk factor was
taking five or more medicines daily. Recipients were less likely
than eligible non-recipients to be taking more than five medi-
cines daily (94% versus 97%,P = 0.019) and were less likely to
be taking 12 doses daily (21% versus 36%, P < 0.001). There
were no significant differences between the groups in the inci-
dence of other risk factors or self-reported adherence.
Recipients’ experiences of
the Home Medicines Review
An HMR had first been suggested to recipients by their GP
(83% of cases), pharmacist (15%) or family and/or friends
(2%). Recipients recorded that they had experienced: one
(64%); two (20%); three (9%); more than three (3%) HMRs
Table 1 Characteristics of respondents*
HMR recipients Eligible non-recipients
c2/Mann–
Whitney U† P% n % n
Gender
Male 49.0 287 50.2 144 0.11 0.739
Female 51.0 299 49.8 143
Age group
Under 65 16.0 94 28.4 83 89636 <0.001
65–74 26.5 155 36.6 107
75–84 41.1 241 28.1 82
85+ 16.4 96 6.8 20
Location
Metropolitan 70.3 418 66.6 197 1.26 0.261
Rural/remote 29.7 177 33.4 99
Education level‡
Year 10 or below 58.9 336 50.2 143 59706 0.006
Year 12, technical certificate or equivalent 27.9 159 30.2 86
University degree 13.2 75 19.6 56
Risk factors for medication misadventure§
Five or more medicines 93.6 556 97.3 287 5.45 0.019
12 or more doses per day 20.7 119 35.9 104 22.03 <0.001
Warfarin, lithium or digoxin 17.3 99 19.8 55 0.77 0.379
Medication regimen changes in last three months 23.9 139 27.0 79 0.96 0.327
Hospital within the last month 11.1 65 10.2 30 0.15 0.695
Multiple regular prescribing doctors 28.8 168 27.0 79 0.31 0.575
Self-reported adherence¶
Adherent (based on MARS results) 74.4 429 77.9 225 1.28 0.258
Non-adherent (based on MARS results) 25.6 148 22.1 64
HMR, Home Medicines Review; MARS, Medication Adherence Report Scale. *Refers to valid responses only, so that the sum of responses may not add up
to the total. †The c2 test statistic is reported for the comparison of binary variables, whereas the Mann–Whitney U-test statistic is reported for ordinal
variables. ‡Within Australia, the two categories of high school education level; year 10 and year 12, indicate 11 and 13 years of formal school education
respectively. §Respondents were dichotomised into those who answered: yes, or those who answered no or don’t know. The numbers and proportions
refer to those who answered yes. ¶Using responses from the MARS questions, respondents were dichotomised into two groups. Non-adherent respon-
dents were those who answered: sometimes, often or always to any of the five MARS questions. Adherent respondents were those who answered: never
or rarely to all five MARS questions.
212 Home Medicines Review: patients’ views
© 2011 The Authors. IJPP © 2011 Royal Pharmaceutical Society International Journal of Pharmacy Practice 2012, 20, pp. 209–217
CHAPTER TWO 69
and 4% responded as not sure. They recorded that their most
recent HMR had occurred: less than 1 month ago (24%),
between 2 and 4 months ago (44%), more than 4 months ago
(32%) and 8% were not sure.
Recipients rated the interpersonal skills of the visiting
pharmacist extremely highly. More than 97% agreed with
each of three statements that: the pharmacist was courteous, a
good listener, and respectful. Ninety-two percent agreed that,
overall, they felt satisfied with their experience of the HMR.
In addition, 95% agreed that they would recommend an
HMR to their family and/or friends who had concerns about
their medicines.
Eligible non-recipients’ awareness of
the Home Medicines Review
Eligible non-recipients’ prior awareness of HMRs was 23%.
Information about HMRs came from pharmacists (68%),
GPs (36%), other sources (28%) and family and friends
(12%). Their recollection of how HMR was described was
overwhelmingly positive, with 80% of eligible non-recipients
recalling either a positive or very positive mention of HMR,
and only 4% recalling a negative discussion.
Benefits of the Home Medicines Review
Table 2 shows that more than 50% of recipients agreed with
five out of seven items relating to the potential benefits. A
high proportion of recipients agreed that they understood
more and had fewer concerns about their medicines. Recipi-
ents recorded low levels of agreement with the two that
suggested that the HMR resulted in taking fewer medicines
(16%) or saving money on medicines (25%). Fewer than 50%
of eligible non-recipients agreed with all items relating to
benefit expectations (Table 2). The benefit statement which
respondents from both groups recorded the highest level of
agreement with suggested that the HMR helped (or would
help) them to understand more about their medicines.
A higher proportion of recipients than eligible non-
recipients agreed with all matching items relating to benefits/
expected benefits (P range < 0.001–0.045).
Barriers and facilitators
Table 3 shows that a majority of all respondents did not agree
with items relating to potential barriers to participation.
Recipients were less likely to agree than eligible non-
recipients for all items. The difference between the groups
reached the 5% level of significance for the following items:
privacy of medical records may be harmed; difficulty arrang-
ing the HMR, no time for an HMR; feeling uncomfortable
with regular pharmacist in the home and feeling uncomfort-
able with an unknown pharmacist in the home.
Table 3 also shows that a majority of all respondents agreed
with the two items related to potential facilitators (Table 3). A
higher proportion of recipients than eligible non-recipients
agreed that: their GP would be happy to be asked for an HMR
(78% versus 66%, P < 0.001); and that it mattered to them
what their GP thought about HMRs (73% versus 58%,
P < 0.001).
Willingness to use Home Medicines Review
The majority of respondents were willing to have an HMR if
their GP suggested it, with recipients more willing than eli-
gible non-recipients (91% versus 71%, P < 0.001). Respon-
dents indicated that they were willing to ask their GP for an
HMR if they had concerns about medicines, with recipients
more willing than eligible non-recipients (82 % versus
63 %, P < 0.001). However, both recipients and eligible non-
recipients were more willing to have an HMR if their GP
Table 2 Potential benefits of a Home Medicines Review*†
Variable
Benefits recorded
by HMR recipients
Expectations of
benefit recorded by
eligible non-recipients
c2 P% n % n
Ease with managing medicines 68.9 379 20.9 61 176.29 <0.001
Fewer concerns about the long term effects of the medicines 67.7 367 32.4 95 95.83 <0.001
Less concern about the effects of combining different medicines 67.8 369 40.5 118 58.05 <0.001
More confident that the medicines are helping 79.2 438 38.7 113 138.20 <0.001
Understand more about the medicines 81.7 447 47.6 139 105.20 <0.001
Take fewer medicines 16.1 83 11.0 32 4.02 0.045
Save money on the medicines 25.4 133 16.2 47 9.35 <0.001
Assist the patient to live independently at home for longer 50.6 274 25.3 74 50.39 <0.001
HMR, Home Medicines Review. *Numbers and percentages represent respondents who agree/strongly agree with each statement. †Refers to valid
responses only, so that the sum of responses may not add up to the total.
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suggested it, than if it meant asking their GP for it (91%
versus 82%, P < 0.001; and 71% versus 63%, P < 0.001
respectively).
Eligible non-recipients who had prior awareness, were
more willing to have an HMR if their GP suggested it, than
those who were previously unaware (83% versus 67%,
P = 0.014). However, prior awareness had no significant effect
on their willingness to ask their GP for an HMR (67% versus
62%, P = 0.478).
Discussion
Main findings
Recipients were overwhelmingly satisfied with the HMR.
They rated the pharmacist’s interpersonal skills extremely
highly and would recommend HMRs to others. Only a
minority perceived barriers to further participation. The
majority were willing to have another HMR if prompted by
their GP. In most cases, recipients would be willing to ask their
GP for another HMR if they had concerns about their medi-
cines. Most believed that their GP would want to be asked
under such circumstances.
Overall, the level of prior awareness of HMRs among
eligible non-recipients was low (23%). After a brief introduc-
tion to HMRs, the majority of eligible non-recipients were
willing to have an HMR if their GP suggested it, and were
willing to ask for one if they were worried about their medi-
cines. Eligible non-recipients, compared to recipients, were
however: less convinced of the potential benefits; more sensi-
tive to emotional barriers; less convinced that their GP
wanted them to ask for an HMR; and overall less willing to
have an HMR.
Strengths and limitations
This study is the largest to date to quantitatively survey the
perceptions of HMR recipients. It is estimated that during the
8-month study period, approximately 32 000 HMR services
would have been provided throughout Australia.[42] There-
fore, the views of 595 respondents represent 2% of the views
of recent HMR recipients. No other quantitative study has
explored the perceptions of persons who would be eligible
but have not yet experienced an HMR. Respondents were
recruited from a wide geographic area throughout Australia,
which meant that there was diversity in respondents’ health
providers, GPs, community pharmacists and consultant
pharmacists. Such diversity of patient backgrounds enhances
the generalisability to the wider Australian population.
A limitation of this study was that the true response rates
could not be calculated. The researchers note, however, a rela-
tively low proportion of questionnaires returned compared
with those sent to pharmacists. This low proportion may have
resulted fromthetwo-stepmethodologywhich involvedques-
tionnaires being sent to practising pharmacists who then had
toeithercontactpatientsorwait foreligible respondents tocall
in before distributing the questionnaires. This occurred
despite repeated reminder calls to pharmacists. Estimates of
the true response rates could have been made if pharmacists
had been asked to return non-distributed questionnaires.
The researchers needed to overcome the difficulty of
recruiting eligible non-recipients. Defining their eligibility
required making assumptions which may limit the generalis-
ability of the study. Pharmacists used their professional
expertise in combination with a list of risk factors to identify
respondents. In practice, however, GPs would use their pro-
fessional expertise in combination with these and other risk
factors to identify patients who may benefit from HMRs.
Table 3 Barriers and facilitators to participating in Home Medicine Reviews*†
Variable
Recipients Non-recipients
c2 P% n % n
Privacy of medical records may be harmed 6.4 35 10.7 31 4.74 0.029
HMR means my GP is checking up on my ability to cope 17.0 94 19.6 57 0.87 0.351
Asking for an HMR causes my GP to feel I have lost confidence in him/her 8.5 47 12.2 35 2.90 0.089
My GP doesn’t need more information from an HMR 30.3 165 35.5 102 2.34 0.126
My Pharmacist doesn’t need more information from an HMR 32.4 177 36.1 104 1.15 0.283
Uncomfortable with regular pharmacist in the home 13.4 74 20.1 57 6.25 0.012
Uncomfortable with unknown pharmacist in the home 18.6 103 39.0 112 41.67 <0.001
Difficulty arranging the HMR 3.6 20 10.8 31 17.04 <0.001
No time for an HMR 4.6 25 11.6 34 14.27 <0.001
Bringing up the subject of the HMR would be difficult 5.7 31 8.0 23 1.61 0.205
My GP would be happy for me to ask for an HMR if I needed one 78.0 435 66.0 192 24.15 <0.001
It matters to me what my GP thinks about HMR 72.5 405 57.6 167 22.32 <0.001
HMR, Home Medicines Review. *Numbers and percentages represent respondents who agree/strongly agree with each statement. †Refers to valid
responses only, so that the sum of responses may not add up to the total.
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Thus, it is possible that GPs and pharmacists may differ in
their use of risk factors, which may in turn have influenced
subject selection and overall results.
Another limitation of the study relates to the potential bias
introduced by pharmacists recruiting respondents. This bias
could occur in two ways. Firstly, it is possible that pharmacists
selectively recruited patients with known favourable attitudes
towards HMRs or pharmacists’ services generally. Secondly,
only 29% of pharmacists agreed to recruit patients. It is pos-
sible that these pharmacists had favourable attitudes, and that
their attitudes were reflected in the responses of respondents.
Further studies could be conducted using a different recruit-
ment strategy. For example, GPs could be contacted to
distribute questionnaires. Random telephone calls or postal
delivery could also be used to recruit non-recipients and a
risk assessment tool could be used to determine eligibility.
However, non-recipients selected in such a way could appear
to be at risk, but actually have adequate medicines knowledge,
practical support and good management skills. This means
that in actual practice, many of these individuals may not
have been considered eligible for HMRs. Caution is therefore
necessary in the use of randomised methods for recruitment
of eligible non-recipients.
Even though the HMR shares many attributes with
other international medication review services, it cannot be
assumed that the overall positive attitudes and willingness to
use HMRs found in the present study, would apply to these
services.
Comparison with published literature
Our finding, that a majority of respondents felt willing to ask
their doctor for an HMR (if they were worried about their
medicines), calls into question the conclusions of another
qualitative study which stated that consumers were unlikely
to ask their GP for an HMR.[23] However, that study involved
only 112 respondents compared with 888 in the present
quantitative study. Our finding has important implications
for pharmacy practice. It demonstrates that patients may
have a role in driving participation in medication review ser-
vices and that research should be directed to understand the
factors which influence patients’ willingness to participate.
Recipients’ positive attitudes and willingness to reuse
HMRs may be the result of them experiencing an extended
interview and patient counselling session with a pharmacist.
This interview and patient counselling session may last for
up to 1 hour.[30] Qualitative studies have shown that patients
have unaddressed concerns about complex medication
regimens.[43–46] Patients may perceive that GPs do not have
enough time with them to adequately cover their medicine
concerns[44] and an HMR may fill that gap. In accordance with
other medicines’ management studies, the majority of recipi-
ents agreed that HMRs provided them with increased under-
standing of the purpose and need for the medicines,[23,27,28]
and reassurance about medication concerns.[23,27,29,30] In addi-
tion, the present study showed that the majority of recipients
agreed that HMRs assisted them with managing their medi-
cines, and approximately half agreed that it helped them to
live independently.
The fact that the majority of eligible non-recipients were
unaware of HMRs is consistent with previous qualitative find-
ings.[22,23] Importantly, the present study showed that a lack of
awareness was associated with decreased willingness to have
anHMR.Thisfindingconfirmsthat lowawarenessmayactasa
significant barrier for HMR participation.[22,24] Of concern,
33% of unaware eligible non-recipients did not indicate that
they were willing to have an HMR, even if their GP suggested
had it.One possible reason for this is that the majority of older
patients wish to retain personal control over medical decisions
and discuss decisions before agreeing to participate in investi-
gations and services.[47] Future studies could further investi-
gate factors which influence whether an eligible non-recipient
would agree to an HMR if their GP suggested it.
Our study found that after describing HMRs to eligible
non-recipients,they held low expectations of personal benefit.
This finding was consistent with a study conducted among
non-recipients of the US MTM programme.[48] These low
expectations contrasted markedly with recipients’ positive
evaluations. Given the link between expectations and
demand,[15] non-recipients’ low expectations of HMRs and
other pharmacist-provided cognitive services is problematic
for expansion of these services.Perhaps understandably,phar-
macists and patients differ in their role beliefs regarding phar-
macists’ provision of cognitive services.[49] Tootelian proposes
that patients see value in pharmacists’ services directly related
to the supply of medicines but they may not be thinking of
pharmacists in broader healthcare roles.[50] However, it has
been argued that widespread consumer recognition of the role
of the pharmacist to provide education and counselling
during supply may be used in promotional campaigns to
increase patient demand for cognitive pharmacy services.[51,52]
Marketing campaigns designed to promote a service would
necessarily include some description of the service. The
description of HMRs we have provided to non-recipients
(Box 1) was adapted from that provided by the Australian
Government.[37] This information briefly mentioned that the
HMR provided patient counselling. A recent content analysis
of information available to consumers on the internet about
HMRs was conducted.[53] This study demonstrated signifi-
cant variation in descriptions of the communication pro-
cesses. For example, some websites described the interview
as a unique opportunity for patients to learn about their
medicines and have their concerns addressed whereas other
websites did not mention these opportunities.[53] In addition,
significant variation was found in related information which
may influence message salience, such as: descriptions of the
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need for or benefit from having an HMR, descriptions of pre-
ventable medication-related problems, and the presentation
of objective and subjective risk factors for medication misad-
venture.[53] Further research among eligible non-recipients
could use vignettes to determine how eligible non-recipients
respond to different descriptions of HMR programme.
Conclusion
A clear majority of recipients were satisfied with their HMR.
Among eligible non-recipients awareness of HMRs had been
provided mainly by health professionals,yet the overall aware-
ness of HMRs was low. Previous experience of HMRs, and to a
lesser extent, prior awareness, increased patients’ willingness
to have an HMR.Therefore, if health professionals introduced
HMRs to patients during their regular consultations it is likely
that, overall, more patients would be willing to use HMRs.
Future research could focus on exploring factors, other than
prior experience and awareness,which may influence patients’
expectations of and willingness to use HMRs.
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Patients’ willingness to use a pharmacist-provided
medication management service: The inﬂuence
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Abstract
Background: Previous research has demonstrated that some patients who are at risk of experiencing
medication-related problems express a lack of willingness to use pharmacist-provided medication
management services. Little is known about the factors that inﬂuence willingness to use these services
among patients who have not yet experienced the service.
Objectives: The aim of this study was to test a model of willingness to use the Australian Home Medicines
Review (HMR) service. Speciﬁcally, this study aimed to determine the inﬂuence of positive and negative
outcome expectancies and communication eﬃcacy over willingness among patients who were eligible to
receive the service but have not yet experienced it.
Methods: A cross-sectional survey was conducted with patients who were recruited by 264 community
pharmacists throughout Australia. Patients were included in the study if they had not yet experienced HMR
but were taking more than 5 medicines daily or more than 12 doses daily. Measurement scales were
developed using exploratory and conﬁrmatory factor analyses. Structural equation modeling was used to
test the model.
Results: Questionnaires received from 286 patients (15.6%) were analyzed. Multi-item measurement scales
were observed to have acceptable construct reliabilities (range, 0.69-0.94). Importantly, respondents held
overall neutral expectations about the personal beneﬁts of HMR (positive outcome expectancies) but high
communication eﬃcacy. Structural equation modeling revealed that positive outcome expectancies
(b¼ 0.56, P! .001) and communication eﬃcacy (b¼ 0.25, P! .05) inﬂuenced willingness to use,
whereas negative outcome expectancies had no signiﬁcant eﬀect.
Conclusions: The extent to which patients believe that HMR would provide them with increased medicines
knowledge, improve their medicines management capability, and reduce their medicine concerns had
a signiﬁcant inﬂuence over willingness to use the service. Because these expectancies are relatively low,
there appears to be signiﬁcant scope for increasing patient demand for these services. Patient-directed
Funding/Support: This project was funded by the Australian Government Department of Health and Ageing, as
part of the Fourth Community Pharmacy Agreement Research & Development Program managed by the Pharmacy
Guild of Australia.
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material about medication management services should highlight the provision of medication information.
 2012 Elsevier Inc. All rights reserved.
Keywords: Collaboration; Patient participation; Patient perception; Medication-related problem; Pharmacist
Introduction
The 2007 Institute ofMedicine (IOM) report on
preventing medication errors highlights the urgent
need for strategies to improvemedication safety.1 It
is likely that there is an international need to de-
velop and expand these strategies. This article deals
with patient willingness to participate in a medi-
cation safety intervention in ambulatory care.
Preventable adverse events that occur in ambula-
tory care are a signiﬁcant cause of morbidity in
Australia.2 It is estimated that adverse events result
in 2% to 3% of all hospital admissions, 50% of
which may be preventable.3 One of the key recom-
mendations of the IOMreport (recommendation 2)
was that regulatory agencies should provide
patients with increased access to medication infor-
mation andmedication self-management support.1
Medication management services provided by
pharmacists are indicated for persons who con-
sume multiple medicines4 and are at elevated risk
of experiencing medication-related problems.5
Studies show that these services resolve medicine-
related problems and improve health outcomes.6-8
Within the backdrop of service provision and
Medicare Part D, a recent editorial highlighted
the importance to the profession of research into
the needs of key stakeholders including patients.9
Research into patient perception is critically impor-
tant because studies conducted within the United
Kingdom, Australia, and the United States have
demonstrated that some patients may be reluctant
to use medication management services.10-13
A recent example of reluctance to participate in
medication management services is provided by
a study of patient attitudes toward a free to the
patient service within Australia, Home Medicines
Review (HMR).14 In a quantitative study con-
ducted by the present group, respondents who
were identiﬁed by pharmacists as having risk fac-
tors for medication misadventure were provided
with a brief explanation of HMR (Appendix 1)
and were asked whether they would be willing to
accept the suggestion of a general practitioner
(GP) to use the HMR service. Some 30% of re-
spondents who had not previously had an HMR
did not indicate willingness to use the service.14
In stark contrast, satisfaction levels among those
who had received an HMR were extremely high,
and only 10% did not indicate willingness to reuse
the service. These ﬁndings highlight the importance
of understanding more about the factors that inﬂu-
ence willingness among eligible nonrecipients.
Demand for health services is inﬂuenced by
patient knowledge and understanding of the ser-
vice15 and expectations about the beneﬁt thatwould
be derived by participating.16,17 An important
problem facing the profession is that the technical
qualities of medication management services are
relatively intangible and therefore the health bene-
ﬁts may not be obvious to the patient. Given that
past experience is a key determinant of a person’s
expectations about a service,18 eligible nonreci-
pients’ expectations about medicationmanagement
services would likely reﬂect their past experience of
pharmacists acting in more familiar roles. Possibly
the most salient of these experiences would be re-
ceiving medication advice during dispensing or
within the hospital ward. Patients expect pharma-
cists to provide medication advice, although the
lack of privacy in community setting is considered
to limit patient demand for such advice.19
The authors contend that an important inﬂu-
ence on eligible nonrecipients’ willingness to use
medication management services is their expecta-
tion that these services would provide medication
information tailored to their individual needs. This
contention is supported by qualitative research
conducted by our research group.20 When eligible
nonrecipients are presented with the concept of
medication management services, they formulate
expectations that the pharmacist would provide
an extended patient counseling session.20 Although
some persons may be unsure about important as-
pects of the service such as pharmacistsmaking rec-
ommendations to the doctor,21 when prompted
many believe that the service could provide them
with medication information tailored to their indi-
vidual needs.20 The desire to search for health
information is a basic step in the process of choos-
ing and participating in medical services.22 It is
well known that patients do prefer to learn about
their medicines from interpersonal sources, such
488 Carter et al. / Research in Social and Administrative Pharmacy 8 (2012) 487–498
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as medical practitioners and pharmacists.23 Writ-
ten information is viewed as a supplement, rather
than a replacement for contact with health
professionals.23
Therefore, a person’s willingness to use medi-
cation management services may depend on how
much they believe that a pharmacist would pro-
vide them with knowledge that would help them
manage their medicines. Furthermore, willingness
may depend on whether patients could overcome
any psychological or practical barriers to seeking
medication information from this unique re-
source. A better understanding of these factors
would provide insights to improving the develop-
ment and implementation of these services. Fur-
thermore, because some of these factors may be
at least partially controllable through the design
of patient-directed descriptions of the service, pa-
tient participation may be maximized. Therefore,
the aim of the research was to test a model of
patient willingness to use HMR.
The HMR service
HMR is a medication review service provided
collaboratively by GPs and pharmacists.24 An
HMR is initiated with a request from the patient’s
GP to a pharmacist, who then visits the patient
and caregivers at their home, for a single patient
interview. After the visit, the pharmacist writes
a report and collaborates with the GP, who then
discusses a revised medication management plan
with the patient.
Model development
Theoretical foundation
According to social cognitive theory (SCT),
whether a person is motivated to undertake
a particular activity may be inﬂuenced by their
expectations about the outcome of participating in
the activity and expectations about their capacity
to undertake the activity.25 The Theory of Moti-
vated Information Management (TMIM) by Aﬁﬁ
andWeiner26 was adapted to the present investiga-
tion because it further develops SCT to help explain
a person’smotivation to seek information from an in-
terpersonal source. Within TMIM, the motivating
force for information seeking about a topic is un-
wanted uncertainty about the topic and the ensuing
anxiety. It is considered that the act of information
seeking assists a person tomanage his or her uncer-
tainty and to reduce his or her level of anxiety.
Whether a person proceeds to seek information
depends on the expectations about the outcomes
and processes of the search. Based on the literature
and qualitative studies,20 constructs were adapted
to the context of this investigation (Fig. 1). The
context explored the willingness to use HMR of
an individual who has not previously received
HMR but who was presented with information
about the service. The model creates links between
expectations about the outcomes and processes in-
volved in HMR and willingness to use the service.
The model
The ﬁrst category of beliefs deals with an
individual’s focus on outcomes expectancies.
These may be further divided into positive expec-
tancies and negative expectancies. This evaluation
broadly follows a beneﬁt versus cost trade-oﬀ. In
identifying potential positive outcome expectan-
cies (POE) for HMR, consistent with TMIM,26
the literature suggests that patients expect to re-
ceive medication information that would assist
medicines management and that they would feel
reassured by receiving this information.12,21,27 It
is therefore hypothesized that POE, centered on
Communication 
efficacy
Positive outcome 
expectancies
WillingnessNegative outcome 
expectancies
H1
H2
H3
Fig. 1. The model of willingness to use HMR.
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these observations, would have a direct and posi-
tive eﬀect on willingness to use HMR (H1).
Consistent with TMIM, willingness to use
HMR would depend on the patient overcoming
negative process-based outcome expectancies. The
HMR service is free to the patient; therefore, any
potential costs (to patients) are nonﬁnancial. A
qualitative study in the United Kingdom con-
cluded that patients who were unwilling and had
declined to use medication management hid com-
plex reasons for declining to participate.12 It is un-
clear at the present, what these negative feelings
represent and whether they would impact on will-
ingness to use. Within the HMRmodel, the patient
interview is performed by a pharmacist whom the
patient may or may not know. Patients have the
option of having the interview in their home. How-
ever, studies conducted by the present study
group14,20 and another’s28 indicate that some pa-
tients express negativity, such as feeling a loss of
privacy and independence. Therefore, it is hypoth-
esized that process-based negative outcome expec-
tancies (NOE), related to the potential discomfort
of being visited at home, would have a direct and
negative eﬀect on willingness to use HMR (H2).
The second broad category of beliefs is assess-
ments about an individual’s ability to perform the
information-seeking action, self-eﬃcacy.25 In the
present context, self-eﬃcacy evaluations most
closely follow those of TMIM’s construct known
as communication eﬃcacy (CE).26 These evalua-
tions center on a patient’s perception of his or
her ability to overcome potential barriers in the
communication process such as making time for;
organizing; and if required, asking the patient’s
doctor for the HMR. In a qualitative study, it
was mentioned that some individuals appeared
to lack the capability or conﬁdence to address
these potential barriers.20 It was apparent that
some patients expressed diﬃculty asking the doc-
tor for an HMR, if they thought the doctor would
interpret the request as an indication that they
lacked conﬁdence in the doctor.20 Therefore, it is
hypothesized that CE would have a direct and
positive eﬀect on willingness (H3).
Most of the research conducted with SCT uses
behavioral intention as the antecedent variable to
actual behavior. In general terms, therefore, our
model includes variables related to intention.
However, Gibbons et al29 argue that willingness
to perform a behavior, that is intention condi-
tioned on certain premises, may explain more var-
iation in actual behavior than intention alone.
Willingness may capture irrational and reactive
inﬂuences.29 Based on a qualitative study,20 it
was hypothesized that respondents may be willing
to use HMR if the family medical practitioner
suggested it to them and/or if they were concerned
about their medicines. Therefore, within the pres-
ent model, willingness, that is, intention condi-
tioned on these 2 premises forms the dependent
variable.
Methods
The study used a cross-sectional survey design
to develop the measures and test the theoretical
model.
Sample
Respondents were eligible for inclusion in this
study if they had not previously received an HMR
but were eligible to receive it because they were
taking either 5 or more medicines daily or 12 or
more doses daily.
Questionnaire
Items included in the questionnairewere derived
from the results of previous qualitative studies.20,27
The questionnaire was assessed for face validity
by a panel of 7 expert community pharmacists, con-
sultant pharmacists, and academic pharmacists.
The questionnaire was pretested with 15 respon-
dents, which resulted in a reﬁnement of question
wording and reduction in the number of variables
measured. A short explanation of the service was
provided within the questionnaire, which was
adapted from an Australian Government con-
sumer brochure (Appendix 1).30
Belief measures
The following belief measures were generated
for the study (Table 1).
POEwere deﬁned as a person’s beliefs about the
eﬀectiveness of an HMR to improve knowledge
about medicines, help manage the medicines, and
reduce anxieties about taking multiple medi-
cines.20,21 Included within the scale were 6 items
to which respondents provided their level of agree-
ment on a 5-point Likert scale.
NOE were deﬁned as negative sentiments re-
lated to uncomfortable feelings about being visited
in the home and the feeling that having an
HMR indicated reduced personal capability.20
Four 5-point Likert scales were used.
CE was deﬁned as beliefs that would poten-
tially assist the respondent to overcome diﬃculties
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with having or asking the GP for an HMR. Five
5-point Likert scales were used. Note that some of
these items were reverse coded before further
analysis.
Willingness to use HMR, hereafter called
willingness was measured with 2 5-point Likert
scales. Respondents indicated their level of agree-
ment as to whether they would accept a GP’s rec-
ommendation to have an HMR and ask their GP
for an HMR if they had medicine concerns.
Sociodemographic data
The demographic information collected in the
questionnaires included sex, age group, education,
and postcode. The postcode was used in combi-
nation with Australian census data to provide an
index of socioeconomic advantage and disadvan-
tage.31 The index is a continuum of advantage
(high values) to disadvantage (low values), which
takes into account factors relating to a person’s
access to materials and social resources. Medica-
tion risk factors were recorded as either present,
absent, or unknown.
Data collection
The survey was conducted from November
2008 through May 2009. Respondents were re-
cruited by community pharmacists. Eight hundred
ninety-eight pharmacists, spread geographically
throughout Australia, were contacted, and 264
(29%) agreed to recruit 5 or more respondents for
the study. In total, 1829 questionnaires were
distributed to pharmacists. Pharmacists were pro-
vided with a study materials kit containing re-
cruitment instructions, a respondent information
statement, a questionnaire, and a reply-paid
envelope for each respondent. Aiming to maxi-
mize distribution, the questionnaires were not
numbered so that the anonymity of the pharma-
cist was preserved. Because eligibility for the
HMR program is premised on the patient being
at risk of medication misadventure,24 pharmacists
were provided with a list of risk factors to assist
recruitment: taking more than 5 regular medicines
daily, taking more than 12 doses daily, taking
medicines that need particular monitoring (warfa-
rin, lithium, or digoxin), having experienced
a change in medication regimen within the past
3 months, experiencing hospitalization within the
past 1 month, and having multiple regular pre-
scribers. These risk factors were selected from
a previous study, which found that patients could
reliably self-report them32 and because commu-
nity pharmacists could also be aware of them
during their day-to-day interactions with patients.
Pharmacists handed questionnaires with paid
reply envelopes to respondents who completed and
posted them directly to the research team, anony-
mously. Follow-up calls were made to the pharma-
cist 5 working days and 4 weeks after dispatching
Table 1
Descriptive statistics of belief measuresa
Construct Item code Item Mean (SD) n
POE POE1 Ease with managing my medicines 2.70 (0.97) 282
POE2 Understand more about my medicines 3.20 (1.09) 282
POE3 Assist me to live at home independently 2.75 (0.98) 283
POE4 Fewer concerns about long-term side eﬀects 2.93 (1.01) 283
POE5 Fewer concerns about drug interactions 3.06 (1.05) 281
POE6 More conﬁdent the medicines are helping me 3.01 (1.07) 282
CE CE1 Diﬃculty arranging (reverse score provided) 3.59 (0.89) 278
CE2 No time (reverse score provided) 3.59 (0.91) 282
CE3 Diﬃculty asking GP (reverse score provided) 3.83 (0.84) 279
CE4 Conﬁdent asking GP 4.04 (0.65) 279
CE5 Asking for HMR indicates that I have no conﬁdence in GP
(reverse score provided)
3.58 (0.93) 276
NOE NOE1 Uncomfortable with regular pharmacist 2.54 (1.05) 274
NOE2 Uncomfortable with unknown pharmacist 3.03 (1.10) 277
NOE3 Privacy compromised 2.41 (0.95) 281
NOE4 HMR feels like a check on my capability 2.54 (1.00) 281
Willingness W1 Willing to have an HMR if suggested by the GP 3.65 (0.92) 283
W2 Willing to ask the GP for an HMR if having concerns about medicines 3.51 (0.95) 282
SD, standard deviation.
a Responses varied from 1 (strongly disagree) to 5 (strongly agree).
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the study materials to assure maximum question-
naire distribution by pharmacists. No incentives
were oﬀered to pharmacists or respondents. Ap-
proval for the project was given by the University
of Sydney Human Ethics Committee.
Analysis
PASW version 18.0.03 (SPSS Inc., Chicago, IL)
(www.spss.com) was used for descriptive statistical
analyses and exploratory factor analyses (EFA).
Conﬁrmatory factor analysis (CFA) and structural
equation modeling (SEM) were performed with
Amos 18.0.0 (Amos Development Corporation,
Crawfordville, FL), which uses a full information
maximum likelihood estimator. With this tech-
nique, the means and intercepts may be estimated
concurrently with the covariance matrix so that
estimates are provided in the presence of missing
data.
Each of the 3 multi-item measurement scales,
(POE, NOE, and CE constructs) were subject to
initial EFA to determine dimensionality and ex-
clude any items with low communality (!0.5).33
After this procedure, CFA was performed in the
presence of the dependent variable. SEM with
maximum likelihood estimation requires the pres-
ences of multivariate normality. Therefore, before
performing CFA, items selected for the measure-
ment scales were examined for evidence of skew-
ness and kurtosis.
Convergent validity of the constructs was as-
sessed by inspection of the results from CFA.
Standardized factor loadings should exceed 0.50
with statistical signiﬁcance to demonstrate high
convergence on a common point.33 In addition, the
average variance extracted should equal or exceed
50%.33 The reliability of the constructs was com-
puted using the formula suggested by Fornell and
Larcker.34 The construct reliability values equal
to or greater than 0.7 indicate that the construct
of the model is reliable, although coeﬃcients of be-
tween 0.5 and 0.8 may be considered acceptable
during preliminary investigations.33 Discriminant
validity was assessed through the use of variance
extracted test.34 Constructs were evaluated by com-
paring the variance extracted estimates for 2 factors
and then compared with the square of the correla-
tion between the 2 factors. Discriminant validity
is demonstrated if both variance extracted esti-
mates are greater than the squared correlation.
Using the method of Westland,35 the minimum
sample size for an appropriate indicator to latent
ratio, with 4 latent constructs and 17 indicators,
was calculated to be 91. Therefore, the study had
suﬃcient power to perform CFA. Measurement
errors were ﬁxed to (1reliability) variance.36
Using the method of Westland,35 a sample size
ofmore than 313was required to detect aminimum
eﬀect size of 0.20 with a power of 0.8 and P! .05.
Using the same method, post hoc it was estimated
that the minimum eﬀect size that could reliably be
determined with the sample of 286 and the same
power and signiﬁcance settings was 0.21.
Results
Questionnaires were received from 319 respon-
dents and after excluding those who did not meet
the inclusion criteria, 286 remained providing an
eﬀective response rate of 15.6%. Descriptive
statistics of the sample are provided in Table 2.
Belief measures
Means and standard deviations for the belief
measures from each group are presented in
Table 1. The following provides some descriptive
statistics of the belief measures and the results of
EFA for each construct.
Positive outcome expectancies
For most variables, the median score was 3, the
neutral response. This indicates that overall, re-
spondents were relatively unconvinced that an
HMR would provide positive outcomes. All 6
items loaded onto the 1 factor with eigenvalues
above 1, which explained 75.5% of the variance.
All items had communalities above 0.5. The factor
loadings ranged between 0.78 and 0.92.
Negative outcome expectancies
For most variables, the median score was 2,
indicating overall low levels of negative expectan-
cies. All 4 items loaded onto the 1 factor with
eigenvalues above 1, which explained 49.2% of
the variance. However, 2 of the items (NOE3 and
NOE4) had relatively low communalities of 0.36
each. The 2 items with (equally) low communal-
ities were therefore excluded. The factor loadings
for the remaining 2 items were 0.72 and 0.74.
Communication eﬃcacy
After reverse coding (as appropriate), the me-
dian score for each variable was 4, indicating
overall high levels of CE. All 5 items loaded onto
the 1 factor with eigenvalues above 1; however, 1
item, CE4, had very low communality (0.26) and
was excluded from further analysis. The 4 remain-
ing items loaded onto the 1 factor, which explained
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56.9% of the variance. The factor loadings ranged
between 0.68 and 0.79.
Willingness
The median score for each of these items was 4,
indicating that overall, respondents were willing
to have an HMR if suggested by the GP and
willing to ask the GP if they had concerns about
their medicines. This 2-item scale was not sub-
jected to EFA.
Conﬁrmatory factor analysis
Inspection of the items of the derived scales
and the dependent variable revealed that skewness
and kurtosis statistics were less than or equal to
an absolute value of 1. Missing data analysis
revealed that the overall level of missing data was
small (!5% for all variables). Examination of the
correlation matrix revealed that no relationships
were above 0.90; therefore, multicollinearity was
not considered problematic.
The parameter estimates and the goodness of ﬁt
indices indicated that overall, the measurement
model was a reasonable ﬁt for the data. Apart from
the signiﬁcant chi-square¼ 156, df¼ 71, P! .001,
model ﬁt indices were good. Model ﬁt statistics:
comparative ﬁt index (CFI)¼ 0.96, Tucker-Lewis
Index (TLI)¼ 0.93, Root Mean Square Error of
Approximation (RMSEA)¼ 0.065 (90% conﬁ-
dence interval, 0.051-0.079). Standardized and
unstandardized factor loadings, construct valid-
ities, and average variances extracted are presented
in Table 3. The variances of the indicator variables
loading onto each latent construct were signiﬁcant.
All the factor loadings were greater than or equal to
0.5. For each of the constructs, average variances
extracted were greater than 50%, with the excep-
tion of the CE scale (44%). Although the CE scale
Table 2
Sample characteristicsa
Characteristic % n
Sex
Male 50.9 141
Female 49.1 136
Age group (y)
Younger than 65 28.4 80
65-74 36.5 103
75-84 28.4 80
85 and older 6.7 19
Location
Metropolitan 66.8 191
Rural or remote 33.2 95
Education level
Year 10 or below 50.2 138
Year 12 or equivalent 30.2 83
University 19.6 54
Presence of medication risk factorsb
12 or more doses daily 36.8 103
Warfarin, lithium, or
digoxin
18.9 51
Medication regimen
change within last 3 mo
26.5 75
Hospital within the last
month
9.5 27
Multiple regular
prescribing doctors
27.2 77
Socioeconomic status by postal locationc
Index of relative
disadvantage and
advantage, mean (SD)
963 (61) 277
SD, standard deviation.
a Refers to valid responses only so that the sum of
responses may not add up to the total.
b Refers to the proportion who responded (yes) to
the presence of the risk factor.
c The index of relative disadvantage/advantage
ranks locations (in this case by postcode) based on
data obtained from the national 2006 census and uses
socioeconomic factors such as income, education, occu-
pation, and housing conditions. A lower index indicates
relative disadvantage, and a higher index indicates rela-
tive advantage. The mean rank for Australia is 1000.
Table 3
Conﬁrmatory factor analysis (N¼ 286)
Item SRW URW SE of URW CR AVE, %
POE1 0.80 1.00 0.00 0.94 71.3
POE2 0.88 1.14 0.07
POE3 0.90 1.20 0.07
POE4 0.91 1.25 0.07
POE5 0.84 1.17 0.07
POE6 0.72 0.90 0.07
NOE1 0.72 1.00 0.00 0.69 53.3
NOE2 0.74 1.10 0.15
CE1 0.63 1.00 0.00 0.75 43.6
CE2 0.70 1.19 0.14
CE3 0.76 1.28 0.14
CE5 0.53 0.93 0.13
W1 0.61 1.00 0.00 0.71 56.1
W2 0.87 1.38 0.19
SRW, standardized regressionweights; URW, unstan-
dardized regression weights; SE, standard error; CR,
construct reliability; AVE, average variance extracted;
W, willingness.
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did not achieve the target average variance ex-
tracted, each of the factor loadings were above
0.5 and the construct reliability of this scale was
reasonable (0.75); therefore, the scale was retained.
The minimum construct reliability estimate was
0.69. Discriminant validity was demonstrated be-
cause for each pair of constructs both average var-
iance extracted estimates were greater than the
squared correlation.
Structural equation model
The parameter estimates and the goodness of ﬁt
indices indicated that overall, the structural equa-
tion model was a reasonable ﬁt for the data. Apart
from the signiﬁcant chi-square¼ 163, df¼ 72,
P! .001, model ﬁt indices were good for the mea-
surement model. Model ﬁt statistics: CFI¼ 0.96,
TLI¼ 0.94, RMSEA¼ 0.065 (90% conﬁdence in-
terval, 0.053-0.080). The model predicted 46% of
the variation in willingness. Fig. 2 provides the re-
sults of hypothesis testing. POE had a strongly pos-
itive eﬀect on willingness (b¼ 0.56, P! .001). CE
had a moderate eﬀect on willingness (b¼ 0.25,
P! .05). NOE had no signiﬁcant eﬀect on
willingness.
Discussion
This study demonstrates that 46% of the
variation in respondents’ willingness to use
HMR may be predicted by the model. Respon-
dents’ expectations about the personal beneﬁts
of HMR and beliefs about their capability to
ask for and arrange an HMR were instrumental
in determining willingness, whereas negative ex-
pectancies about the processes of HMR had no
signiﬁcant eﬀect.
Consistent with the Theory of Motivated
Information Management (TMIM), the extent to
which respondents believed that HMR would
provide them with increased medicines knowl-
edge, improve their medicines management capa-
bility, and reduce their medicine concerns had
a strong inﬂuence over whether they were willing
to use the service. It appears therefore that
patients view HMR as an information resource
and that their willingness to use HMR is in part
driven by expectations about the services’ capacity
to provide medication information. That willing-
ness to use pharmacist-provided services is moti-
vated by information seeking is consistent with
the ﬁndings of 2 international studies that investi-
gated factors inﬂuencing participation in these
programs. A study of patients who either volun-
tarily participated in a Swedish service or not con-
cluded that “patients receiving a Pharmaceutical
Care service are a worried, vulnerable, and
information-seeking group.”37 Similarly, some of
the patients who accepted rather than declined
to participate in the UK Medicine UR Review
program12 did so because it was “a good thing
to keep up their knowledge.”
However, multiple medicine users in the present
study were overall unconvinced that they would
beneﬁt from HMR as an information resource. A
quantitative study within the United States13 also
demonstrated that persons who use multiple medi-
cines and who are naive to pharmacist-provided
medicines management services have low to mod-
erate expectations of receiving personal beneﬁt.
The relatively low expectations about the beneﬁts
of HMR should be compared with the high level
of outcome beneﬁts reported by respondents after
receiving the service.14 For example, whereas only
21% of nonrecipients expected that having an
Communication 
efficacy
Positive outcome 
expectancies
WillingnessNegative outcome 
expectancies
0.56**
n.s.
0.25**
-0.32*
-0.57**
n.s.
Fig. 2. Results of structural equation model (N¼ 286). Standardized regression weights and correlations. *P! .05,
**P! .001, n.s., not signiﬁcant.
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HMRwould help them to manage their medicines,
after having an HMR 69% of recipients agreed
that the HMR did help them with medicines man-
agement.14 It is plausible that low expectations of
receiving the beneﬁts explored in the present study
could be themain reasonwhy eligible nonrecipients
of HMR are signiﬁcantly less willing than recipi-
ents to use HMR.14
In summary, among eligible nonrecipients, pos-
itive expectations about the capacity for pharmacist-
provided services toprovidemedication information
that would improve self-eﬃcacy for medicines
management have strong inﬂuences over willing-
ness, yet these expectations are not high. These
ﬁndings have important implications for the future
of the pharmacy profession and for themarketing of
these services. There appears to be scope for the
profession to increase demand for these services,
through lifting expectations of medication manage-
ment services as information resources.
The present study did not investigate the in-
ﬂuence of patients’ expectations of other intangible
beneﬁts of medication management services on
willingness to participate. For example, the study
did not examine whether willingness depended on
patients’ thoughts about pharmacists making
recommendations to the doctor or about the phar-
macists checking the appropriateness of their med-
ication. However, it has been argued by Chewning
and Schommer38 and Nau et al39 that the profes-
sion needs to address the diﬃculty of clearly artic-
ulating the range of beneﬁts of participation to
patients. Yet, describing intangible beneﬁts to pa-
tients is diﬃcult. A recent study that analyzed the
content of patient-directed information regarding
HMR found that descriptions of the service may
lack salience for the patient.40 It was suggested
that laypersons may ﬁnd the concept of
medication-related problems, the resolution of
which underpins the programs, unclear.40 Descrip-
tions of HMR did not generally inform readers
about concepts of dose problems, appropriateness,
age-related change in sensitivity, or drug-drug/
food-drug interactions. Patients may therefore
not understand the need to be informed about these
issues.40 In addition, the beneﬁts need to be articu-
lated without causing excessive medicine-related
anxiety. Health professionals may understand
that medication-related problems occur because
of timing of administration, drug interactions,
and incorrect doses or that prescribed medications
may, for a variety of reasons, be inappropriate.
Explaining these concepts to patients may gen-
erate suﬃcient medicine-related anxiety to seek
information because anxiety motivates informa-
tion seeking.26 However, it is also possible that ex-
cessively increasing medicine-related anxiety could
stimulate nonadherence, as demonstrated by the
work of Horne et al.41-43 Further research could in-
vestigate the relationship betweenmedicine-related
anxiety and outcome expectancies.
Consistent with predictions made by the
model, the present study demonstrated that CE
had a moderate eﬀect on willingness to use HMR.
Perhaps this is not surprising because self-eﬃcacy
beliefs may be the most powerful of constructs
within SCT.25,44,45 Although it would seem that
arranging for a single patient interview would ap-
pear to be a relatively simple process for the
patient, HMR is a relatively new concept and pa-
tients may not be able to clearly conceptualize
what would occur during an interview. This lack
of clarity about the process and the fact that pa-
tients may feel insecure about asking the family
medical practitioner for an HMR may explain
why CE was only moderately important. Al-
though the measurement scale for CE had good
factor loadings and good construct reliability, av-
erage variance extracted was below the target. It
should also be noted that the scale did not include
any items to probe the CE required to ask the
pharmacist for advice during the HMR interview.
Items of this nature were not included because this
communication barrier did not appear to limit
willingness to ask for advice in the qualitative re-
search.20 It is recommended that future research
should attempt to improve the measurement of
CE in the present context.
The present study found that previously re-
ported uncomfortable feelings about having
a known or unknown pharmacist visit the
home14,20,29 did not signiﬁcantly inﬂuence willing-
ness to use the service. To some extent, this should
be a reassuring ﬁnding for the pharmacy profes-
sion. This ﬁnding possibly reﬂects the trust that
patients have in community pharmacists as an in-
formation resource, both within Australia46 and
internationally.47 Because the study was not able
to develop a reliable scale that included other neg-
ative feelings,14,20,29 such as that having the HMR
indicated reduced personal capability or was
a threat to privacy, it is not possible to comment
on whether these factors may be inﬂuential.
Limitations
A limitation of this study was the relatively low
response rate (12.5%), which may have resulted
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from the 2-step method for distributing question-
naires. Questionnaires were sent to practicing
pharmacists who then had to either contact
patients or wait for eligible respondents to call
in before distributing the questionnaires. Low
response rates occurred despite several reminder
calls to pharmacists. The recruitment process did
not allow for other strategies to address non-
responder bias.
Another limitation of the study relates to the
potential bias introduced by pharmacists recruit-
ing respondents. This bias could occur in 2 ways.
First, it is possible that pharmacists selectively
recruited patients with known favorable attitudes
toward HMR or pharmacists’ services generally.
Second, only 29% of pharmacists agreed to re-
cruit patients. It is possible that these pharmacists
had favorable attitudes. Therefore, the study re-
sults may be biased by not obtaining the views
of patients who obtain medicines from pharma-
cists that may not have these favorable attitudes.
Further studies could be conducted using a diﬀer-
ent recruitment strategy. For example, GPs could
be contacted to distribute questionnaires. Ran-
dom telephone calls or postal delivery could also
be used to recruit respondents.
Although HMR shares many attributes with
other international medication review services
provided in the United States,13 Canada,48 New
Zealand,49 or the United Kingdom,12 it cannot
be assumed that the ﬁndings of the present study
would necessarily apply to these services.
Conclusion
For patients who are at risk of experiencing
medication-related problems, a lack of willing-
ness to use medication management services is
potentially a safety issue. Eligible nonrecipients’
willingness to use HMR was strongly inﬂuenced
by their expectations that it would provide them
with increased medicines knowledge, help them
manage their medicines, and reduce their medi-
cine concerns. Consistent with studies around
the world, these expectations are relatively low.
Therefore, there appears to be signiﬁcant scope
for increasing patients’ willingness to use these
services. Given the diﬃcult task of articulating
other intangible beneﬁts of these services to eligi-
ble patients, this study suggests that patient-
directed material about medication management
services should highlight the provision of medica-
tion information.
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Appendix 1
Description of HMR provided to eligible
nonrecipients, adapted from an Australian
Government consumer brochure50
An HMR, a free service funded by Medicare,
provided jointly by your GP and pharmacist, is
particularly useful for people who take multiple
medicines each day or who have recently spent
time in hospital or who are concerned or un-
certain about their medicines. After being referred
by a GP, the pharmacist usually visits the patient
in his or her own home at a mutually agreed time.
The pharmacist will look at all medicines that the
patient has, discuss any diﬃculties or concerns the
patient may have with using the medicines, and
write a report to the GP. The GP will then discuss
the results of the HMR with the patient. HMRs
help patients and carers to understand better how
to use their medicines.
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Abstract Background Patients at risk of experiencing
medicine-related problems do not always appear willing to
participate in collaborative medication management ser-
vices. Little is known about the psycho-social factors
which motivate patients to participate in these services.
The theory of motivated information management (TMIM)
suggests that patients’ willingness to participate may be
motivated by their uncertainty and worry about their
medicines. Objective The objective of this study was to
investigate factors which may motivate patients to partic-
ipate in a collaborative medication management program.
Setting Fourteen semi-structured focus group interviews
held throughout Australia provided the data for the study.
Eighty participants were recruited by community pharma-
cists. Participants were recruited into the study if they had
experienced Australia’s Home Medicines Review (HMR)
program or would be eligible to participate in the program
because they were at risk of experiencing medicine-related
problems. Methods An interview guide was developed
which was informed by TMIM. Focus group data were
audio-recorded, transcribed and where necessary, trans-
lated into English. Main outcome measure Qualitative data
were thematically analysed to identify participants’
expectations about the outcomes of HMR and the factors
which may influence these expectations. Results Partici-
pants’ most salient outcome expectancies of HMR were
that it was a medication-information source which would
assist them to manage their medicines. Recipients of the
program held overall positive outcome expectancies,
whereas nonrecipients’ expectancies varied widely. Con-
sistent with theory, participants who expressed some worry
about their medicines, generally held positive outcome
expectancies and were willing to participate in HMR.
Compared with younger participants, older participants
(those aged [74 years) tended to engage less in their
thoughts about being at risk, and consequently did not
experience worry. Conclusion Worry about medicines is a
key factor in motivating participants to engage in medi-
cines information-seeking. Older persons who rely heavily
on heuristics appeared less likely to worry about their
medicines and willing to participate in medication man-
agement services. Age-related reduction in the motivation
to participate may have important implications for medi-
cation safety. Further examination of this effect is war-
ranted because older persons are at greatest risk of
medicine related problems.
Keywords Australia  Heuristics  Home Medication
Review  Medication Review  Medicine information 
Medicine-related problems  Motivation  Uncertainty
Introduction
In many developed nations, throughout Europe [1, 2],
North America [3] and in Australia [4] the population is
ageing and the burden of chronic disease and co-morbidity
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is growing. Multiple medications are often used to manage
common chronic diseases [5], resulting in complex medi-
cation regimens [6]. Medication-related problems are a
significant cause of morbidity in Australia [7]. It is esti-
mated that they result in 2–3 % of all hospital admissions,
50 % of which may be preventable [8]. One option avail-
able in Australia to improve medication safety is to provide
patients who are at risk of experiencing medication-related
problems with a Home Medicines Review (HMR) [9].
HMR is a medication review service provided collabora-
tively by general practitioners (GPs) and pharmacists
which aims to resolve medication-related problems and
improve health outcomes [10–12]. An HMR is initiated
with a request from the patient’s GP to an accredited
pharmacist. The referral may be made directly to the
pharmacist or to the patient’s preferred community phar-
macy [9]. The pharmacist then conducts a patient interview
at the patient’s home or at location which suits the patient.
Following the interview, the pharmacist collaborates with
the GP, who then discusses a revised medication manage-
ment plan with the patient. There is evidence that this
collaborative program increases patients’ use of appropri-
ate and evidence-based therapies [13–15], and may provide
additional safety benefits such as delaying hospital
re-admission for patients with heart failure [16].
Patients can have a key role in medication safety
through their: involvement in decision-making regarding
treatment; adherence to therapy; and self-management
strategies [17]. Therefore, it is likely that a key benefit of
HMR for patients is the information they receive during the
patient interview. A meta-analysis investigating the impact
of a range of medication review services carried out by
pharmacists found that these programs provide patients
with important knowledge and may help adherence [18]. In
focus group research, recipients of HMR believed that the
service provided them with personalized medicines infor-
mation and reassurance [19]. Yet it is unclear whether
these benefits are expected by eligible non-recipients.
It has been reported that some patients who are at risk of
experiencing medication-related problems decline to par-
ticipate in the HMR program [20, 21]. It is likely that the
patient’s GP has a motivating role however, research has
found that around 30 % of such patients are ambivalent or
unwilling to have an HMR, even if their own GP were to
suggest it [22]. This lack of willingness to participate in
medication review services has also been demonstrated in
studies conducted in the USA [23], and in the UK [24].
An individual’s intent to engage in health information-
seeking is a basic step in the process of choosing and
participating in medical services [25]. It is also well known
that patients prefer to learn about their medicines from
interpersonal sources, such as GPs and pharmacists [26].
Therefore, patients’ lack of willingness to participate in the
HMR program to discuss their medicines face-to-face is
somewhat surprising. It has important implications for
patient participation in the HMR program and for medi-
cation-safety in general.
Theoretical framework
The theory of motivated information management (TMIM)
[27] was selected as the theoretical framework for the study
because this theory deals with information-seeking partic-
ularly from interpersonal sources. TMIM suggests that an
individual’s motivation to engage in information-seeking
arises through uncertainty discrepancy [28]. A person
experiences uncertainty discrepancy when their current
threshold for uncertainty about an important issue is
breached. Up until this point, the individual is comfortable
with their state of uncertainty. However, after an event
occurs which causes them to be no longer be comfortable
with their level of uncertainty, they experience anxiety.
This anxiety then motivates the individual to focus their
thoughts and feelings on managing the anxiety. They
weigh-up the expected benefits and costs (outcome
expectancies) of engaging in information-seeking. An
overall positive evaluation of outcome expectancies then
motivates behaviour, although positive communication
efficacy also has a role to play. In the context of the present
study, we use the term ‘‘worries’’ to mean anxiety related
to the possibility of experiencing medicine-related harm.
Aim
The aim of this qualitative study was to investigate psy-
chosocial factors which may motivate patients who are at
risk of experiencing medication-related problems to par-
ticipate in the HMR program.
Methods
Overview
This study was part of a larger study investigating patient
and carer attitudes towards the Australian Home Medicines
Review (HMR) program this paper reports on the qualita-
tive data which were relevant to the stated aims.
Participants
Fourteen focus groups comprising 88 participants were
conducted across Australia. Participants comprised patients
at risk of medication-related problems and carers. Partici-
pants for 13 of the focus groups (n = 84) were recruited by
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community pharmacists during routine contact within the
pharmacy. Participants for one focus group comprising
women of older age were recruited by invitation during a
general meeting of the Council of the Ageing (NSW).
Participants were provided with an information statement
and consent form. Given the focus of the present study, the
data from eight participants who nominated themselves as
carers only, were excluded from the analysis, leaving 80
participants. A purposive approach to sampling was
adopted so that participants with pre-defined demographic
characteristics were recruited. These were: age group,
gender, location (metropolitan versus rural), previous par-
ticipation in the HMR program, and language. Two lan-
guages were chosen besides English: Mandarin and
Arabic—as these were two of the top five languages other
than English spoken at home in Australia [29]. Partici-
pants’ demographic details are presented in Table 1. The
sample included patients who had experienced an HMR
within the last 6 months, and eligible non-recipients (those
who were eligible, but who had not yet had an HMR).
Eligible non-recipients were recruited if they had at least
one of six medication risk factors [9]: taking more than five
medicines daily; taking more than 12 doses daily; taking
medicines which need particular monitoring, such as war-
farin, carbamazepine or digoxin; a change in medication
regimen within the past month; hospitalisation within the
past 3 months; and having multiple regular prescribers.
Data collection
Qualitative researchers in the field of medication-related
problems report that participants may be reluctant to dis-
cuss their concerns with researchers [30, 31]. Gordon et al.
[30] found this in one-on-one interviews. However, Moen
et al. [31] reported that this effect was overcome to some
extent during focus groups as people opened up in the
group environment. Focus groups allow participants to
refine their individual viewpoints by comparing them to
other people’s [32]. Therefore, semi-structured focus
groups were selected as the most appropriate data collec-
tion method. Facilitators used semi-structured discussion
guides, which were developed following a comprehensive
review of the literature. Questions were refined through
consultation with practising and academic pharmacists
(Tables 2, 3).
In order to facilitate optimal group interaction, focus
groups were arranged to be as homogenous as possible
[33]. All focus groups were facilitated by a pharmacist and
participants were informed that the facilitator was a phar-
macist. Each focus group was digitally recorded and tran-
scribed verbatim. For focus groups conducted in Mandarin
and Arabic, the authenticity of the translations was ensured
by an iterative process, whereby two bilingual health
workers checked and re-checked translations until con-
sensus was achieved. In addition, field notes were recorded
during and immediately after each focus group.
Data analysis
Thematic analysis was used for this study [34]. Following
several readings of transcripts and field notes, initial coding
of the entire dataset was shared between two qualitative
analysts with experience in health research. Analysts aimed
to draw subthemes relevant to the two major themes,
patients’ worries about medicines and their expectations
about medicines information sources. To ensure rigor, the
first author (SC) independently coded a random sample of
six focus groups. During this stage, a series of meetings
with the analysts and researchers were held to discuss
subthemes, map and refine them, and to achieve interpre-
tative consensus. Next, using the hierarchical thematic
structure developed, SC recoded the data to the entire
dataset. Finally, meetings of the analysts and the
Table 1 Participant characteristics
Total (n = 80)a Category n (%)
Sex
Male 36 (45.0)
Female 44 (55.0)
Age group
Under 50 7 (8.8)
50–65 12 (15.0)
65–74 33 (41.3)
75? 22 (27.5)
Unrecordedb 6 (7.5)
Location
Metropolitan 54 (67.5)
Rural/remote 26 (32.5)
Language spoken
English 70 (87.5)
Arabic 4 (5.0)
Mandarin 6 (7.5)
Patient and carer status
Patient only 65 (81.3)
Both patient and carer 15 (18.8)
Home Medicine Review
Recipient 28 (35.0)
Eligible non-recipient 52 (65.0)
a The present study excluded the data from eight participants who
were carers but who themselves were not multiple medicine users.
Therefore, the characteristics reported above represent only those of
the study sample
b The age group of six participants were not recorded due to
administrative oversight
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researchers were held to refine the labelling of themes. The
NVivo 8 programme was used for data management.
This study was approved by The University of Sydney
Human Ethics Committee.
Results
The data were categorized into subthemes which emerged
within each of the two broad themes: (1) Worries about
medicines; and (2) Expectations about sources of medi-
cines-information.
Theme 1: worries about medicines
This theme identified that participants vary in their level of
uncertainty and worry about their medicines. It was
apparent that some participants had little engagement in
thoughts and feelings about the possibility of experiencing
medication-related problems. However some participants
were worried about these problems, especially during
episodes which created new uncertainties. There were four
subthemes: Making mistakes; Consuming multiple strong
medicines is harmful; Needing more or less information;
Age-related decline in medication-related worries.
Subtheme: making mistakes
As expected by the researchers, many participants initially
interpreted the question ‘‘how likely are you to experience
problems with your medicines?’’ as an enquiry about the
intrinsic harmfulness of medicines. Others however, inter-
preted the question as an enquiry about their self-efficacy to
follow their GPs’ instructions. When a participant declared
that they had made errors with self-management, others
tended to report their own experiences.
I’m also like you [another participant]; I doubt myself
sometimes whether I took my tablet or not. I would
sometimes take my Disprin (aspirin) and write on the
Table 2 Focus group interview guide: eligible non-recipients
1. How do you obtain your medicines?
2. What sort of medicine problems do you experience?
3. How do you manage them? How do you cope? Do you use dose administration aids? Do you have a carer?
4. How likely are you to: get sick from your medicines; see a doctor; or need to go to hospital because of them?
5. How much do you worry about your medicines?
6. Who do you approach for advice regarding medicines, medicine problems? Where else do you go for information?
7. Before being asked to participate in this study, had you heard of the term Home Medicines Review?
I will read to you now some information about Home Medicines Review (HMR)a
8. In general, how do you think patients will benefit from HMR?
9. How do you think you would personally benefit? What would you expect to be the health benefits?
10. Would you want an HMR? Why or why not?
This document includes only those questions designed to elicit perceptions about motivations to participate in HMR. Other questions regarding
barriers to participation in HMRs are excluded
a Consumer directed information regarding HMR: Available from the authors
Table 3 Focus group interview guide: Home Medicines Review recipients
1. How do you obtain your medicines?
2. What sort of medicine problems do you experience? How do you manage them? How do you cope? Do you use dose administration aids?
Do you have a carer?
3. How likely are you to: get sick from your medicines; see a doctor; or need to go to hospital because of them?
4. How much do you worry about your medicines?
5. Who do you approach for advice regarding medicines and medicine problems? Where else do you go for information?
6. How did you first hear about Home Medicines Review (HMR)? Did you already know about it? What did people say about HMR? What
did you expect?
7. What was it like during the interview? What did the pharmacist cover? What happened after the interview?
8. Overall, how do you feel it benefitted you? How would it benefit people, generally?
9. Would you want another HMR? Why or why not?
This document includes only those questions designed to elicit perceptions about motivations to participate in HMR. Other questions regarding
barriers to further participation in HMRs are excluded
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pack that I took it but I would forget whether I took
the Lipitor or not. (FG7, male, age unrecorded,
Arabic)
Therefore, the sub-theme ‘‘making mistakes’’ arose
because participants recognised that medication-problems
could arise because of their own actions. Overall, partici-
pants appeared to be not very worried about the implica-
tions of making mistakes. They tended to dismiss the
importance of making mistakes and discussed these prob-
lems without demonstrating verbal and non-verbal signs of
worry.
Subtheme: consuming multiple strong medicines is harmful
Some participants were not concerned about the harmful-
ness of their medicines, which is discussed in subtheme:
age-related decline in medication-related worries. Others
operated on the heuristic: Medicines are potentially
harmful, and people should be wary or ‘‘suspicious’’ of
taking them. ‘‘Ideally, nobody wants to take medicine’’,
and if possible, one should ‘‘get off it as soon as you can or
not take it all.’’ Many participants felt that they were
probably taking ‘‘too many’’ medicines, and they had
feelings of mild dread several times a day—whenever they
had to take another dose. This attitude was particularly
evident among Mandarin-speaking participants.
Some participants were concerned about taking a wide
variety of medicines over a long period of time. They were
afraid that liver damage, kidney failure, or bleeding
stomach ulcers could result in hospitalisation and negative
lifelong consequences. Some participants (particularly
those who had been recently hospitalized) showed their
fear through non-verbal body language by responding with
a worried countenance and shrugging their shoulders as if
to say: ‘‘There’s nothing I can do about it.’’ Others
described coping with their fear by adopting intentional
non-adherence, such as: adjusting doses; adjusting timing
of doses; omitting doses; self-experimenting to detect
which medicine was causing an adverse effect; and
rejecting treatment outright.
I go through a process of elimination, I’ll stop taking
each drug until I find which one is causing the
problem and then I go and see the doctor and try to
get it changed. (FG6, male, [74 years, English)
Subtheme: needing more or less information
Participants who felt they lacked basic information said
they wanted to learn more about their medicines such
as: the purpose or benefit of the medicine; what to expect
in terms of effectiveness; side-effects; doses and
administration times; and the expected length of treatment
required. Participants’ information need was therefore most
apparent after changing medications or starting new ones
and particularly after leaving hospital. Participants also
expressed bewilderment about the necessity of taking
medicines for chronic diseases indefinitely. They wanted to
know more about the actual decision-making processes that
medical practitioners use when selecting medicines and
doses.
It beats me how they work sometimes, taking all
these tablets, you know A goes here [points to
abdomen] and B goes here [points elsewhere]. (FG13,
male, [74 years, English)
Some participants felt positive about receiving Written
Medicines Information (WMI). However, many (particu-
larly older persons) felt apprehensive about reading long
lists of potential adverse effects, and doubted their own
ability to correctly attribute adverse effects to their
medicines.
When you’ve finished reading them [WMI] you’d be
a bit shy about picking up a glass of water…I’m not
saying that’s the wrong thing but they do warn you
of the dangers of absolutely everything. (FG16,
male [74 years, English)
Many participants felt uncertain and worried after
receiving risk information during conversations with health
professionals, as well as through print and electronic
media.
Subtheme: age-related decline in medication-related
worries
Compared with younger participants, older participants
(those aged [74 years) tended to focus their thoughts less
on their medicines; they answered questions without
expressing worry. Many older persons relied on heuristics
such as the availability heuristic: they believed that it was
highly unlikely that they were at risk for medication-related
problems because they were unable to recall any problems
in the past. Many older persons preferred a passive role in
their medicines-taking and actively avoided information
such as WMIs.
I think the less you read about the side effects, the
better off you are, don’t read them, you’ll become a
hypochondriac. (FG6, male, [74 years, English)
They believed that once they had delegated their deci-
sion-making to ‘‘qualified health professionals’’, it was
unnecessary for them to worry about medication-related
problems. Furthermore, they assumed their medicines were
safe since the pharmacists always ‘‘double-checked’’ them.
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In contrast, relatively younger persons tended to focus
more on being at risk of medication-related problems.
Well actually, I went to hospital yesterday with a
migraine and they’ve just gone on to this new
e-record thing, they didn’t even ask me what medi-
cations I was on… so you know things could be
pretty dangerous. (FG13, female, 50–64 years,
English)
Theme 2: expectations about sources of information
This theme identified how expectations about the sources
of information influenced participants’ decisions to seek
medicines information. It demonstrated that information-
seeking is clearly motivated by the need to manage worry
about experiencing problems. This theme overlaps with
Theme: needing more or less information, as some par-
ticipants perceived that they normally had little opportunity
to discuss medication-related problems with health pro-
fessionals. There were two subthemes: Preference for
interpersonal sources; and Home Medicines Review.
Subtheme: preference for interpersonal sources
For many participants there was a clear preference to seek
information about medicines from health professionals
with whom they had a good relationship. They valued those
who were able to listen carefully, demonstrate respect, and
take the time to explain things in lay terms. However,
participants were often frustrated when their health pro-
fessionals did not automatically provide them with clear
explanations about their medicines. Participants felt
uncertain when health professionals simply provided
WMIs instead of taking the time to discuss medicine issues.
In contrast, other participants spoke positively about the
detailed information their GPs provided, even when the
information was confronting. Some patients felt reassured
when their GPs provided them with individualized medi-
cation lists stating the purpose of each medicine.
Some participants, who wanted to seek information from
interpersonal sources, were prevented from doing so due to
various barriers. For example, Mandarin-speaking partici-
pants appeared to become emotional when talking about
how they were forced to make independent decisions due
to language barriers.
They always give too much information for us to
read. For people like us who have difficulty in read-
ing English, especially the medical terminology, such
as the name of medications, it is hard to understand.
We even cannot trust what we look up in the dic-
tionary. (FG4, female, age unrecorded, Mandarin)
Arabic-speaking participants discussed the need to tra-
vel through the city to find an Arabic-speaking pharmacist
to discuss problems. Participants from rural areas spoke
about there being not enough GPs in the region, while
older persons talked about transport that was difficult and
costly. In general, participants talked about the lack of
time available with ‘‘overworked’’ GPs and ‘‘busy’’
pharmacists.
Subtheme: Home Medicines Review
Participants’ positive outcome expectancies about partici-
pating in HMR were centred on the need to feel reassured
about the possibility of experiencing medication-related
harm. They expected to receive information about how best
to manage their medicines. The majority of participants
who had already participated in the HMR program said
they wanted another one. They often described pleasant
feelings about their experience, such as feeling respected
and cared for. They enjoyed the feeling of not being
rushed. In three focus groups, several participants had
experienced three or four HMRs annually with the same
HMR pharmacist each time. These participants spoke
glowingly about the relationship that had developed
between themselves and the pharmacist(s) and how the
pharmacist(s) were very empathetic to their needs.
Those participants who had not experienced an HMR
also expected to receive information and to feel reassured,
but many did not appear motivated to participate. Partici-
pants, who were not worried about the risk of experiencing
medication-related problems, appeared the least motivated.
It was often the older persons (those aged over 74 years)
who were the least motivated. Some of these participants
mentioned that they got all the information about medi-
cines they needed from their own community pharmacist or
their medical practitioner.
Participants explained that one of the benefits of having
an HMR was the opportunity to discuss the consequences
of non-adherence. It should be mentioned that participants
did not always discuss their intentional non-adherence with
their GP. Participants said they would value the indepen-
dent knowledge that they believed a HMR pharmacist
would provide: they believed it would empower them to
make more informed decisions.
[The HMR pharmacist] could tell me, with every
tablet that I’m taking, what it is doing… just to sit
down and have that hour session I think would be
great. (FG13, female, age unrecorded, English)
The opportunity that an HMR afforded, to discuss
intentional non-adherence, was highly regarded by Man-
darin-speaking participants.
Int J Clin Pharm (2012) 34:658–666 663
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If they can not only have a look at what medications I
take, but also integrate everything that I take, and give
an overall opinion. For example, I take 3 medications
for the one disease, whether this is suitable, you [HMR
pharmacist] give your own judgment. Otherwise,
everyday a full hand of medications… [worried tone]
(FG4, male, age unrecorded, Mandarin)
These participants wanted to arrange an HMR at the end
of the session, and were disappointed that they needed their
doctor’s approval. They then expressed reluctance to ask
their GP for the service because they felt ‘‘shy’’ and con-
cerned about ‘‘hurting the feelings’’ of the GP.
… you could discuss this [HMR] with the pharmacist,
but not the doctor. It’s very difficult to discuss this
with the doctor. Because the medication is prescribed
by the doctor himself, he will think ‘I give you this
medication, and you don’t trust me…instead you go
to find a pharmacist to take charge of me’ [laugh-
ter]… they won’t be happy. (FG4, male, age unre-
corded, Mandarin)
Discussion
As expected, participants were motivated to participate in
HMR by their positive outcome expectancies. They
expected that having an HMR would provide them with
personalized medicines-information, as well as reassur-
ance—which they may not have been able to receive from
their current health providers or non-interpersonal sources.
An important motivation to choose HMR to learn about
medication-related problems was the preference that many
participants (including older persons) expressed for com-
municating interpersonally.
Although participants in the present study valued good
relationships with their GPs, similarly to other studies, many
reported poor access to health professionals, communication
barriers and system failures [30, 31]. These results align with
previous research which suggest that patients feel that con-
sultations with GPs are too brief [31], to discuss: the purpose
or benefit of the medicine; what to expect in terms of
effectiveness; side-effects; drug-interactions; doses and
administration times; and the expected length of treatment
required [30, 31]. HMR consultations with pharmacists
(which may last for an hour) are therefore very acceptable
for discussing medication regimens. HMR is generally
provided annually and as such, patients may take a long time
to develop trust in a particular HMR pharmacist. Never-
theless, those patients who received repeated annual HMRs
with the same accredited pharmacist valued the relationship
which developed with that pharmacist.
Timing of medication management services
Consistent with theory, patients’ thoughts and feelings were
more focussed on positive outcome expectancies about
information sources (including HMR) when they were
worried about medication-related problems. This is also
consistent with the findings of a Swedish study which con-
cluded that patients who had volunteered to participate in a
pharmacist-provided medication safety intervention as ‘‘a
worried, vulnerable, and information-seeking group’’[35].
In the present study, participants reported experiencing
worry when they perceived that they had received either too
little or too much information—which created uncertainty
discrepancy for them. However, many participants did not
experience uncertainty discrepancy because they tended not
to engage with their thoughts about being at risk of medi-
cation-related problems. Therefore, these participants were
the least motivated to engage in medicines information-
seeking. However, when patients were stimulated to focus
their thoughts on being at risk—such as, beginning a new
medicine; have their medication regimen changed; or being
discharged from hospital [36–38], they experienced uncer-
tainty discrepancy, and the accompanying worry which they
had previously not experienced. Therefore, at these critical
times, patients may be more motivated to engage in medi-
cines information-seeking, such as HMR.
Decreasing worry with age
Importantly, however, it appeared that worry and therefore
motivation to seek medicines information may be lowest
among older participants, those at greatest risk of medi-
cation-related harm [39]. This finding is consistent with
socioemotional selectivity theory [40]. It is believed that
‘‘age-related constraints on time horizons’’ are associated
with motivational changes. These changes cause older
persons to increasingly focus on positive over negative
emotions [40]. As described by Williams and colleagues,
the present study found that many older patients seemed to
have an optimistic bias (i.e. unrealistic optimism) regarding
medication-related problems [41]. Relying on heuristics,
some emphatically denied the possibility (for them) of
experiencing medication-related problems and did not
worry about them. These patients may have been suscep-
tible to problems without realising it. Although all patients
use heuristics in decision-making [42], older patients may
rely on them more. We found that many older participants
often delegated their decision-making as a way of avoiding
worry. This was consistent with the findings of Say and
Murtagh, where many older participants do not wish to be
active in decision-making regarding the choice of medi-
cation treatments [43]. Also, Miller et al. [44] found that
older patients delegate decision-making and as in our
664 Int J Clin Pharm (2012) 34:658–666
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study, are less likely to read WMI. They found that many
older patients are not aware of the potential problems in
using non-steroidal anti-inflammatory medicines [44].
Limitations
There are several potential weaknesses of this study.
Firstly, the inclusion of carers in the focus groups (whose
data was not included in the analysis) may have influenced
patients’ responses. However, the researchers found no
evidence of this. Secondly, pharmacists facilitated the
focus groups, raising the possibility that participants
offered socially desirable answers. Participants’ plethora of
negative comments argues against this as a significant bias.
Finally, focus groups by nature will appeal to those par-
ticipants who are willing to discuss issues in a public
forum. Therefore, it is possible that the views of persons
who do not wish to discuss medication-related problems on
an interpersonal level may be underrepresented.
Conclusion
Worry, the emotional arousal that is activated when a
patient is no longer comfortable with their level of uncer-
tainty about being at risk of medication-related problems,
is likely to be a key factor in their motivation to participate
in the HMR program. Patients who are aged 75 years and
older may be at the highest risk of medication-related
problems and should probably be targeted to have an HMR.
However, these patients may be the least likely to worry
about medication-related problems, the least motivated to
participate in HMR and the least motivated to seek medi-
cines information elsewhere. This is due to their tendency
to focus on positive emotional goals rather than unpleasant
medicines information. Further research is needed on
communication strategies that would be most effective in
medication-safety interventions for older persons.
The GP plays a powerful role in increasing medication-
safety. Many patients will agree to have an HMR simply
because their GPs suggest it. For those patients who decline
to participate, it is possible that they have difficulty in
formulating positive outcome expectancies of HMR. In
order to motivate them, GPs could verbally reinforce
benefits such as: many HMR recipients report feeling
valued and cared for; and that the hour-long patient inter-
view gives them time to ask important questions that they
can’t think of during the consultation with their GP. Fur-
ther, GPs need to be mindful that patients may be more
receptive to their suggestions to have an HMR at times
when they are at most at risk [36–38], such as when taking
a new medicine; having a change to their medication reg-
imen; and being discharged from hospital.
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Abstract
Background: Some consumers at risk of experiencing medication-related problems have chosen not to use
pharmacist-provided medication management services. Previous research has shown that consumers’
willingness to use the Australian Home Medicines Review (HMR) service depends on the extent to which
they believe that they will receive medication information to assist them with self-management.
Objectives: The aim of this study was to develop and test a model of willingness to use HMR among
consumers who were eligible to receive the service but have not yet experienced it. Speciﬁcally, this study
aimed to determine the eﬀects of consumers’ medication-related worry and the social inﬂuence of the
consumer’s general practitioner (GP) over willingness.
Methods: A cross-sectional postal survey was conducted among 1600 members of Council on the Ageing
(NSW, Australia). Respondents were included in the study if they had not experienced an HMR and were
taking more than 5 medicines daily or more than 12 doses daily. Measurement scales were developed or
were based on previous research. Conﬁrmatory factor analysis was used to test the reliability and validity
of the multi-item scales. Multiple regression analysis and structural equation modeling (SEM) were used to
test the model.
Results: Surveys received from 390 respondents (24.3%) were analyzed. Respondents held overall
low-to-neutral positive outcome expectancy (POE). The SEM analysis revealed that worry had a direct
eﬀect on POE (b¼ 0.35, P! .05) and an indirect eﬀect on willingness (b¼ 0.22, P! .05). Subjective
norms had a direct eﬀect on willingness (b¼ 0.27, P! .05) but not POE. Worry was higher among
those who had experienced a change in the medication regimen within the past 3 months (b¼ 0.19,
P! .001).
Conclusions: Those consumers who were worried about their medicines were more willing to use HMR.
The consumer’s GP appeared to exert a signiﬁcant positive social inﬂuence over willingness to use this
medication management service.
 2012 Elsevier Inc. All rights reserved.
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Introduction
Preventable adverse events that occur in am-
bulatory care are a signiﬁcant cause of morbidity
in Australia.1 It is estimated that adverse events
result in 2-3% of all hospital admissions, 50%
of which may be preventable.2 There is increasing
interest in medication safety interventions to
prevent these problems. For example, the 2007
Institute of Medicine’s report on Preventing
Medication Errors recommended that regulatory
agencies should provide consumers with increased
access to medication information and medication
self-management support.3 Medication manage-
ment services provided by pharmacists are pro-
vided for persons who consume multiple
medicines4 and are at elevated risk of experiencing
medication-related problems.5 There is evidence
that these services resolve medication-related
problems,6–8 which in turn can improve health
outcomes. This article investigates one issue,
which is fundamentally important to the success
of medication management programsdconsumer
willingness to use them. Although consumers
who have experienced an Australian medication
management service are quite willing to reuse
the service, those who would be eligible but have
not yet experienced it are less willing.9,10 Research
into eligible nonrecipients’ willingness to use med-
ication management services is important because
studies conducted with the UK’s Medicines Use
Reviews,11 Australia’s Home Medicines Review
(HMR),12,13 and the U.S.’ Medication Therapy
Management (MTM)14 show that some are reluc-
tant to use these services. Although procedural
aspects of the programs vary, the services share
similarities in that the consumer has an in-depth
interview with a pharmacist about the consumer’s
medicines. Because these services resolve
medication-related problems, which in turn can
improve health outcomes, a lack of consumer
participation is a quality use of medicines issue.
Furthermore, enhanced uptake of medication
management services may depend on understand-
ing the factors, which inﬂuence eligible nonreci-
pients’ willingness to use them.
The HMR service
The HMR15 is a quality use of medicines inter-
vention, which aims to resolve medication-related
problems and improve health outcomes for those
at greatest risk of medicine-related problems.6–8
The HMR also aims to increase consumer and
caregiver knowledge of medicines. An HMR is
provided collaboratively by general practitioners
(GPs) and pharmacists. The providers claim for
the full cost of service provision from the Austra-
lian government. An HMR is initiated with a re-
quest from the consumer’s GP to the consumers’
preferred pharmacy or to the GP’s preferred ac-
credited pharmacist. The pharmacist generally
visits the consumer and caregiver(s) at their
home, for an extended interview regarding medi-
cation management issues. Following the visit,
the pharmacist sends a written report document-
ing medication review ﬁndings and recommenda-
tions to the GP, who then formulates a revised
medication management plan with the consumer.
Previous research conducted by the authors of
this article has shown that eligible nonrecipients’
willingness to use HMR, is at least in-part, driven
by consumers’ expectations, which are centered on
the provision of medication information.16 Given
that the past experience is a key determinant of
a person’s expectations about a service,17 it was
proposed that eligible nonrecipients’ expectations
about medication management services would
likely reﬂect their past experience of pharmacists
acting in roles that are familiar to them. Multiple
medicine users would have interacted with phar-
macists and received medication advice during
dispensing or within the hospital ward. Although
consumers may be unfamiliar with some of the
technical aspects of the service, their expectations
of receiving information during HMR would be
reasonably tangible and may therefore act to
motivate participation.
A theoretical model based on Social Cognitive
Theory (SCT)18 and the Theory of Motivated In-
formation Management (TMIM) have recently
been developed by the authors of this manu-
script.19 After providing respondents with a brief
description of HMR within a cross-sectional sur-
vey, 46% of the variation in eligible nonrecipients’
willingness to use HMR was explained by the
model.16 There were 2 important ﬁndings from
that study. First, the most important inﬂuence
on willingness to use HMR was positive outcome
expectancy (POE) (b¼ 0.56, P! .001). The POE
was deﬁned as the extent to which consumers
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expect that HMR would provide them with in-
creased medicines knowledge, improve their med-
icines management capability, and reduce their
medicine concerns. Second, the consumers were
overall not convinced that HMR would provide
these beneﬁts. This second ﬁnding is consistent
with the ﬁndings of a study conducted with the
U.S.’ MTM program, which suggested that con-
sumers who are naive to pharmacist-provided
medicines management services have low-to-
moderate expectations of receiving personal bene-
ﬁt.14 Aiming to improve consumer participation,
the previous study recommended that consumer-
directed descriptions of medication management
services should highlight that HMR is an informa-
tion source.16
This study builds on previous research by
investigating the inﬂuence of antecedent variables,
which may have inﬂuenced willingness either
directly or indirectlydby inﬂuencing expectations
about the outcomes and communication processes
involved. In keeping with the proposition that
willingness to use HMR is driven by information
seeking, this article considers the inﬂuence of 2
types of psychosocial factors, which are thought
to motivate information seeking in the ﬁeld of
health. First, the theory suggests that a person’s
emotional engagement with the topic motivates
information seeking.19,20 In this case, worry about
health problems that could arise as a result of tak-
ing medicines is likely to be important. Second,
the theory suggests that a person’s search for in-
formation may be inﬂuenced by people who are
important to that person.21–23 Here, because
HMR involves collaboration among the con-
sumer, their GP, and a pharmacist, it is likely
that the consumers’ GP would be have
a signiﬁcant social inﬂuence over their willingness
to use HMR.
A better understanding of the inﬂuence of
consumers’ worry (about health problems that
could arise as a result of taking medicines) and
perceived social pressure (of the GP) to partici-
pate would provide insights to improving the
development and implementation of these medi-
cation management services. Therefore, the aim of
the research was to develop an extended model of
consumer willingness to use HMR and to test the
model in a group of respondents who were
recruited anonymously.
Methods
Model development
Theoretical foundation
Based on previous research,9,16 constructs were
adapted to the context of this investigation
(Fig. 1). The context explored the willingness to
use HMR of an individual who has not previously
received HMR but who was presented with infor-
mation about the service. According to SCT,
whether a person is motivated to undertake a par-
ticular activity may be inﬂuenced by their expecta-
tions about the outcome of participating in the
activity and expectations about their capacity to
undertake the activity.18 Constructs from the
TMIM of Aﬁﬁ and Weiners19 were adapted to
the present investigation because it further de-
velops SCT to help explain a person’s motivation
to seek information from an interpersonal source.
In addition, the model adapts constructs from
the Theory of Planned Behavior (TPB)23 to ac-
count for the perceived social pressure to use
H8,+
H1,+ 
Social norms of 
GP 
Communication 
efficacy 
Willingness 
to use
H2,+ 
H4,+ 
H5,- 
H6,+ 
Risk factors 
for 
medication-
related 
problems 
Medication-
problem worry 
H3,+ 
Positive 
outcome 
expectancy 
H7,+
H9,+
Fig. 1. Willingness to use Home Medicines Reviews. The þ or  symbol refers to the hypothesized direction of
inﬂuence.
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HMR. The model creates links between eligible
nonrecipients’ worry (about health problems
that could arise as a result of taking medicines),
the perceived social pressure to participate, expec-
tations about the outcomes and processes in-
volved in HMR, and willingness to use the service.
Willingness to use HMR
Most of the research conducted with SCT uses
behavioral intention as the antecedent variable to
actual behavior. In general terms, therefore, the
present model includes variables related to inten-
tion. However, Gibbons et al24 argue that willing-
ness to perform a behavior, that is, intention
conditioned on certain premises, may explain
more variation in actual behavior than intention
alone. Willingness may capture irrational and re-
active inﬂuences.24 Consistent with the previous
study,16 willingness to use HMR was deﬁned as
to whether the respondent was (1) willing to use
HMR if their GP suggested it to them and (2) will-
ing to ask their GP for an HMR if they were
concerned about their medicines.
Positive outcome expectancy
This category of beliefs deals with an in-
dividual’s focus on behavioral-outcome expec-
tancy. These may be further divided into positive
expectancy and negative expectancy. Consistent
with the previous study,16 POE was deﬁned as
expectations that the HMR would provide med-
ication information, which would assist medi-
cines management, and that a person would
feel reassured by receiving this informa-
tion.11,25,26 It is hypothesized that POE would
have a direct and positive eﬀect on willingness
to use HMR (hypothesis 1). Although it is possi-
ble that negative outcome expectancydrelated
to the consumers’ potential discomfort of being
visited at homedmay have a negative eﬀect on
their willingness to participate, this category of
beliefs were not inﬂuential in the previous
study,16 and were therefore not investigated in
the present model.
Communication eﬃcacy
The second broad category of beliefs is assess-
ments about an individual’s ability to perform the
information-seeking action, self-eﬃcacy.18 In the
present context, self-eﬃcacy evaluations follow
those of TMIM’s construct known as communica-
tion eﬃcacy (CE).19 Therefore, CE was deﬁned as
a person’s perception of their ability to overcome
potential barriers in the communication process,
such as making time for; organizing; and if
required, asking their own doctor for an
HMR.16 It is hypothesized that CE would have
a direct and positive eﬀect on willingness (hypoth-
esis 2).
In SCT, self-eﬃcacy is thought to inﬂuence
a person’s intention to act both directly and
indirectly by increasing outcome expectancy.18
Maddux et al27 and Aﬁﬁ and Weiner,19 however,
contend that the direction of inﬂuence between
self-eﬃcacy and outcome expectancy is reversed.
That is, that outcome expectancy inﬂuences
self-eﬃcacy. Both theories oﬀer compelling argu-
ments to support their respective position; how-
ever, there remains an element of uncertainty in
the true direction of the causal relationship be-
tween these constructs and the manner in which
the controversy could be resolved.28 In a cross-
sectional study such as this, it is not possible to
determine the direction of inﬂuence, and the au-
thors share the view of Maddux et al27 Aﬁﬁ and
Weiners19 view that POE inﬂuences CE positively
(hypothesis 3).
Medication-problem worry
There is increasing interest in the role of
emotional states in health behaviors29 and in partic-
ular with regard to information seeking.30 Health
information seeking is often framed as a coping
strategy, which attempts to reduce the cognitive
stress and negative aﬀect surrounding uncertainty
or perceptions of being at risk.31 For example, in
both the Risk Information Seeking and Processing
(RISP) model21 and the Planned Risk Information
Seeking Model (PRISM),22 negative aﬀect (which
arises with risk perception [RP]) motivates infor-
mation seeking. In the TMIM model,19 a person’s
motivation to engage in information seeking arises
when they are no longer comfortable with their
level of uncertainty. In that case, the person experi-
ences negative aﬀect (anxiety), which motivates
them to consider the outcome expectancy of infor-
mation seeking.19 However, rather than investigat-
ing the relationship between outcome expectancy
and discomfort with uncertainty, the presentmodel
explores the relationship between outcome expec-
tancy and the negative aﬀect (worry), which arises
with RP.32 In qualitative research, worry about
the safety of medicines appeared to be a key factor
in motivating participants to consider the beneﬁts
of using HMR.33 The present model proposes gen-
erally that when a person experiences worry about
the possibility of experiencing a health problem,
they are motivated to consider the positive behav-
ioral outcomes of seeking information about that
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health problem. To apply this general eﬀect to the
context of this study, 2 constructs were deﬁned.
First, RP was deﬁned as a person’s perception of
the likelihood of them experiencing problems as
a result of taking their medicines. Second, medica-
tion-problem worry (MPW) was deﬁned as the spe-
ciﬁc (and mild) anxiety state, which arises in
tandemwith thisRP. It is proposed thatwhen aper-
son experiences MPW, they are likely to consider
that an interpersonal information source such as
HMRwould bemore salient, relevant, and reassur-
ing than if they experienced no such worry. There-
fore, it is hypothesized that MPW increases POE
(hypothesis 4).
In consideration of the possible relationship
between MPW and CE, it should be noted that
there is a close relationship between anxiety and
low self-eﬃcacy.18 It is possible that experiencing
a high level of MPW may therefore have a detri-
mental eﬀect on the self-conﬁdence required
to perform tasks associated with information seek-
ing. It is hypothesized that medication problem-
related anxiety may decrease CE (hypothesis 5).
Medication risk factors
The RISP21 and the PRISMmodels22 place var-
ious demographic and situational factors as ante-
cedents to RP and worry. This article focuses on
the potential impact of 3 diﬀerent situations facing
a multiple medicine user, which could induce RP
and MPW: (1) while a person adjusts to changes
to themedication regimen.During this time theper-
son undergoes a period of “self-monitoring” to de-
tect any physiological response to the change.
Prescribers, pharmacists, and nurses often encour-
age such self-monitoring to avoid preventable ad-
verse eﬀects; (2) while a person adjusts to changes
in their overall health after hospitalization. It
should also be noted that medication regimens are
changed quite frequently during hospitalization
and extensive changes increase the risk of further
changes in the regimen after discharge34; and
(3) when a person is required to implement the in-
structions of multiple regular prescribers, which
could at times be conﬂicting.35 Each of the situa-
tions mentioned above: (1) having a change in the
regimen within the past 3 months, (2) having been
hospitalized within the past month, and (3) having
multiple regular prescribers place an individual at
increased risk of experiencing medication-related
problems.5,36 These risk factors may also be used
to identify consumers who may beneﬁt from
HMR,15 and it is hypothesized that these risk fac-
tors would increase MPW (hypothesis 6).
Subjective norms of the GP
The ﬁnal construct in this model concerns the
eﬀect of social pressure to use the HMR service.
Within SCT, social persuasion is a recognized
antecedent to both outcome expectancy and self-
eﬃcacy.18 Subjective norms, derived from TPB,23
is a related construct. Within the context of infor-
mation seeking, subjective norms operate such
that if the subject thinks that someone close to
themselves, such as a family member, friend, or
carer, would approve of the utilization of the
information resource; and if the subject has moti-
vation to comply with the wishes of the close per-
son, then the subject is more likely to seek
information.21 Subjective norms have been inte-
grated into the RISP21 and the PRISM models,22
and they have been shown to be one of the stron-
gest predictors of health information-seeking in-
tent.22 In qualitative studies, it was found that
some participants who thought HMR would be
beneﬁcial were not willing to use a pharmacist-
provided service because they could not be sure
that their GP approved of the service.9 Given
the strong relationship between a consumer and
their GP, subjective norms of the GP (SNGPs)
could have a potentially powerful and direct inﬂu-
ence over medication behaviors. For example,
SNGPs has increased the likelihood of patient
persistence with antidepressant medicines.37 In
the context of the present study, therefore,
SNGP was deﬁned as the perceived social pressure
(of the consumer’s GP) to use HMR. Therefore, it
is hypothesized that SNGP would have a direct
and positive eﬀect on willingness (hypothesis 7).
It is also possible that SNGP could inﬂuence will-
ingness indirectly. The SNGP could inﬂuence
a person’s expectations about the outcomes of
having an HMR. The implication here is that if
a person believes that the GP thinks that HMR
is beneﬁcial, and the person felt social pressure
to participate, then the person may also believe
that it would be personally beneﬁcial. Therefore,
it is hypothesized that SNGP would have a posi-
tive eﬀect on POE (hypothesis 8). In addition,
SNGP could inﬂuence a persons’ expectations
about their own capability to arrange an HMR
and to ask the GP to have an HMR. Therefore,
it is hypothesized that SNGP would inﬂuence
CE (hypothesis 9).
Model testing
The study used a cross-sectional survey design
to test the theoretical model.
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Sample
The study sample was drawn from membership
of Council on the Ageing (COTA, New South
Wales, Australia). The COTA is a community
group that provides community information and
education, and social policy leadership for elderly
persons in New South Wales and Australia. The
COTA NSW was chosen because many members
are elderly persons who were therefore likely to be
using multiple medicines. In addition, COTA
participates in community programs to improve
the quality use of medicines. Respondents were
eligible for inclusion in this study if they had not
previously received an HMR but were eligible to
receive it because they were taking either 5 or
more medicines daily or 12 or more doses daily.
Survey
Items included in the survey were derived from
the results of previous qualitative9 and quantita-
tive16 studies. The survey was assessed for face
validity by a panel of 7 expert community phar-
macists, consultant pharmacists, and academic
pharmacists. The survey was pretested with 15 re-
spondents, which resulted in a reﬁnement of ques-
tion wording and reduction in the number of
variables measured. A short explanation of
HMR was provided within the survey, which
was adapted from an Australian Government
consumer brochure (Appendix 1).38
Belief measures
Belief measures used in the study are reported
in Table 1. The following belief measures were
used in the previous study.16
Positive outcome expectancy. The POE was mea-
sured with 6 items to which respondents provided
their level of agreement on a 5-point Likert scale.
This scale previously had good construct reliabil-
ity (CR¼ 0.94).16
Communication eﬃcacy. The CE was measured
with 4 items to which respondents provided their
level of agreement on a 5-point Likert scale. Note
that these items were reverse coded before further
analysis. This scale previously had acceptable CR
of 0.75.16
Willingness. Willingness to use HMR (W), here-
after called willingness, was measured with 2 items
to which respondents provided their level of
agreement on 5-point Likert scales. This scale pre-
viously had acceptable CR of 0.71.16
The following measures were developed for the
present study.
Risk perception. The RP was measured with
a single 5-point semantic diﬀerential scale with
available responses ranging from 1¼ “very un-
likely” to 5¼ “very likely.”
Medication-problem worry. In this article,
medication-problem worry (MPW) was identiﬁed
as the frequency with which a person worries
about the health problems resulting from taking
medicines. It was measured with a single 5-point
semantic diﬀerential scale with available responses
ranging from 1¼ “never” to 5¼ “always.”
Subjective norms of the GP. The SNGP was
adapted from studies conducted with the TPB.23
Subjective norms have 2 dimensions therefore, 2
question items were included following the results
of the qualitative study.9 Respondents were asked
to provide their level of agreement on a 5-point
Likert scale to 1 question for each of the 2 dimen-
sions: (1) Subjective normative beliefsdbeliefs that
their GP would approve of HMR. This was oper-
ationalized by asking whether respondents
thought that their GP would be happy to be asked
for an HMR (if they themselves considered that
an HMR was needed); and (2) Motivation to
complydthe degree to which their GPs thoughts
about HMR mattered to the respondent. As is
recommended,39 the measure for subjective nor-
mative beliefs was coded to range between 2
and þ2, whereas motivation to comply was coded
to range between 1 and 5. The responses were then
multiplied to create a single measure of SNGP,39
a continuous variable that could theoretically
vary between 10 and þ10.
Sociodemographic data
The demographic information collected in the
surveys included gender, age group, education,
and postcode. The postcode was used in combi-
nation with Australian census data to provide an
index of socioeconomic advantage and disadvan-
tage.40 The index is a continuum of advantage
(high values) to disadvantage (low values), which
takes into account factors relating to a person’s
access to materials and social resources. Medica-
tion risk factors were recorded as either present,
absent, or unknown.
Data collection
Respondents were recruited through a single
mail sent to 1600 members of COTA NSW. No
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incentives were oﬀered to respondents or COTA
NSW. Approval for the project was given by the
University of Sydney Human Ethics Committee.
The survey was conducted between November
2008 and March 2009.
Analysis
The PASW version 18.0.03 (SPSS Inc., Chicago,
IL; www.spss.com) was used for descriptive statisti-
cal analyses, Spearman’s correlation, and linear re-
gression. Conﬁrmatory factor analysis (CFA) and
structural equation modeling (SEM) were
performed with EQS 6.1 build 97 (Multivariate
Software, Inc. Encino, CA; www.mvsoft.com). Hy-
pothesis testing was performed by SEM and by lin-
ear regression. Evidence of data non-normality,
particularly in the dependent variable, required
that structural equation parameter estimates were
madeusingmaximum likelihood estimationwith ro-
bust errors (which is used within the EQS program).
Convergent validity of the constructs was as-
sessed by inspection of the results from CFA.
The CFA was performed in the presence of the
single-item scales of MPW and SNGP. Standard-
ized factor loadings should exceed 0.50 with statis-
tical signiﬁcance to demonstrate high convergence
on a common point.41 In addition, the average
Table 1
Descriptive statistics of belief measures
Construct/item code Item Median [IQR] Mean (SD) n
Positive outcome expectancya
POE1 Ease with managing my medicines 2 (2-3) 2.45 (0.96) 387
POE2 Understand more about my medicines 3 (2-4) 2.92 (1.15) 387
POE3 Assist me to live at home
independently
3 (2-3) 2.55 (1.15) 387
POE4 Fewer concerns about long-term side
eﬀects
3 (2-3) 2.60 (1.09) 384
POE5 Fewer concerns about drug
interactions
3 (2-4) 2.76 (1.13) 387
POE6 More conﬁdent that the medicines are
helping me
3 (2-4) 2.68 (1.10) 386
Communication eﬃcacya (reverse score provided)
CE1 Diﬃculty arranging 4 (3-4) 3.74 (0.84) 383
CE2 No time 4 (3-4) 3.67 (0.84) 382
CE3 Diﬃculty asking GP 4 (3-4) 3.79 (0.79) 370
CE4 Asking for HMR indicates that I have
no conﬁdence in GP
4 (3-4) 3.55 (0.84) 369
Subjective norms
Normative beliefs: SNGP1b My GP would be happy for me to ask
me for an HMR if I needed one
1 (0-1) 0.65 (0.71) 371
Motivation to comply: SNGP2a It matters what my GP thinks about
HMR
4 (3-4) 3.65 (0.71) 373
Risk perceptionc
RP Perceived likelihood of experiencing
medication-related problems
2 (1-3) 2.06 (1.24) 388
Medication-problem worryd
MPW Frequency of worry about problems
caused by my medicines
2 (1-3) 2.10 (0.94) 390
Willingness to use HMRa
W1 Willing to have an HMR if suggested
by the GP
4 (3-4) 3.64 (0.84) 384
W2 Willing to ask the GP for an HMR
if having concerns about medicines
4 (3-4) 3.40 (0.98) 385
IQR, interquartile range; SD, standard deviation.
a Responses varied from 1 (strongly disagree) to 5 (strongly agree).
b Responses varied from 2 (strongly disagree) to þ2 (strongly agree).
c Responses varied from 1 (very unlikely) to 5 (very likely).
d Responses varied between 1 (never) to 5 (always).
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variance extracted should equal or exceed 50%.41
The reliability of the constructs was computed
using the formula suggested by Fornell and
Larcker.42 The CR values equal to or greater than
0.7 indicate that the construct of the model is reli-
able, although coeﬃcients of between 0.5 and 0.8
may be considered acceptable during preliminary
investigations.41 Discriminant validity was assessed
through the use of variance-extracted test.42 The
variance-extracted estimates for 2 factors were
compared with the square of the correlation be-
tween the factors. Discriminant validity is demon-
strated if both variance-extracted estimates are
greater than the squared correlation. Measurement
errors were ﬁxed to (1 reliability) variance.43
Using the method of Westland,44 the minimum
sample size for an appropriate indicator to latent
ratio, with 3 latent constructs and 11 indicators,
was calculated to be 122. Therefore, the study had
suﬃcient power to performCFA.Measurement er-
rors were ﬁxed to (1 reliability) variance.43
Using the method of Westland,44 a sample size
ofmore than 271was required to detect aminimum
eﬀect size of 0.20 with a power of 0.8 and P! .05.
Using the same method post hoc, it was estimated
that the minimum eﬀect size that could reliably be
determined with the sample of 342 (the number of
respondents with a complete data set) and the
same power and signiﬁcance settings was 0.18.
A stepwise linear regression analysis was used to
test the inﬂuence of each of the 3 medication risk
factors onMPW.Before performing the regression,
the skewness and kurtosis of the variable was
calculated. Independent variables were gender
(reference category, male), age (reference category,
age! 65 years), education level (reference cate-
gory, year 10 or below), index of socioeconomic
advantage and disadvantage, and the 3 risk factors
for medication-related problems. The reference
category for the risk factorswas “no”or “not sure.”
Results
Surveys were received from 610 (38.1%) re-
spondents and after excluding those that did not
meet the inclusion criteria, 390 remained pro-
viding an eﬀective response rate of 24.3%. De-
scriptive statistics of the sample are provided in
Table 2.
Belief measures
Means and standard deviations for the belief
measures from each group are presented in Table 1.
Positive outcome expectancy
For most variables, the median score was 3, the
neutral response. The median for the item mea-
suring easier medicines management was 2. This
indicates that overall, respondents were relatively
unconvinced that an HMR would provide posi-
tive outcomes.
Communication eﬃcacy
Following reverse coding, the median score for
each variable was 4, indicating overall high levels
of CE.
Risk perception
The median response to perceived likelihood of
experiencing medication-related problems was
“unlikely”¼ 2.
Table 2
Sample characteristicsa
Characteristics n (%)
Gender
Male 141 (33.8)
Female 136 (66.2)
Age group (y)
!65 27 (7.1)
65-74 111 (29.4)
75-84 190 (50.3)
R85 50 (13.2)
Education level
Year 10 or below 106 (28.7)
Year 12 or equivalent 131 (35.5)
University 132 (35.8)
Presence of medication risk factorsb
Medication regimen change within
last 3 mo
74 (19.5)
Hospital within the last month 39 (10.1)
Multiple regular prescribing doctors 111 (29.0)
Socioeconomic status by postal
location (n¼ 372)c
Mean (SD)
Index of relative disadvantage and
advantage
1084 (90)
a Refers to valid responses only, so that the sum of
responses may not add up to the total.
b Refers to the proportion who responded (yes) to
the presence of the risk factor.
c The Index of relative disadvantage/advantage
ranks locations (in this case by postcode) based on
data obtained from the national 2006 census and uses
socioeconomic factors such as income, education, oc-
cupation and housing conditions. A lower index indi-
cates relative disadvantage and a higher index
indicates relative advantage. The mean rank for Aus-
tralia is 1000.
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Medication-problem worry
The median response to the frequency of MPW
was “rarely”¼ 2.
Subjective norms of general practitioner
The median response to the measure of subjec-
tive normative beliefswasþ1 (range:2, 2), indicat-
ing overall agreement that respondents believed
that the GP would be happy to discuss HMR.
The median response to the measure of motivation
to comply was 4 (range: 1-5), indicating overall
agreement that the GPs opinion of HMR was im-
portant to the respondent. The measure of SNGP,
after multiplying the responses of subjective nor-
mative beliefs with that of motivation to comply,
ranged between8 andþ10. The median response
was þ3 indicating that the GP had positive social
pressure over the respondent to use HMR.
Willingness
The median score for each of these items was 4,
indicating that overall, respondents were willing
to have an HMR if suggested by the GP and
willing to ask the GP if they had concerns about
their medicines.
Conﬁrmatory factor analysis
Missing data analysis revealed that the overall
level of missing data was small (!5% for all
variables) and only 45 cases were excluded. Exam-
ination of the correlation matrix revealed that no
relationships were above 0.90; therefore, multi-
collinearity was not considered problematic.
The parameter estimates and the goodness-of-
ﬁt indices indicated that overall, the measurement
model was a reasonable ﬁt for the data. Apart from
the signiﬁcant Satorra-Bentler c2¼ 191, df¼ 69,
P! .001, model ﬁt indices were reasonable.Model
ﬁt statistics: comparative ﬁt index (CFI)¼ 0.94,
Tucker-Lewis Index (TLI)¼ 0.91, root mean
square error of approximation (RMSEA)¼ 0.072
(90% conﬁdence interval¼ 0.060-0.084). Stan-
dardized and unstandardized factor loadings, con-
struct reliabilities, and average variances extracted
are presented in Table 3. The variances of the indi-
cator variables loading onto each latent construct
were signiﬁcant. For each of the constructs, all of
the factor loadings were greater than or equal to
0.50, with the exception of 1 item on the CE scale
(CE4) for which the loading was 0.48. Construct
reliabilities were above the target of 0.7 for the
POE (0.95) scale and the CE (0.71) scale, but just
below target for the Willingness scale (0.65). Aver-
age variance extracted was above the target of 50%
for the POE scale (75%), approached 50% for the
willingness scale (49%), but was below target for
the CE scale (36%). Discriminant validity between
each of the constructs was demonstrated, as for
each pair of constructs both average variances ex-
tracted estimates were greater than the squared
correlation.
Structural equation model
The SEM ﬁt statistics indicated that the mea-
surement model was a reasonable ﬁt for the data.
Apart from the signiﬁcant Satorra-Bentler scaled
c2¼ 189, df¼ 70, P! .001, model ﬁt indices
were reasonable. Model ﬁt statistics: CFI¼ 0.94,
TLI¼ 0.92, RMSEA¼ 0.068 (90% conﬁdence
Table 3
Conﬁrmatory factor analysis (n¼ 390)
Item Standardized
regression weights
Unstandardized regression
weight (URW)
Standard error
of URW
Construct
reliability
Average variance
extracted (%)
Positive outcome expectancy
POE1 0.83 1.00 0.00 0.95 75
POE2 0.85 1.21 0.07
POE3 0.76 0.96 0.06
POE4 0.91 1.24 0.05
POE5 0.93 1.32 0.06
POE6 0.89 1.23 0.06
Communication eﬃcacy
CE1 0.70 1.00 0.00 0.71 38
CE2 0.61 0.88 0.11
CE3 0.65 0.87 0.11
CE4 0.48 0.69 0.11
Willingness to use HMR
W1 0.75 1.00 0.00 0.65 49
W2 0.64 0.97 0.11
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interval¼ 0.059-0.083). The model predicted 55%
of the variation in willingness (W), 12% of the var-
iation in POE, and 24% of the variation in CE.
Fig. 2 provides the results of hypothesis testing.
The SEM analysis revealed that POE had a strong
direct eﬀect on willingness (b¼ 0.66, P! .05).
The CE had a moderate direct eﬀect on willingness
(b¼ 0.19, P! .05). The MPW had a moderate di-
rect eﬀect on POE (b¼ 0.35, P! .05), no signiﬁ-
cant eﬀect on CE, but had an indirect eﬀect on
willingness (b¼ 0.22, P! .05). The SNGPs had
a moderate direct eﬀect on CE (b¼ 0.48, P! .05)
andno eﬀect onPOE. Subjective normshad adirect
eﬀect (b¼ 0.27,P! .05) but no signiﬁcant indirect
eﬀect on willingness.
Spearman correlation
The RP measured as the perceived likelihood
of experiencing medication-related problems was
highly correlated with the measure of MPW
(a¼ 0.55, P! .001).
Fig. 2. Structural equation model showing correlation and regression coeﬃcients (*P! .05; ns, indicates no signiﬁcant
relationship).
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Multiple regression
The measure of MPW score had a skewness of
0.69 and kurtosis of 0.06 and was therefore
determined to be an appropriate dependent vari-
able for linear regression. The stepwise regression
resulted in a model with the following statistics:
adjusted R2¼ 0.061, F¼ 8.38, P! .001. There
were 2 signiﬁcant categories of predictor variables
with signiﬁcant eﬀects; having a recent change in
the medicine regimen increased worry (b¼ 0.19,
P! .001) and increasing age decreased worry.
Compared with the reference category (age below
65 years), those persons aged 75-84 years
(b¼0.17, P¼ .002), and those 85 years and
older (b¼ 0.11, P¼ .032) were signiﬁcantly less
likely to worry.
Discussion
This study demonstrated that 55% of the
variation in respondents’ willingness to use
HMR may be explained by the hypothesized
model. The SEM analysis revealed that willing-
ness was higher among those respondents who
had greater: (1) POEdrespondents’ expectations
that HMR would provide them with increased
medicines knowledge, improve their medicines
management capability, and reduce their medicine
concerns; (2) CEdbeliefs about their capability to
ask for and arrange an HMR; and (3) SNGPsd
the perceived social pressure of the GP to use
HMR. Of these factors, the strongest was POE.
These ﬁndings support the previous-held notion
that multiple medicine users view HMR as an
information resource and that their willingness to
use it is driven by expectations about the services’
capacity to provide medication information.16
Similar to the previous ﬁndings, consumers’
POE was low to neutral.16 There appears to be
scope for the profession to increase demand for
these services, through lifting expectations of
medication management services as information
resources. Although the present study ﬁndings
are consistent with the previous study, the conclu-
sions to be drawn are now more generalizable,
bearing in mind the use of 2 diﬀerent recruitment
strategiesdrecruitment by community pharma-
cists16 and by anonymous postal survey. In the
previous case, community pharmacists recruited
respondents and it was possible that pharmacists
may have selectively recruited consumers with
known favorable attitudes toward HMR or phar-
macists’ services generally. In summary, it is now
clear that to motivate consumers who have not ex-
perienced medication management services to par-
ticipate, it is important that they realize that their
participation results in receiving medication infor-
mation, which assists them to manage their medi-
cines. When discussing medication management
services with consumers, health professionals
should use verbal encouragement and written re-
sources to reinforce this issue. It is acknowledged
that medication management services provide
consumers with a variety of health beneﬁts, in-
cluding, for example, but not limited to solving
medication-related problems, rationalization of
medication regimen, monitoring for medication
eﬀectiveness/adverse eﬀects, and improved collab-
oration between health providers. However, de-
scribing these intangible beneﬁts to consumers
who have not yet experienced medication manage-
ment is challenging.45
As predicted by theories of information seek-
ing, respondents were more convinced that they
would receive medication information during an
HMR and were more willing to use the service, if
they were worried about health problems resulting
from taking their medicines. This ﬁnding supports
the conclusions of a Swedish study, which found
that consumers who participated rather than
avoided a pharmacist-provided medication man-
agement intervention were a “worried, vulnerable,
and information-seeking group.”46 This is the ﬁrst
article to demonstrate the motivating eﬀect of
MPW on medication information seeking. As ex-
pected, this speciﬁc form of worry was correlated
with the respondents’ RPs. That is, the more a re-
spondent thought that it was likely that they may
experience medication-related problems, the more
often they worried about the health consequences
of taking their medicines. In accordance with
a study of willingness to prevent medical errors,32
the correlation between RP and worry was very
high, and worry was a good predictor of willing-
ness to act.
This article also showed that the respondents’
worry about the risk of experiencing medication-
related harm responded to actually being at risk.
In this case, those respondents whose medication
regimen had changed within the previous 3 months
worried more frequently about experiencing health
problems from their medicines, than those who
had no change. Qualitative studies report that
consumers’ worries about taking new medicines
are centered in knowledge gaps about the
purpose or beneﬁt of the medicine, what to expect
in terms of eﬀectiveness, side eﬀects, doses and
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administration times, and length of treatment
required.47,48 When taking new medicines, con-
sumers may be uncertain about attributing symp-
toms to adverse eﬀects because adverse eﬀects
may overlap with disease symptoms.49 Patient
counseling services provided by medical practi-
tioners and pharmacists encourage patients to
self-monitor and it is therefore not surprising that
worry about experiencing harm is present after
medication changes. In accordance with program
guidelines, HMR could be provided to consumers
after a signiﬁcant change in their regimen. This ar-
ticle adds that consumers are more worried about
experiencing harm after such changes. Given the
link between worry and POE, it is likely that
consumers will also be more receptive to sugges-
tion and promotion of medication management
services after medication changes. Consumer-
directed information about HMR could be pro-
vided to multiple medicine users after changes to
medication regimen in the same manner that writ-
ten medicines information (WMI) is provided. It
should be noted that the authors do not advocate
building positive expectations of medication man-
agement services by intentionally increasingMPW.
It would probably be easy to increase consumers’
worry about medicines within service information
leaﬂets. This possibly could be achieved by describ-
ing in detail the manner in which medicines may
cause problems. The WMI leaﬂets already cause
some concern among some consumers.50 However,
excessively increasing medication-related anxiety
could also stimulate nonadherence, as demon-
strated by the work of Horne et al.51–53 Rather,
this new knowledge of the relationship between
worry and willingness to use medication manage-
ment services could be used to appeal to consumers
who are worried about their medicines and who
may also be nonadherent.
It is noteworthy that it was the oldest of
respondents who were the least worried about
medication problems. This is consistent with
qualitative study, which suggested that older
participants were the least engaged in topics
relevant to medication risk and were the least
willing to have HMR.9 It is possible that older
persons’ declining experience of MPW may pre-
vent them from focusing on the positive outcomes
of participating in medication management ser-
vices. Such changes may be explained by socioe-
motional selectivity theory.54 It is believed that
“age-related constraints on time horizons” are
associated with motivational changes. These
changes cause older persons to increasingly focus
on positive over negative emotions.54 In addition,
older persons may attribute symptoms, which
may be medication adverse eﬀects, to the conse-
quences of aging.55 Older persons may require
more encouragement to use medication manage-
ment services than younger persons.
Social inﬂuence of the consumer’s GP
It is clear that in Australia, consumers’ will-
ingness to use medication management services
depends on their perceptions of what the GP
thinks of the service. The SEM analysis revealed
that the main eﬀect of the social inﬂuence of the
GP, measured as subjective norms, was to act
directly on willingness to use. The social inﬂuence
of the GP did not extend to increasing POE. In
other words, this social inﬂuence was eﬀective,
although it had no bearing over whether respon-
dents thought that the HMR was personally
beneﬁcial. This result reinforces the powerful
eﬀect that a person’s GP has over health-related
decisions.
Limitations
Although HMR shares many attributes with
other international medication review services
provided in the United States,14 Canada,56 New
Zealand,57 or the United Kingdom,11 it cannot
be assumed that the ﬁndings of the present study
would necessarily apply to these services.
The generalizability of the study may be
limited by the relatively low response rate. Before
applying the inclusion criteria, only 38.1% of the
COTA members responded. Response rate could
have possibly been improved by a repeat mailing;
however, limited funding prevented this strategy.
Consistent with predictions made by the model
and with previous ﬁndings,16 the present study
demonstrated that CE was associated with in-
creased willingness to use HMR. However, al-
though the measurement scale for CE had good
CR, there was 1 factor loading below the target
and the average variance extracted was below
the target. It is recommended that future research
should attempt to improve the measurement of
CE in the present context.
The present study deﬁned MPW as the fre-
quency with which a person worries. McCaul and
Goetz58 have identiﬁed 2 dimensions of worry in
relation to health behaviordthe intensity and the
frequency. They suggest that there is no consensus
about which is themost inﬂuential inmodifying be-
havior. Future research could develop a scale to
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probe the intensity of worry experienced. Further-
more, the present research used only single vari-
ables to model RP and MPW constructs. Future
research could use multiple indicators to tap these
latent constructs.
Conclusion
This study makes a signiﬁcant contribution
to the theoretical understanding of health
information-seeking behavior. This was the ﬁrst
research to show that the speciﬁc worry a person
experiences when they consider themselves to be at
risk of a health problem is associated with in-
creasing their POE of seeking information about
the problem from an interpersonal source. In turn,
POE was associated with increased willingness to
use the interpersonal source. Speciﬁcally, eligible
nonrecipient consumers’ worry about medication
problems was associated with greater expectations
that HMR would provide them with increased
medicines knowledge, help them manage their
medicines, and reduce their medicine concerns.
Consistent with studies around the world, it was
shown that consumers who have not experienced
medication management services have low expec-
tations of receiving these beneﬁts. This study
reinforces the need to explain to prospective
consumers that they should expect to receive these
beneﬁts. It is likely that eligible nonrecipients
would expect more of HMR and be more willing
to use it if it were oﬀered after a change in the
medication regimen. Furthermore, this study dem-
onstrates that social pressure has a demonstrable
eﬀect on willingness to use collaborative medica-
tion management services. Many consumers will
need to feel that they have the social approval of
their GP to participate.
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Appendix 1
Description of HMR provided to eligible
nonrecipients, adapted from an Australian
Government consumer brochure59
A Home Medicines Review, a free service
funded by Medicare, provided jointly by your GP
and pharmacist, is particularly useful for people
who take multiple medicines each day, or who
have recently spent time in hospital or who are con-
cerned or uncertain about their medicines. After be-
ing referred by a GP, the pharmacist usually visits
the patient in their own home at a mutually agreed
time. The pharmacist will look at all medicines that
the patient has, discuss any diﬃculties or concerns
the patient may have with using their medicines,
and write a report to the GP. The GP will then dis-
cuss the results of the HMR with the patient. The
HMRs help patients and carers to understand bet-
ter how to use their medicines.
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Abstract
Objectives Informal caregivers experience daily hassles – a form
of persistent stress, as a consequence of caregiving. This study
aimed to develop and test a new theoretical model of health infor-
mation-seeking behaviour, the Knowledge Hassles Information
Seeking Model (KHISM). KHISM hypothesized that the knowl-
edge hassles of caregivers – daily stressors experienced while deal-
ing with tasks which require knowledge about the safety and
eﬀectiveness of the care-recipients’ medicines – would inﬂuence
caregivers’ willingness to assist their care-recipient to use an Aus-
tralian medication management service, Home Medicines Review
(HMR).
Methods A cross-sectional postal survey was conducted among
2350 members of Carers (NSW, Australia). Respondents were
included in the study if they were involved in medication-related
tasks for their care-recipient and were not paid as caregivers.
Also, their care-recipient needed to be taking more than ﬁve medi-
cines daily or more than 12 doses daily and had not yet experi-
enced HMR. Structural equation modelling was used to test the
model.
Results A total of 324 useable surveys were returned yielding a
response rate of 14%. Respondents were quite willing to assist
their care-recipient to use HMR (willingness). The model predicted
51% of the variation in willingness. Knowledge hassles increased
positive outcome expectancy (b = 0.40, P < 0.05) and indirectly
increased willingness.
Conclusions The more caregivers experience hassles with medica-
tion knowledge, the more they perceive HMR to be a helpful
information source and the more willing they are to use it. Tar-
geted marketing centred on HMR as an information source may
increase caregivers’ demand for HMR. Further exploration of the
phenomenon of knowledge hassles is warranted.
ª 2013 John Wiley & Sons Ltd Health Expectations 1
doi: 10.1111/hex.12092
CHAPTER SIX 118
Background
In many developed nations, throughout Eur-
ope,1,2 North America3 and in Australia,4 the
population is ageing and the burden of chronic
disease and comorbidity is growing. The bur-
den of disease and associated stress is often
shared with informal caregivers. For the pur-
pose of this study, informal caregivers (caregiv-
ers) are those persons who care for a person
who uses multiple medicines and is not paid to
do so. They are very likely to be family mem-
bers. One of the key reasons for reduced care-
givers’ quality of life and poor coping
strategies is a lack of knowledge about the
duties expected of them.5 One duty that care-
givers lack knowledge about pertains to the
speciﬁc knowledge required to manage the
care-recipient’s medicines.6 Medication regi-
mens have become increasingly complex,7 as
multiple medicines are often used to manage
common chronic diseases of ageing.8 The more
complex a care-recipient’s medication regimen,
the more stress a caregiver experiences.9 Better
caregiver access to medication information
may lower their stress and could help them
avoid medication problems.10 Problems related
to the use of medicines are a signiﬁcant cause
of morbidity within Australia.11 It is estimated
that they result in 2–3% of all hospital admis-
sions, 50% of which may be preventable.12
This study deals with caregivers’ perceptions
of Home Medicines Review (HMR),13 a medi-
cation safety intervention which aims to resolve
medication-related problems and improve
health outcomes for those at greatest risk of
medication-related problems.14–16 HMR also
aims to increase patient and caregiver knowl-
edge of medicines. HMR is provided collabora-
tively by general practitioners (GPs) and
pharmacists. An HMR is initiated with a
request from the patient’s GP to a pharmacist,
who may be their preferred community phar-
macist or a consultant pharmacist who works
independently. Pharmacists who perform HMR
must be accredited by an approved credential-
ing body.13 The pharmacist generally visits the
patient and caregiver(s) at their home, for an
extended interview regarding medication man-
agement issues. Following the visit, the phar-
macist sends a written report documenting
medication review ﬁndings and recommenda-
tions to the GP, who then formulates a revised
medication management plan with the patient.
Caregivers (whose care-recipients have
received the service) report that the medication
information they themselves receive during the
HMR service is useful and helps to relieve their
emotional stress resulting from dealing with
medication issues.17 Even though this program
increases patients’ use of appropriate and evi-
dence-based therapies,18–20 evaluation commis-
sioned by the Australian government reported
that there had been a suboptimal uptake of
HMR, particularly among patients at greatest
risk including those with dementia.21 The
report suggested that caregivers have a key role
in enhancing participation and suggested that
both patients and their caregivers need to be
better informed of the beneﬁts.21 The present
study deals with the factors that may inﬂuence
caregivers’ willingness to participate in the pro-
cesses of HMR (for their care-recipient). Will-
ingness to participate is therefore deﬁned as
the willingness of a caregiver to undertake the
tasks required to assist their care-recipient to
use HMR. In this context, a care-recipient was
a person who was eligible to receive HMR but
had not previously received the service.
Enhancing participation among caregivers
could be challenging because research has dem-
onstrated a lack of willingness to participate
among patients who have not yet experienced
the service.22 In addition, caregivers of frail,
older patients tend not to use many of those
services available to them, and further work is
needed to understand how to encourage partic-
ipation.23,24
At present, there is currently no existing the-
oretical framework which links caregivers’
stress with their intentions to participate in
health services. Furthermore, there are no
quantitative studies that have investigated care-
givers’ willingness to participate in HMR. A
better understanding of the factors that inﬂu-
ence caregivers’ willingness to participate
ª 2013 John Wiley & Sons Ltd Health Expectations
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would provide insights to improving the devel-
opment and implementation of medication
management services. Speciﬁcally, descriptions
of HMR intended for caregivers could better
promote participation in the service. Therefore,
the aim of the research was to develop and test
a model of caregivers’ willingness to participate
in HMR (for their care-recipient).
Methods
The theoretical model for this study was ﬁrstly
developed then tested in a cross-sectional sur-
vey of caregivers.
Knowledge Hassles Information Seeking Model
(KHISM) development
Based on the literature and qualitative stud-
ies,17,25 several constructs were adapted to the
context of the study. The study explored care-
givers’ willingness to participate in HMR, after
being presented with information about the
service. It is hypothesized that caregivers’ moti-
vations to use HMR are primarily inﬂuenced
by their expectations of HMR as a medication
information source. In other words, their will-
ingness to participate is dependent on medica-
tion information seeking. In this context, the
Knowledge Hassles Information Seeking
Model (KHISM) model creates links between
caregiver stress dealing with medication infor-
mation; expectations about the outcomes and
processes involved in HMR; and willingness to
participate (Fig. 1).
Theoretical foundation
According to cognitive–social theories, whether
a person undertakes a particular activity is inﬂu-
enced by their behaviour-outcome expectancy
(outcome expectancy) and their self-eﬃcacy
expectancy (self-eﬃcacy). These expectancies
are essential components of Bandura’s
Social Cognitive Theory (SCT),26 Rogers’ and
Maddux’s Protection Motivation Theory
(PMT)27 and Aﬁﬁ and Weiners’ Theory of
Motivated Information Management (TMIM).28
Of these theories, TMIM most closely suits
the present investigation because it deals
with information seeking from interpersonal
sources.
Intention – Willingness to participate
Most of the research conducted with SCT uses
behavioural intention as the antecedent variable
to actual behaviour. In general terms, there-
fore, our model includes variables related to
intention. However, Gibbons et al.29 argue that
willingness to perform a behaviour, that is
intention conditioned on certain premises, may
explain more variation in actual behaviour
than intention alone. Willingness may capture
irrational and reactive inﬂuences.29 Therefore,
willingness to participate in HMR forms the
dependent variable for this model. Based on a
qualitative study30 and a quantitative study
H3,+
H2,–
H1,+
Other hassles Communication 
efficacy
Willingness 
to participate
Positive 
outcome 
expectancy
H2,–
H4,+
H5,+
H6,+
Risk factors 
for 
medication-
related 
problems
Knowledge
hassles
Figure 1 Knowledge Hassles information-seeking model (KHISM): informal caregivers’ willingness to participate in Home
Medicines Reviews. + or – refers to the hypothesised direction of influence.
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conducted with patients,31 willingness to partic-
ipate was therefore deﬁned as whether respon-
dents would help arrange an HMR for their
care-recipient, whether the care-recipient’s gen-
eral practitioner (GP) recommend it, and
whether they would ask the GP for an HMR if
they had concerns about their care-recipients’
medicines.
Outcome expectancy
Outcome expectancy deals with an individual’s
focus on the behavioural outcomes to be
derived from information seeking, which in this
case is participating in HMR. Outcome expec-
tancy may be further divided into positive
expectancy and negative expectancy. This eval-
uation broadly follows a beneﬁt vs. cost trade-
oﬀ. In identifying potential positive outcome
expectancy for HMR, the literature suggests
that patients expect to receive personally rele-
vant medication information that would be
reassuring and assist in self-management.32–34
Caregivers too had similar expectations in
focus group research.17,35 Positive outcome
expectancy (OE) was therefore deﬁned as a
caregiver’s beliefs about the eﬀectiveness of an
HMR to correct their knowledge deﬁciency;
improve their medication management capabil-
ity; and to reduce their anxieties about the
safety of their care-recipients’ medication regi-
men. In SCT, positive outcome expectancy
increases intentions to act. In patients, positive
outcome expectancy (of HMR) was strongly
associated with increased willingness to partici-
pate in HMR.31 While it is possible that nega-
tive outcome expectancy – related to the
caregivers’ potential discomfort of being visited
at home – may have a negative eﬀect on their
willingness to participate, this category of
beliefs has not shown to be inﬂuential in
patients31 and was not therefore investigated in
the present model.
Self-eﬃcacy – communication eﬃcacy
Self-eﬃcacy deals with an individual’s percep-
tion of their ability to perform the informa-
tion-seeking action.26 In SCT, self-eﬃcacy
increases intention to act. In the present con-
text, self-eﬃcacy most closely follows communi-
cation eﬃcacy in accordance with TMIM.28
Here, communication eﬃcacy centres on a
caregiver’s perception of their conﬁdence to
overcome potential barriers in the communica-
tion process such as making time for an HMR;
organizing it and, if required, asking the
patient’s doctor to initiate it.30 In a study con-
ducted with patients, lack of conﬁdence to per-
form these tasks decreased willingness to
participate in HMR,31 and it is likely the same
would hold for caregivers.
In SCT, self-eﬃcacy is thought to inﬂuence a
person’s intention to act both directly and indi-
rectly by increasing outcome expectancy.26
Maddux,36 Aﬁﬁ and Weiner,28 however, con-
tend that the direction of inﬂuence between
self-eﬃcacy and outcome expectancy is
reversed. That is, that outcome expectancy
inﬂuences self-eﬃcacy. Both sides of the debate
oﬀer compelling arguments to support their
respective theories; however, there remains an
element of uncertainty in the true direction of
the causal relationship between these con-
structs, and the manner in which the contro-
versy could be resolved.37 In a cross-sectional
study such as this, it is not possible to deter-
mine the direction of inﬂuence, and the authors
share Maddux, Aﬁﬁ and Weiners’ view that
outcome expectancy inﬂuences communication
eﬃcacy.
Daily hassles – antecedent to outcome
expectancy and communication eﬃcacy
In the context of health, information seeking is
often framed as a coping strategy, which
attempts to reduce the cognitive stress and
emotional arousal arising from uncertainty.38
For example, TMIM,28 which adapts con-
structs from SCT26 and PMT,27 suggests that
an individual’s motivation to engage in infor-
mation seeking arises when an individual is no
longer comfortable with their level of uncer-
tainty. In this case, the person experiences neg-
ative aﬀect (anxiety) which motivates that
person to consider the outcomes expectancy of
information seeking.28 However, rather than
investigating the relationship between outcome
ª 2013 John Wiley & Sons Ltd Health Expectations
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expectancy and anxiety (arising from discom-
fort with uncertainty), this model explores the
relationship between outcome expectancy and
daily hassles. KHISM proposes that when a
person experiences daily hassles, speciﬁcally
related to knowledge processing, they are moti-
vated to consider outcome expectancy of infor-
mation seeking.
Daily hassles are the ‘irritating, frustrating,
distressing demands that to some degree char-
acterize everyday transactions with the environ-
ment’. Experiencing hassles can represent an
on-going and insidious threat to health. For
example, the frequency and severity of daily
hassles is a better predictor of psychological
distress and somatic disease than major life
events such as death in a relative, marital
changes and serious ﬁnancial problems.39 Past
research has shown that experiencing daily has-
sles with friends, family, environment and life’s
practicalities is associated with negative
aﬀect.40 Furthermore, experiencing daily has-
sles is associated with the tendency to interpret
events as threatening and with the tendency to
seek out threat-relevant information (known as
‘monitoring’41).40
It is known that caregivers experience daily
hassles as a result of performing tasks related
to managing their care-recipients’ medi-
cines.42,43 These daily hassles have also been
documented among Mexican caregivers’ who
speak the Spanish language at home.44 Con-
sider the task involved in managing a care-
recipients complex medication regimen. The
caregiver needs to understand the processes
involved in the procurement and administra-
tion of medicines. These processes may require
caregivers to negotiate with prescribers, phar-
macists, nurses and the care-recipient. They
may need to understand how and when the
medicines are taken, monitor for beneﬁcial
eﬀects and adverse eﬀects, adjust doses and/or
cease medicines. Travis and colleagues have
investigated the dimensionality of these daily
hassles and have developed the Family Care-
giver Medication Administration Hassles
(FCMAHS) Scale.42 In one setting, the FCM-
AHS scale had four dimensions: (i) information
seeking/information sharing, (ii) safety issues,
(iii) scheduling logistics, and (iv) polypharma-
cy. In another study, factor analysis revealed
that data were best represented by six dimen-
sions: (i) initial information seeking, (ii) safety
issues, (iii) advanced information acquisition,
(iv) scheduling, (v) daily routine, and (vi) pre-
scription ﬁlling.44
Knowledge hassles
This study further extends an understanding of
the inﬂuence of daily hassles on information
seeking by proposing that only speciﬁc types of
hassles, knowledge hassles cause a person to
consider the outcomes of information seeking,
whereas the other types of hassles will not.
Knowledge hassles were deﬁned generally as
those daily hassles experienced because of the
need to repeatedly process information on a
health topic which requires specialized knowl-
edge. KHISM suggests that when a person
experiences knowledge hassles, they are likely
to consider an interpersonal information source
on the health topic particularly relevant and
reassuring. In other words as knowledge has-
sles rise so does positive outcome expectancy.
In this study, the authors compare the eﬀect
of other hassles with knowledge hassles. In the
present context, knowledge hassles are daily
stressors experienced by caregivers while deal-
ing with tasks that require knowledge about
the safety and eﬀectiveness of the care-recipi-
ents’ medicines, whereas the other hassles are
medication administration hassles that result
from performing tasks which do not require
specialized knowledge. Other hassles include
hassles with interpersonal interactions between
the caregiver and care-recipient and hassles
with maintaining the logistics of supply. In
seeking to separate knowledge hassles from
other hassles, eight items from FCMAH scale
were adapted. The authors chose not to use the
whole FCMAH scale to produce a reasonably
parsimonious questionnaire. This was also car-
ried out to reduce the cognitive load on the
older respondents. For the purpose of this
study, four items were selected to represent
knowledge hassles: recognizing adverse eﬀects;
ª 2013 John Wiley & Sons Ltd Health Expectations
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knowing whether the medicine is eﬀective;
knowing why the medicine is used; and know-
ing what questions to ask the doctor. Four
items were selected to represent other hassles:
scheduling medicines into the daily routine;
sharing responsibility with the care-recipient;
arguing with care-recipient about when to take
medicines; and giving medicines on time. Expe-
riencing other hassles would not necessarily
have any inﬂuence over positive outcome
expectancy because seeking information (about
medicines) would not resolve these stressors.
In seeking to understand how experiencing
hassles may inﬂuence communication eﬃcacy,
it is clear that there is a close association
between experiencing hassles and anxiety.40
There is also a close relationship between anxi-
ety and low self-eﬃcacy.26 It is possible that
experiencing hassles may therefore have a det-
rimental eﬀect on the self-conﬁdence required
to perform the communication tasks associated
with information seeking. Whereas only knowl-
edge hassles should inﬂuence positive outcome
expectancy, experiencing any hassles may
decrease communication eﬃcacy.
Situational factors that may inﬂuence knowledge
hassles
While daily hassles are persistent daily stres-
sors, it is expected that the level of hassles
would ﬂuctuate according to certain situations.
Knowledge hassles would ﬂuctuate according
to a person’s current perception of the special-
ized knowledge demanded of them at the time.
Knowledge hassles would be more stressful
during extended episodes of uncertainty. There
are three situations in the present context,
which would be associated with extended peri-
ods of uncertainty and potentially heightened
knowledge hassles; (i) while a caregiver adjusts
to the demands of changes to the care-recipi-
ent’s medication regimen. This could occur
quite frequently for care-recipients who use
multiple medicines for chronic diseases, (ii)
while a caregiver adjusts to changes in the
care-recipients’ overall health after hospitaliza-
tion. It should also be noted that medication
regimens are changed quite frequently during
hospitalization and extensive changes increase
the risk of further changes in the regimen after
discharge,45 and (iii) a caregiver would perceive
extra demand on knowledge if they were
required to implement the instructions of mul-
tiple regular prescribers, which could at times
be conﬂicting.46 Each of the situations men-
tioned above: (i) having a change in the regi-
men within the past 3 months, (ii) having been
hospitalized within the past month, and (iii)
having multiple regular prescribers, place an
individual at increased risk of experiencing
medication-related problems.47,48 These risk
factors may also be used to identify patients
who may beneﬁt from HMR.13
The KHISM model tests the following
hypotheses.
• Knowledge hassles (but not other hassles)
would increase positive outcome expectancy
(H1).
• Knowledge hassles and other hassles would
decrease communication eﬃcacy (H2).
• Positive outcome expectancy would increase
communication eﬃcacy (H3).
• Communication eﬃcacy would increase will-
ingness to participate (H4).
• Positive outcome expectancy would increase
willingness to participate (H5).
• Knowledge hassles would be heightened in
the presence of three risk factors for medica-
tion-related problems: (i) having a change in
the regimen within the past 3 months, (ii)
having been hospitalized within the past
month, and (iii) having multiple regular pre-
scribers (H6).
Model testing
Respondents
During February and March 2009, respondents
were recruited through mail-out to 2350 mem-
bers of a caregiver interest group, based in
Sydney, Australia; Carers (NSW). No incen-
tives were oﬀered to respondents or Carers
(NSW). Approval for the project was given by
the University of Sydney Human Ethics Com-
mittee.
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Inclusion criteria. The study included informal
caregivers of adult persons who had not previ-
ously experienced HMR but were eligible
because they were taking more than ﬁve medi-
cines daily or more than 12 doses daily.13
Informal caregivers were deﬁned as those who
were not paid to provide care, other than
receiving government allowances and who pro-
vided a certain level of care. Therefore, the
study included caregivers who sometimes, often
or always were involved in at least one of the
following four medication-related caring duties
for their care-recipient: Purchase, order or col-
lect his/her medicines; organize how and when
he/she takes the medicines; give him/her a
dose; or make decisions to increase or decrease
a dose, or not take a dose, or discontinue the
medicine altogether.42
Questionnaire
Caregiver and care-recipient characteri-
stics. The demographic information collected
in the questionnaires included the caregivers’
and care-recipients’ gender, age, education and
location by postcode. Data were also collected
on the relationship status between caregiver
and care-recipient, the level of care provided
and whether the caregiver was paid to provide
care. To determine whether the care-recipient
had risk factors for medication-related prob-
lems, respondents were asked whether (i) there
had been a change in the care-recipients’ medi-
cines or doses prescribed within the past
3 months, (ii) whether the care-recipient had
been discharged from hospital within the previ-
ous month, and (iii) whether the care-recipient
had multiple regular prescribers. These ques-
tions had a response format of yes, no and not
sure.
Psychosocial measures. Daily hassles. As
explained in the model development section,
four items were used to measure each of the
knowledge hassles (KH) and other hassles
(OH) constructs. Respondents were asked to
rate each task on a scale from 0 = no hassle at
all to 5 = the worst of all hassles as to how
much of a hassle it is to help manage the care-
recipient’s medicines.
All other psychosocial measures were adapted
from a questionnaire conducted with patients.31
Each of the Likert scales had a response format
of 1 = strongly disagree to 5 = strongly agree.
The questions were modiﬁed such that caregiv-
ers’ beliefs, thoughts and feelings were examined
in relation to caregiving. For example: If I had
a Home Medicines Review, managing my medi-
cines would be easier was reconstructed to: If
(the person I care for) had a Home Medicines
Review, managing (the person I care for)’s med-
icines would be easier.
Outcome expectancy (OE). Respondents pro-
vided their level of agreement with six items on
a 5-point Likert scale. The scale has shown to
have good construct reliability (0.94) among
patients.31
Communication eﬃcacy (CE). Respondents
provided their level of agreement with four
items on a 5–point Likert scale. Note that these
items were reverse coded prior to further analy-
sis. The scale has shown to have acceptable
construct reliability (0.75) among patients.31
Dependent variable. Willingness to participate
(W). Respondents provided their level of agree-
ment with two items on a 5–point Likert scale.
The scale has shown to have acceptable con-
struct reliability (0.71) among patients.31
The questionnaire was examined for face
validity by a panel of seven expert community
pharmacists, consultant pharmacists and phar-
macy academics. A short explanation of the
service was provided which was adapted from
an Australian Government consumer brochure
(Appendix).49
Analysis
PASW version 18.0.03 (SPSS Inc., Chicago, IL,
USA, www.spss.com) was used for descriptive
statistical analyses, multiple regression and
exploratory factor analyses (EFA). Principal
components analysis was used with oblimin
rotation because the scales were expected to be
correlated. Conﬁrmatory factor analysis (CFA)
and structural equation modelling (SEM) were
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performed with EQS 6.1 build 97 (Multivariate
Software Inc., Encino, CA, USA, www.mvsoft.
com). Hypothesis testing was performed by mul-
tiple regression analysis and with SEM. Evi-
dence of data non-normality in willingness to
participate required that structural equation
parameter estimates were made using maximum
likelihood estimation with robust errors (which
is used within the EQS program). All eight items
contained within the two hassles scales were
subject to an initial EFA to conﬁrm that there
were two dimensions. Each of the other multi-
item measurement scales was also subject to ini-
tial EFA to determine dimensionality and to
detect items with low communality (<0.5).50 Fol-
lowing this procedure, CFA was performed in
the presence of willingness to participate (W).
Conﬁrmatory factor analysis
Convergent validity of the constructs was
assessed by inspection of the results from CFA.
Standardized factor loadings should exceed
0.50 with statistical signiﬁcance, to demonstrate
high convergence on a common point.50 In
addition, the average variance extracted should
equal or exceed 50%.50 The reliability of the
constructs was computed using the formula
suggested by Fornell and Larcker.51 The con-
struct reliability values equal to or greater than
0.7 indicate that the construct of the model is
reliable, although coeﬃcients of between 0.5
and 0.8 may be considered acceptable during
preliminary investigations.50 Discriminant
validity was assessed through the use of vari-
ance-extracted test.51 Constructs were evalu-
ated by comparing the variance-extracted
estimates for two factors with the square of the
correlation between the two factors. Discrimi-
nant validity is demonstrated if both variance-
extracted estimates are greater than the
squared correlation. Measurement errors were
ﬁxed to (1-reliability) X variance.52
Structural equation model
Using the method of Westlund,53 it was calcu-
lated that the minimum sample size for an
appropriate indicator to latent ratio, with ﬁve
latent constructs and 19 indicators, to be 112.
Therefore, the study had suﬃcient power to
perform CFA. Using the method of Westl-
und,53 it was estimated that a sample size of
more than 344 was required to detect a mini-
mum eﬀect size of 0.20 with a power of 0.8
and P < 0.05. Using the same method, post
hoc, it was estimated that the minimum eﬀect
size that could reliably be determined with the
sample of 297 (the number of respondents with
a complete data set) and the same power and
signiﬁcance settings was 0.22.
Multiple regression analysis
A stepwise linear regression analysis was used
to test the inﬂuence of each of the three situa-
tional factors on knowledge hassles. For this
procedure, the dependent variable was the
summated factor-based score, which was calcu-
lated by summing the responses to each of the
four knowledge hassle items. The possible
range for the factor score was 0–20. Prior to
performing the regression, the skewness and
kurtosis of the summated factor score was cal-
culated. Independent variables were caregiver
characteristics, gender, age, education level,
and the three risk factors for medication-
related problems. The reference category for
the risk factors was ‘no’ or ‘not sure’.
Results
Questionnaires were received from 600 respon-
dents and of these, 324 met the inclusion crite-
ria. This provided a 14.4% eﬀective response
rate. Descriptive statistics of the sample are
provided in Table 1.
Psychosocial measures
Means and standard deviations for the psycho-
social measures from each group are presented
in Table 2. The following provides some
descriptive statistics of the belief measures and
the results of EFA for each construct.
Daily hassles
Overall, respondents reported experiencing low
levels of daily hassles related to managing their
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care-recipients’ medicines. Yet, a minority of
respondents (n = 60, 18.5%) recorded 0 (no
hassles at all) to all eight daily hassles items.
The median score for three of the four knowl-
edge hassles (KH) items was 1, whereas the
median was 0 for the item which dealt with
hassles related to knowing why a medicine is
being given. The median score for each of the
four other hassles (OH) items was 0. Following
EFA, eight items loaded onto two factors with
eigenvalues above 1 which explained 65.3% of
the variation. All items had communalities
above 0.5, and all items loaded onto the
expected factors. The factor loadings ranged
between 0.63 and 0.93, and there were no
cross-loadings above 0.3.
Outcome expectancy
For most variables, the median score was 3,
the neutral response. This indicates that over-
all, respondents were not convinced that an
HMR would provide these positive outcomes.
All six items loaded onto the one factor with
eigenvalues above 1 which explained 76.4% of
the variance. All items had communalities
above 0.5. The factor loadings ranged between
0.78 and 0.92.
Communication eﬃcacy
Following reverse coding, the median score for
each variable was four, indicating overall high
levels of communication eﬃcacy. All four items
loaded onto the one factor with eigenvalues
Table 1 Descriptive statistics
Demographic characteristics1
Caregiver Care-recipient
Mean (SD), range Mean (SD), range
Age 64.6 (11.8), 27–88 67.7 (18.2), 18–98
n (%) n (%)
Gender
Male 87 (26.9) 167 (52.2)
Female 236 (73.1) 153 (47.8)
Relationship
Spouse 207 (64.3)
Other family relationship 101 (31.4)
Unrelated 14 (4.3)
Location
Metropolitan 272 (84.0) 273 (84.3)
Rural or remote 52 (16.0) 51 (15.7)
Education level2
Year 10 or below 107 (33.8) 147 (45.9)
Year 12 or equivalent 100 (31.7) 113 (36.5)
University 108 (34.3) 50 (16.1)
Medication risk factors3
Change in the medication regimen within the previous 3 months 129 (41.0)
Discharged from hospital within the previous month 44 (13.8)
Multiple regular prescribers 113 (35.9)
Frequency of care provided with medicine tasks4
Purchase, order or collect his/her medicines 315 (97.2)
Organize how and when he/she takes the medicines 273 (84.8)
Give him/her a dose 235 (73.0)
Make decisions to increase or decrease a dose, or not take a dose,
or discontinue the medicine altogether
56 (17.3)
1Refers to valid responses only, so that the sum of responses may not add up to the total.
2Within Australia, the two categories of high school education level; year 10 and year 12, indicate eleven and 13 years of formal school
education, respectively.
3Respondents were divided into two groups, those who answered ‘yes’, or those who answered ‘no’ or ‘don’t know’. The numbers and
proportions refer to those who answered ‘yes’.
4Refers to the proportion who responded ‘sometimes’, ‘often’ or ‘always’ to the level of care provided to the care-recipient.
ª 2013 John Wiley & Sons Ltd Health Expectations
Caregivers’ willingness to use Home Medicines Review, S R Carter et al. 9
CHAPTER SIX 126
above 1 which explained 48.5% of the vari-
ance. Two items had communalities below 0.5,
being 0.47 and 0.44 for CE3 and CE4, respec-
tively. These items were retained to provide a
multi-item scale for the study. Factor loadings
ranged between 0.67 and 0.73.
Willingness to participate
The median score for each of these items was
four, indicating that overall, respondents were
willing to participate in HMR if suggested by
the GP and willing to ask the GP if they had
concerns about the care-recipients medicines.
This two item scale was not subjected to EFA.
Confirmatory factor analysis
Missing data analysis revealed that the overall
level of missing data was small (<5% for all
variables), and only 27 cases were excluded.
Examination of the correlation matrix revealed
that no relationships were above 0.90; there-
fore, multicollinearity was not considered prob-
lematic.
The CFA ﬁt statistics indicated that the mea-
surement model was a reasonable ﬁt for the
data. Apart from the signiﬁcant Satorra-Ben-
tler scaled chi-square = 320, d.f. = 160,
P < 0.001, model ﬁt indices were good for the
measurement model. Model ﬁt statistics:
CFI = 0.94, TLI = 0.93, RMSEA = 0.058
(90% conﬁdence interval = 0.049, 0.067). Stan-
dardized and unstandardized factor loadings,
construct reliabilities and average variances
extracted are presented in Table 3. The vari-
ances of the indicator variables loading onto
each latent construct were signiﬁcant. For each
of the constructs, with the exception of com-
munication eﬃcacy, all of the factor loadings
were greater than or equal to 0.48, and average
variances extracted were greater than or equal
to 50%. For these scales, the minimum con-
struct reliability estimate was 0.71. There was
some question, however, about the reliability
of the CE scale. Two of the items had rela-
tively low factor loadings of 0.42 for CE3 and
0.40 for CE4. In addition, construct reliability
(0.62) and average variance extracted (30%)
Table 2 Descriptive statistics of psychosocial measures
Construct Item code Item Mean (SD) n
Hassles1
Knowledge
hassles
KH1 Recognizing adverse effects 1.66 (1.54) 322
KH2 Knowing whether the medicine is effective 1.66 (1.56) 323
KH3 Knowing why the medicine is used 0.88 (1.32) 322
KH4 Knowing what questions to ask the doctor 1.25 (1.42) 323
Other
hassles
OH1 Scheduling the medicines into the daily routine 0.71 (1.17) 322
OH2 Arguing with care-recipient about when to take medicines 0.95 (1.37) 319
OH3 Sharing responsibility with the care-recipient 0.91 (1.39) 323
OH4 Giving medicines on time 0.87 (1.25) 322
Outcome
expectancy2
OE1 Ease with managing the medicines 3.01 (1.01) 318
OE2 Fewer concerns about long-term side-effects 3.25 (1.09) 320
OE3 Fewer concerns about drug interactions 3.32 (1.11) 318
OE4 More confident the medicines are helping 3.29 (1.08) 320
OE5 Understand more about the medicines 3.40 (1.10) 317
OE6 Assist care-recipient to live at home independently 2.80 (1.07) 316
Communication
efficacy2
CE1 Difficulty arranging (reverse score provided) 3.62 (0.97) 318
CE2 No time (reverse score provided) 4.00 (0.95) 319
CE3 Asking for Home Medicines Review (HMR) indicates that
I have no confidence in GP (reverse score provided)
3.66 (0.97) 319
CE4 Difficulty asking GP (reverse score provided) 3.76 (0.96) 319
Willingness to
participate2
W1 Willing to help arrange an HMR if suggested by the GP 3.96 (0.80) 318
W2 Willing to ask the GP for an HMR if having concerns about medicines 3.88 (0.85) 319
1Responses varied from 0 (no hassle at all) to 5 (the worst of all hassles).
2Responses varied from 1 (strongly disagree) to 5 (strongly agree).
ª 2013 John Wiley & Sons Ltd Health Expectations
Caregivers’ willingness to use Home Medicines Review, S R Carter et al.10
CHAPTER SIX 127
were below the limit of acceptability by the
standards preset. The performance of the scale
could not be improved by deleting either item;
therefore, these items were retained to provide
a multi-item scale for this study. Discriminant
validity between each of the constructs was
demonstrated, as for each pair of constructs
both average variances extracted estimates were
greater than the squared correlation.
Structural equation model
The SEM ﬁt statistics indicated that the mea-
surement model was a reasonable ﬁt for the
data. Apart from the signiﬁcant Satorra-
Bentler scaled chi-square = 321, d.f. = 162,
P < 0.001, model ﬁt indices were good for
the measurement model. Model ﬁt statistics:
CFI = 0.94, TLI = 0.93, RMSEA = 0.058
(90% conﬁdence interval = 0.048, 0.067). The
model predicted 54% of the variation in will-
ingness (W), 18% of the variation in outcome
expectancy (OE) and just 3% of the variation
in communication eﬃcacy. Figure 2 provides
the results of hypothesis testing. Outcome
expectancy (OE) (b = 0.55, P < 0.05) and
communication eﬃcacy (b = 0.50, P < 0.05)
had strongly positive eﬀects on willingness
(W). Knowledge hassles (KH) had a moder-
ate eﬀect (b = 0.40, P < 0.05) on outcome
expectancy (OE) but no signiﬁcant eﬀect on
communication eﬃcacy (CE). Knowledge has-
sles (KH) had weak indirect eﬀects on will-
ingness (W) (b = 0.19, P < 0.05). Other
hassles (OH) were correlated with knowledge
hassles (KH) (r = 0.59, P < 0.05) but had no
signiﬁcant eﬀect on other variables in the
model.
Multiple regression
The summated knowledge hassle factor score
had a skewness of 0.64 and kurtosis of 0.47
and was therefore determined to be an appro-
priate dependent variable for linear regression.
The stepwise regression resulted in a model
with the following statistics; adjusted R-
squared = 0.082, F = 14.16, P < 0.001. There
Table 3 Confirmatory factor analysis (N = 324)
Item
Standardized
regression weights
Unstandardized regression
weights (URW)
Robust SE
of URW
Construct
reliability
Average variance
extracted (%)
KH1 0.73 1.12 0.06 0.85 59
KH2 0.57 1.00 0.08
KH3 0.63 0.71 0.08
KH4 0.82 1.00 0.00
OH1 0.73 1.00 0.00 0.79 50
OH2 0.53 0.84 0.14
OH3 0.46 1.07 0.13
OH4 0.68 1.18 0.11
OE1 0.79 0.80 0.04 0.94 72
OE2 0.92 1.00 0.00
OE3 0.91 1.01 0.03
OE4 0.89 0.95 0.03
OE5 0.84 0.92 0.04
OE6 0.71 0.76 0.05
CE1 0.62 1.00 0.00 0.62 30
CE2 0.69 1.12 0.19
CE3 0.42 0.70 0.16
CE4 0.40 0.65 0.15
W1 0.81 1.00 0.00 0.71 56
W2 0.67 0.91 0.11
KH, knowledge hassles; OH, other hassles; OE, outcome expectancy; CE, communication efficacy; W, willingness to participate.
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were two signiﬁcant predictor variables
(P < 0.05); having a recent change in the
medication regimen (b = 0.21, P < 0.001) and
age of the respondent (b = 0.16, P = 0.006).
Discussion
This study demonstrates that a majority of
informal caregivers experience a speciﬁc type of
daily hassles as a consequence of their role as
medication managers. The authors coined the
phrase ‘knowledge hassles’ to describe the has-
sles experienced when dealing with the special-
ized knowledge of their care-recipients’
medicines’ eﬀects and side-eﬀects. While the
overall levels of these hassles were not high,
they were clearly inﬂuential. As predicted, the
higher the level of these hassles, the more per-
sonally beneﬁcial for them a caregiver would
ﬁnd HMR and the more willing they would be
to arrange an HMR for their care-recipient.
This eﬀect was expected by the researchers
because caregivers’ positive outcome expectan-
cies of HMR centre on receiving information
about medication issues, reassurance about
medication-related concerns and improvement
of medication management capability. These
expectancies cover the same topics as patients
and have the same motivating eﬀect on willing-
ness to participate.31 Similar to the experience
with patients, caregivers’ expectancies were
fairly neutral, and they were overall uncon-
vinced that HMR would provide these bene-
ﬁts.22,31These ﬁndings align with other research
which suggests that many users of pharmacy
services do not expect that pharmacists would
provide modern pharmaceutical care services.54
Because these expectancies are relatively low,
there appears to be signiﬁcant scope for
increasing caregiver demand for medication
management services.
Alternatively, experiencing ‘other hassles’,
the daily hassles resulting from tasks which do
not require knowledge of medicines, was not
found to be inﬂuential. This is the ﬁrst time
that a relationship has been drawn between the
speciﬁc feelings of being stressed about process-
ing information on a health topic; and a willingness
KH1
KH2
KH3
KH4
0.86*
0.75*
0.63*
0.82*
KH
OH1
OH2
OH3
OH4
0.73*
0.53*
0.68*
0.83*
OH
0.59*
POE
POE6 POE5 POE4 POE3 POE2 POE1
0.72* 0.84* 0.89* 0.91* 0.92* 0.79*
CE
0.40*
SE4 SE3 SE2 SE1
0.40* 0.42* 0.69* 0.62*
W
W2
W1
0.67*
0.81*
0.55*
0.50*
Figure 2 Structural equation model. Solid lines indicates significant correlation and regression coefficients (*P < 0.05). The
dashed lines indicate no significant relationship. R2 = 0.54. KH = Knowledge hassles, OH = Other hassles, POE = Positive
outcome expectancy, CE = Communication efficacy, W = Willingness to participate.
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to seek information about that topic. These
ﬁndings have important implications for phar-
macotherapy and for the development of theory
of information-seeking behaviour. Further
research into knowledge hassles is warranted. If
conﬁrmed in other contexts, the assessment of
knowledge hassles could be a useful tool in
health provider – client communication.
It is noteworthy that it was the oldest of the
caregivers who experienced the least knowledge
hassles. This is consistent with an observed
decline in stress levels with age among Austra-
lian caregivers.55 Such changes may be
explained by socioemotional selectivity the-
ory.56 It is believed that ‘age-related constraints
on time horizons’ are associated with motiva-
tional changes. These changes cause older per-
sons to increasingly focus on positive over
negative emotions.56 It is possible that older
caregivers’ declining experience of daily knowl-
edge hassles may prevent them from focussing
on the outcomes of participating in health
information services.
Limitations
The main limitation of the study was the
potential for bias within the particular group
of respondents which may limit the general-
izablity of the results. These caregivers were
recruited because they belonged to a support
group, Carers NSW. One of the core goals of
this support group is to ‘Develop, promote and
distribute information, resources and publica-
tions to carers’. Therefore, the respondents
recruited for this study may be more likely
than others to seek out information about
caregiving tasks. Further studies could be con-
ducted among diﬀerent populations using the
measurement scales developed within this study
to examine the relationships between the key
variables. Another limitation was the relatively
low eﬀective response rate (14.4%). This
resulted from an overall poor response 600/
2350 (25.5%) and the strict inclusion criteria.
Another limitation to the study was that the
measurement scale for communication eﬃcacy
was not as reliable as had been hoped. It is
possible that the construct, communication eﬃ-
cacy is multidimensional and that the present
study used an inadequate number of indicators
(four) to tap the dimensionality of this latent
construct. Despite the modest reliability of the
scale, communication eﬃcacy appeared to have
a strong inﬂuence over willingness to partici-
pate. Future studies could use more indicators
or alternative indicators to determine the
dimensionality of this inﬂuential construct.
The measurement scales used for the hassles
constructs used only selected items from Travis
et al.’s FCMAHS scale.9 Ideally, the study
should be replicated with the complete scale.
Conclusions
This study highlights that some caregivers
experience quite a degree of stress dealing with
medication information. As expected, this
stress is heightened when the medication regi-
men is changed. Services and support should
be provided to these caregivers to assist them
in their important and unpaid role as the com-
munities’ hands-on medication managers.
Home Medicines Reviews is one avenue for
supporting the information needs of caregivers.
Building expectations of HMR as an informa-
tion resource among informal caregivers would
likely increase overall consumer demand for
this service and may ease the stress and burden
of caregiving. General practitioners who sense
that informal caregivers seem stressed about
medication information will most likely ﬁnd
them quite receptive to suggestions to have
HMR, particularly after the medication regi-
men has changed.
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Appendix
Description of HMR provided to eligible non-
recipients, adapted from an Australian Govern-
ment consumer brochure.49
A Home Medicines Review, a free service funded
by Medicare, provided jointly by your General
Practitioner (GP) and pharmacist, is particularly
useful for people who take multiple medicines
each day, or who have recently spent time in hos-
pital or who are concerned or uncertain about
their medicines. After being referred by a GP, the
pharmacist usually visits the patient in their own
home at a mutually agreed time. The pharmacist
will look at all medicines that the patient has, dis-
cuss any diﬃculties or concerns the patient may
have with using their medicines and write a report
to the GP. The GP will then discuss the results of
the Home Medicine Review with the patient.
Home Medicine Reviews help patients and carers
to understand better how to use their medicines.
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CHAPTER SEVEN   
DISCUSSION 
 
Given the worldwide prevalence of medication-related harm, collaborative 
interventions which employ the skills of medical practitioners and pharmacists have 
great potential for improving outcomes. Utilising what is known about the perceptions 
of consumers when designing and implementing these interventions could improve 
consumers’ acceptance of them. The overall aim of this thesis was to determine the 
factors which influence consumers’ willingness to use HMR and caregivers’ willingness 
to assist their care-recipient to use HMR, prior to service provision.  
Chapter One described the development of the theoretical framework which guided 
the research. The framework set out four phases in the decision-making process 
regarding consumers’ willingness to use HMR (Figure 2, page 47). The research 
examined the first three phases of that framework: a) the interpretation phase, where 
individuals’ thoughts and feelings about medication-related problems are influential; b) 
the evaluation phase, where individuals’ expectations about the outcomes and 
processes of HMR are influential; and c) the intention phase, where an individual 
decides whether they are willing to use HMR. This discussion is organised into these 
three phases. In terms of the order of presentation however, this section works 
backwards through the three phases.     
7.1 Intention phase – Willingness to use HMR 
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In order to explore consumers’ and informal caregivers’ intentions toward HMR this 
research used the behavioural expectation, willingness. This was in accordance with 
the recommendation of Gibbons, Houlihan et al. (2009), who have suggested that 
willingness, which is intention conditioned by specific premises, is likely to explain 
more variation in human behaviour than intention alone. Therefore, a latent construct 
named willingness was created for the purpose of quantitative exploration of 
consumers’ behavioural expectations. The items selected for the construct reflect that 
in order for a person to experience HMR, they need to employ certain communication 
tasks.   
Chapter Two compared responses to the willingness items provided by HMR 
recipients with those of eligible non-recipients. Compared with recipients, eligible non-
recipients were less willing to have an HMR if their GP suggested it and less willing to 
ask for an HMR if they were having concerns about their medicines. The lower level of 
willingness to use HMR among eligible non-recipients is consistent with qualitative 
findings (White, Klinner et al. 2012) and previous Australian government evaluations of 
the HMR program (Schwartzkoff 2005; Campbell Research and Consulting 2008).  
Despite this, it was heartening that nearly two-thirds of eligible non-recipients agreed 
that they were willing to ask their GP for an HMR (if they were concerned about their 
medicines). There was a high level of consistency in response to this item across three 
types of respondents: a) patients recruited by community pharmacists (Chapter 
Three); b) consumers recruited through COTA, NSW (Chapter Five); and c) informal 
caregivers recruited through CARERS, NSW (Chapter Six).  It appears that if 
consumers’ and informal caregivers were informed of HMR, they be willing to ask for it, 
under the right circumstances. These findings demonstrate the important role that 
consumers have in driving participation in medication management services.   
 
138 
 CHAPTER SEVEN - DISCUSSION  
7.2 The influence of prior awareness on willingness 
 
Previous research intimated that a lack of awareness of HMR was one reason for 
consumers declining the offer to use it (Yu, Nguyen et al. 2007). Yet, no quantitative 
study had determined whether a lack of awareness had influenced willingness to use 
any medication management service. Little was known about the underlying 
awareness of HMR within the Australian community other than anecdotal reports from 
qualitative studies (Campbell Research and Consulting 2008; Lee, George et al. 
2012). For the first time in Australia, a systematic investigation among eligible non-
recipient consumers revealed a low level of awareness of HMR.  
Chapter Two reported that the overall level of awareness was 23% - predominantly 
provided by pharmacists and GPs. Furthermore, compared with eligible non-recipients 
who were unaware, those who had prior awareness indicated that they would be more 
willing to have an HMR if their GP suggested it. Combined, these findings highlight the 
social pressure that health professionals exert on modifying consumers’ intentions to 
use health services. If health professionals can influence consumers’ willingness by 
mentioning it during health consultations, it is possible that other forms of promotion 
will prove positively influential.  
Campaigns aimed at improving consumer awareness of HMR have occurred. The 
National Prescribing Service provides consumer-directed information on their web 
page, and actively promotes HMR using a peer education campaign in partnership 
with Council on the Ageing NSW (COTA, NSW) (National Prescribing Service 2012). 
HMR has been promoted within specific consumer groups. In 2011, Australian’s 
Veterans’ Mates program promoted HMR to 176,000 veterans and their general 
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practitioners. The promotional program included the distribution of a brochure to 
veterans which described the reasons why they should consider having an HMR 
(Australian Government Department of Veterans' Affairs 2011). The benefit of this type 
of promotion was demonstrated in a study which showed that  the rate of HMR delivery 
could be increased by providing patient-specific feedback provided to GPs and 
educational material mailed directly to patients (Roughead, Pratt et al. 2007). Another 
approach included the provision of an education session for elderly residents of 
retirement villages of the benefit of HMR. Residents were provided with a risk 
assessment checklist to take to their GP (Lee, George et al. 2011). Other promotional 
programs supported by Divisions of General Practice, include the coordinated 
promotion of HMR to GPs, practice nurses, pharmacists and consumers (Fitzgerald, B 
et al. 2010).    
The finding that awareness of HMR improved willingness to use it highlights the 
importance of understanding other factors which influence consumers’ decisions 
regarding HMR. Greater understanding of these factors could help health 
professionals and health promotion agencies optimise the content of promotional 
messages regarding HMR.  
In order to simplify the text, in the discussion from this point onwards, willingness 
refers to the underlying latent construct of willingness to use HMR (as described in 
Section 7.1, page 136) or willingness to use any medication management service in 
general. Here it is worthwhile to mention that the measurement scale for willingness 
had good construct reliability in each of the studies which used structural equation 
modelling (Chapters Three, Five and Six).    
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7.3 The evaluation phase 
 
This section summarises the research which covered the variables within the 
evaluation phase, and the relationship between them and willingness.  
7.3.1 Positive outcome expectancy  
 
Positive outcome expectancy was defined as consumers’ and informal caregivers’ 
expectations about the positive outcomes of HMR. Chapter Four presented a 
qualitative study where it was reported that focus group participants focussed on the 
idea that HMR would provide an extended patient counselling session. Many believed 
that HMR would provide them with medication information tailored to their individual 
needs as well as reassurance.  An important motivation to choose HMR was 
participants’ preference to communicate via an interpersonal mode. Participants said 
they would value the independent knowledge that an HMR pharmacist would provide: 
they said it would empower them to make more informed decisions. However, not all 
participants agreed that such information was necessary or that HMR was needed for 
them personally. Previous qualitative research reported that although some 
participants perceived HMR to be a valuable service, they perceived it in terms of 
benefitting others, who may be older or have cognitive decline (White, Klinner et al. 
2012). Consistent with previous studies of HMR (Lee, George et al. 2012) and MTM 
(Law, Okamoto et al. 2008; Truong, Layson-Wolf et al. 2009; Friedrich, Zgarrick et al. 
2010), Chapters Three, Five and Six report that consumers’ and informal caregivers 
had low to moderate positive outcome expectancy. While positive outcome expectancy 
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was not high, structural equation modelling revealed that it had a strong influence on 
willingness in all groups.  
The finding that positive outcome expectancy was relatively low yet highly influential 
indicates that there is significant scope for increasing both consumers’ and caregivers’ 
willingness. This could be achieved by designing promotional campaigns which aim to 
increase positive expectations of HMR. It is here that attention is drawn to the 
consumer-directed information about HMR which was available on the internet at the 
time the research was conducted. The information available to consumers was 
evaluated at that time (Appendix B). One of the conclusions drawn in that study was 
that the information made available to consumers did not focus on the communication 
opportunity afforded during the HMR interview. Given that many multiple medicine-
users report that GP consultations are too short to discuss their medicine concerns 
(Gordon, Smith et al. 2007; Moen, Bohm et al. 2009), there is an opportunity for 
descriptive messages about HMR to promote the pharmacists role in addressing 
patients’ concerns during the relatively long HMR pharmacist consultation.   
7.3.2 Negative outcome expectancy  
 
Negative outcome expectancy was defined as an individual’s negative expectations 
about the communication processes involved in HMR. A qualitative study reported that 
a minority of eligible non-recipients expressed negative sentiments regarding the 
processes of HMR (White, Klinner et al. 2012). These sentiments related to 
uncomfortable feelings about being visited in the home, concern about privacy and 
confidentiality, and the feeling that having an HMR indicated reduced personal 
capability. These findings align with a previous qualitative study which investigated 
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consumers’ attitudes towards USA’s MTM services, where some consumers said they 
were concerned about confidentiality and privacy (Truong, Layson-Wolf et al. 2009).    
The quantitative study of Chapter Two presented descriptive statistics to demonstrate 
that a minority of eligible non-recipients had negative outcome expectancy. In Chapter 
Three, research is presented which used structural equation modelling to test the 
hypothesis that negative outcome expectancy reduces willingness. For that purpose, a 
measurement scale for negative outcome expectancy was chosen which included two 
items related to consumers’ uncomfortable feelings about being visited at home by a 
pharmacist. Using this scale, consumers’ negative outcome expectancy did not have a 
significant influence on their willingness - when positive outcome expectancy and 
communication efficacy were included in the model. To some extent, this should be a 
reassuring finding as it reflects the trust that patients have in community pharmacists 
as medication information resources, within Australia (Tio, LaCaze et al. 2007) and 
internationally (Ngorsuraches, Lerkiatbundit et al. 2008). 
Nevertheless, medication management services should ideally be designed to 
minimise consumers’ negative outcome expectancy. GPs and accredited pharmacists 
who are faced with a lack of willingness should enquire as to whether the reluctance is 
due to the location of the interview, as the HMR program allows for flexibility in the 
location. However, best practice guidelines published by the Pharmaceutical Society of 
Australia recommend that the consumer’s home is the preferred setting for the HMR 
interview (The Pharmaceutical Society of Australia 2012). These guidelines remind the 
reader that having the accredited pharmacist interview and observing the consumer in 
their own home will assist with the identification of aspects of medication management 
that may not be possible in another setting. This has recently been confirmed in a 
study by Freeman, Cottrell et al. (2012) Compared with HMR performed in a medical 
 
143 
 CHAPTER SEVEN - DISCUSSION  
surgery, those performed in the home uncover more medication-related problems 
specifically related to the use of a medication aid or device (Freeman, Cottrell et al. 
2012).   If consumers indicate a choice to have the interview in the GP’s surgery or in 
the community pharmacy, they should at least be advised that the home is considered 
best practice.  
Due to the fact that the measurement scale for negative outcome expectancy in 
Chapter Three did not include items related to reduced personal capability, 
dependency, or compromised privacy, it was not possible to comment on whether 
these feelings reduced willingness. Nevertheless, consumer-directed information 
regarding HMR should explicitly state that the consumer’s medical record is treated as 
confidential. Further, descriptions of HMR should use language that engenders 
feelings of empowerment, rather than failing independence. A study conducted in the 
UK reported that consumers’ medicines information tend to use language consistent 
with an “educational” rather than an “empowerment model” (Nicolson, Knapp et al. 
2006). Further, a qualitative study of consumer-directed information regarding UK’s 
Medicine Use Reviews (MUR) (van den Berg and Donyai 2010) concluded that “The 
educational role of the MUR overshadowed the intended patient empowerment that 
would take place with a true concordance-centred approach”.   
One way to increase consumers’ sense of empowerment surrounding the HMR 
process may be to inform consumers that they would be provided with a written report 
at the conclusion. This could simply be the accredited pharmacists report to the GP.  In 
the HMR model, there is no specific directive as to whether the HMR report is provided 
to the consumer or caregiver.  Presumably it is left to the consumers, caregivers, 
pharmacists and general practitioners to negotiate whether the HMR report is provided 
to the consumer. It is likely that some of the information provided by the pharmacist to 
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the GP would deal with the consumer’s adherence behaviour and their capacity to 
manage their medicines. Some consumers and caregivers may feel demeaned by this. 
Some of the information may be technically difficult for consumers to understand which 
in-turn could cause anxiety. If it were mandatory that consumers did receive the HMR 
report, the pharmacist may have to word the report with this understanding and it is 
possible that this may influence how the GP dealt with this information. Of course, it is 
possible for accredited pharmacists and GPs to collaborate in private.  
Another alternative may be to provide the consumer with a consumer-directed report, 
with particular attention given to the language used. This extra step would increase the 
workload of the pharmacist, but could provide better outcomes for the consumer by 
reinforcing the verbal information provided. If the provision of a consumer-directed 
report were mandated and advertised to consumers, consumers’ sense of 
empowerment may increase. However, it is also possible that some consumers may 
find the concept of there being two different reports not empowering. It is not known 
the extent to which consumers are provided with written materials as a part of the 
HMR. Overall, it would appear that the provision of written materials to consumers and 
caregivers during the HMR process should be the subject of public policy discussion.  
7.3.3 Communication efficacy 
 
Communication efficacy was defined as a person’s perception of having the capability 
to initiate and proceed through the communication tasks required to participate in 
HMR. In the current context these perceptions related to making time for an HMR 
and/or asking a GP to have an HMR.  Time constraints were identified as a potential 
barrier to consumers’ use of MTM (Garcia, Snyder et al. 2009; Truong, Layson-Wolf et 
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al. 2009) and HMR (Lee, George et al. 2012).  However, Chapters Three, Five and 
Six, reported that few participants agreed that they lacked the time for an HMR or that 
arranging an HMR would be difficult.  Chapter Four reported that some consumers 
would not ask their doctor for an HMR because they were unsure whether their GP 
would approve of HMR. Despite this, Chapters Three, Five and Six, reported that few 
participants agreed that they would have difficulty asking their GP for an HMR. In 
summary, consumers’ and informal caregivers had high communication efficacy.  
Consistent with the conceptual model, communication efficacy had a moderate and 
significant effect on consumers’ and informal caregivers’ willingness. Perhaps this is 
not surprising since self-efficacy may be the most powerful of constructs within social 
cognitive theory (Maddux and Rogers 1983; Schwarzer 1992; Bandura 1997).  These 
findings indicate that efforts should be made to make the process of asking for an 
arranging HMR as transparent and easy as possible for eligible consumers and their 
informal caregivers. The two main themes contained with communication efficacy deal 
with confidence to initiate conversations about HMR and confidence in arranging the 
interview. 
Community pharmacists could initiate conversations with eligible non-recipients using 
consumer-directed promotional materials. They could explain how the HMR process 
works and offer to assist consumers overcome communication barriers. This could 
involve calling GPs, if consumers express a wish to have an HMR. Ideally, consumer-
directed promotional material would use language and imagery that encourages 
dialogue with health providers.  
Multiple medicine-users are likely to have multiple morbidities. Many would have to 
attend medical appointments in multiple locations on a regular basis. Having the 
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pharmacist interview occur in the consumer’s home obviates the need for the 
consumer to travel for that purpose, but not necessarily the medical appointment 
which follows. In addition, time is required for both interviews. Perhaps the best way to 
overcome the time barrier is for health professionals to deal with this if it arises. Ideally, 
when GPs enter into discussions with their patients regarding the possibility of having 
an HMR, they should ensure that the patient understands that accredited pharmacists 
have a degree of flexibility the timing of appointments.  Ideally, accredited pharmacists 
should ensure that GPs, community pharmacists and their clients understand that such 
flexibility is available.   
7.3.4 Subjective norms of the GP  
 
Chapter Four presented qualitative findings to suggest that some participants who 
thought HMR would be personally beneficial were not willing to use it because they 
were not sure that their GP would approve. Therefore, the conceptual model was 
extended in Chapter Five to include the social influence of the GP. For that study, the 
social influence of the GP was adapted from the construct named subjective norms in 
the Theory of Planned Behavior (Ajzen 1991).  While subjective norms have been 
shown to influence information-seeking intent (Liu, Doucette et al. 2005; Kahlor 2010), 
this was the first research to use subjective norms to explore consumers’ intentionsa to 
use medication management services.  
Subjective norms operate in two dimensions (Ajzen 1991).  The two dimensions were 
operationalized for the present research thus; a) subjective normative beliefs – 
                                               
a Willingness is considered to be intention qualified on certain premises (Section 1.5.4) 
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consumers’ thoughts that the GP would approve of them using HMR, and b) motivation 
to comply - consumers’ motivation to comply with the wishes of the GP. In the study of 
Chapter Five, most respondents agreed with both propositions. This indicated that the 
subjective norms of the GP had an overall positive influence on willingness. Using 
structural equation modelling analysis, it was shown that subjective norms of the GP 
increased respondents’ willingness even though it had no bearing over whether they 
thought that the HMR was personally beneficial. This result reinforces the powerful 
effect that a person’s general practitioner has over health related decisions.  
It is possible however, that in the future consumers’ motivation to comply with the GPs 
wishes may decline. As elucidated by Buetow, Jutel et al. (2009), “the modern patient” 
sees less social distance between themselves and their GP. Driven by greater access 
to medical information, and supported by a worldwide trend towards more autonomy in 
health, more consumers may not care what their GPs think about HMR and may 
demand access to it.  
At present, it is likely that some form of GP endorsement of HMR such as promotional 
messages within GPs surgeries would increase consumers’ intentions to ask their GP 
about the service. This could be achieved with posters or brochures about the service, 
or perhaps on GP network television commercials.  Community pharmacists could 
assist in this regard by knowing the sentiments of their local GPs towards the HMR 
program and explaining to eligible non-recipients that their GP has positive views 
about HMR, if that is the case.        
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7.4 The interpretation phase  
 
The conceptual model shows that a person’s thoughts and feelings (cognitions and 
emotions) about the possibility of experiencing harm motivate them to consider the 
outcomes and processes of information-seeking (Section 1.5.6, page 52). And as 
explained, it is emotional arousal or negative affect which is central to this process. It 
was therefore predicted that, an individuals’ negative affect generated by the 
possibility of experiencing medication-related problems, would increase their positive 
outcome expectancy. However, negative affect could reduce communication efficacy. 
The net effect on willingness was tested for both eligible non-recipient consumers 
(Chapter Five) and the caregivers of eligible non-recipient consumers (Chapter Six) 
using different measures of negative affect.  
7.4.1 Medication-problem worry 
 
In the case of consumers, the negative affect measured was a specific (and mild) form 
of worry, medication-problem worry.  It was defined as the worry a person feels when 
they consider themself to be at risk of experiencing medication-related problems. In 
the study of Chapter Five, structural equation modelling revealed that medication-
problem worry had a moderate effect on positive outcome expectancy, but no 
significant effect on communication efficacy. Therefore, medication-problem worry had 
an indirect positive effect on willingness to use HMR.   
In summary, consumers who are more worried about the possibility of experiencing 
medication-related problems are more likely to believe that they would personally 
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benefit from the information received during HMR, more likely to feel reassured by this 
information and more willing to undertake the communication tasks required to use 
HMR.  
A possible relationship between consumers’ thoughts and feelings about the problems 
resulting from consuming medicines and their willingness to use medication 
management services has been alluded to in the past and this was discussed in 
Section 1.4.5.6 (page 34). There were two studies which examined this relationship in 
detail and they provide somewhat conflicting results. One study showed that 
consumers with higher values for the “specific concerns” construct from the Beliefs 
about Medicines Questionnaire (BMQ) (Horne, Weinman et al. 1999) were more likely 
to have volunteered to use a Swedish medication management service (Montgomery, 
Kälvemark Sporrong et al. 2010). Another study however, found that having higher 
values for “specific concerns” was not associated with perceptions of personal benefit 
from patient counseling activities or other MTM activities (Doucette, Witry et al. 2007).  
It is important here, to highlight how consumer’s thoughts and feelings about 
experiencing medication-related problems was estimated in those studies (Doucette, 
Witry et al. 2007; Montgomery, Kälvemark Sporrong et al. 2010) and compare that with 
the methods used in Chapter Five. The conceptual model separates cognition from 
emotion (Section 1.5.6, page 52) so that in Chapter Five, risk perception (cognition) 
and worry (emotion) were modelled and measured separately. The “specific concerns” 
construct of Beliefs about Medicines Questionnaire (BMQ) elicits consumers’ affective 
representations of their concerns about the possible harm they may experience from 
taking medicines (Horne, Weinman et al. 1999).  However, as explained the construct 
also elicits cognitive representations (Horne, Weinman et al. 1999). The specific 
concerns construct has been very useful at predicting non-adherence behaviour 
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(Horne and Weinman 2002; Clifford, Barber et al. 2008; Menckeberg, Bouvy et al. 
2008; Clatworthy, Bowskill et al. 2009; Horne, Parham et al. 2009). Future research 
could determine whether consumers’ “specific concerns” influence their positive 
outcome expectancy in the present context.   
7.4.2 Knowledge hassles 
 
The study reported in Chapter Six was undertaken because it was recognised that 
informal caregivers have a key role in assisting some of the most vulnerable members 
of the community to access HMR. In Chapter Six the conceptual model (Section 
1.5.6.3, page 56) was extended to encompass the willingness of informal caregivers to 
assist their care-recipient to use HMR (willingness). The phrase “knowledge hassles” 
was coined to describe a specific form of negative affect which motivates informal 
caregivers to consider the outcomes and processes of HMR. Knowledge hassles were 
defined as the daily stressors informal caregivers experienced whilst dealing with tasks 
which require knowledge about the safety and effectiveness of the care-recipients’ 
medicines.  Using structural equation modelling it was demonstrated that there was a 
strong relationship between experiencing knowledge hassles and positive outcome 
expectancy (β = 0.40, p<.05). Furthermore, knowledge hassles had no significant 
effect on communication efficacy. Therefore, knowledge hassles had a significant 
indirect effect on willingness (β = 0.19, p<0.05). This is the first research to draw a 
relationship between the specific feelings of being stressed about processing 
information on a health topic; and a willingness to seek information about that topic.  
Building expectations of HMR as an information resource among informal caregivers 
would likely increase overall consumer demand for HMR. GPs who sense that informal 
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caregivers seem stressed about medication information will most likely find them quite 
receptive to suggestions to have HMR. Informal caregivers, by definition, are often 
involved in collecting medicines from pharmacies. Pharmacists who sense that 
informal caregivers appear stressed about complicated medication regimens should 
also consider whether the care-recipients’ GP may be interested in requesting an 
HMR.   
   
7.4.3 The effect of having medication risk factors 
 
The studies of Chapter Five and Six used multiple regression analysis to explore the 
relationship between the presence of three medication risk factors and negative affect, 
whilst taking demographic factors into account. The three risk factors examined were; 
having a recent change in the medication regimen (within the previous three months), 
a change having been discharged from hospital within the previous month, and b) 
having multiple regular prescribers.  
The results obtained were consistent for consumers and informal caregivers. Having a 
recent change in the medication regimen increased medication-problem worry in 
consumers and knowledge hassles in informal caregivers. In accordance with program 
guidelines, HMR could be provided to eligible consumers after a significant change in 
their regimen (Australian Government Department of Human Services 2011). These 
findings add that consumers and their caregivers may be more receptive to suggestion 
and promotion of medication management services after medication changes. 
Consumer-directed information about HMR could be provided to multiple medicine-
users after changes to medication regimen in a similar manner to the way written 
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medicines information is provided (The Pharmacy Guild of Australia 2009). It should be 
noted that the consumer-directed brochure entitled “8 reasons for having a Home 
Medicines Review” published by Australia’s Veterans’ Mates program listed having a 
new medicine as the first reason (Australian Government Department of Veterans' 
Affairs 2011).   
7.4.4 Demographic factors 
 
In Chapter Five, it was the oldest of the consumers who experienced the least 
medication-problem worry.  This was consistent with the focus group study of Chapter 
Four where older participants were the least engaged in topics relevant to medication 
risk, appeared the least worried about medication problems and were the least willing 
to have HMR. In Chapter Six, it was the oldest of the caregivers who experienced the 
least knowledge hassles. This is consistent with an observed decline in stress levels 
with age among Australian caregivers (Cummins, Hughes et al. 2007). Such changes 
in consumers and caregivers may be explained by socioemotional selectivity theory 
(Lockenhoff and Carstensen 2007). It is believed that “age-related constraints on time 
horizons” are associated with motivational changes. These changes cause older 
persons to increasingly focus on positive over negative emotions (Lockenhoff and 
Carstensen 2007). In addition, older persons may attribute symptoms which may be 
medication adverse effects to the consequences of ageing (Shiyanbola and Farris 
2010). It is possible that older persons’ declining experience of negative affect 
regarding the possibility of experiencing medication-related problems may prevent 
them from focussing on the positive outcomes of participating in medication 
management services.  
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It is also possible that the decreased negative affect with increasing age relates to the 
fact that the consumers and their caregivers who participated in the study were not a 
random segment of the population. Studies in this area using randomised samples 
appear warranted.  
 
7.5 Methodological strengths and limitations  
 
7.5.1 Study Sample  
 
One of the gaps identified in the literature review of consumers’ perceptions of 
medication management services (Section 1.4.6.2, page 39) was the lack of studies 
undertaken among consumers who were systematically identified as being eligible to 
use medication management services. Therefore, the findings of many studies lacked 
generalisablity because the samples were underrepresented by those who would be 
eligible for medication management services. One of the strengths of the thesis was 
that the research reports on the perceptions of non-recipients who were systematically 
identified as being eligible to receive HMR. 
Eligibility criteria form an integral component of the processes of medication 
management services. Eligibility criteria need to be defined for the purposes of 
promotion and administering the service and for conducting research into consumer 
perspectives. The eligibility criteria provided below was obtained from the Australian 
Government Department of Human Services website: (Australian Government 
Department of Human Services 2011)   
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A general practitioner must assess that a review of a patient living at 
home is clinically necessary to ensure the quality use of medicines or to 
address a patient’s needs. Examples of risk factors include patients: 
 
 currently taking five or more regular medications  
 taking more than 12 doses of medication per day  
 with significant changes to their medication regimen in the last three 
months, including recent discharge from hospital  
 taking medication with a narrow therapeutic index or required 
therapeutic monitoring  
 with symptoms suggestive of an adverse drug reaction  
 having difficulty managing their own medicines because of literacy 
or language difficulties, impaired sight  
 attending a number of different doctors, both general practitioners 
and specialists  
  
Eligibility for HMR is therefore guided by the patient having risk factors for medication 
misadventure. Therefore, for the study reported in Chapter Two, community 
pharmacists were asked to recruit non-recipients with at least one of five risk factors 
(adapted from items 1, 2, 3, 4, and 7 from the above list). These items were selected 
because pharmacists may be aware of these risk factors as a consequence of regular 
dispensing and counselling activities.  These items were included within each of the 
surveys for the thesis in order to determine whether the presence of these risk factors 
influenced willingness to use HMR. Such inclusion was justified because Levy 
demonstrated that patients could reliably self-record them (Levy 2003). For those 
studies which used structural equation modelling (Chapters Three, Five and Six) it was 
felt that the research should be conducted only among non-recipients who were using 
multiple medicines (defined as more than five medicines daily or twelve individual 
doses daily). This allowed for the researchers to compare the results obtained using 
different recruitment strategies (See Section 7.5.2, page 155).     
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A limitation of the thesis was that the views of persons with certain disabilities may be 
underrepresented because their disabilities prevent them participating in focus groups 
or completing surveys.  This limitation was acknowledged in an Australian study 
investigating risk factors for medication misadventure (Pit, Byles et al. 2008). In that 
study, just 70% of the study population were able to complete the questionnaire by 
themselves or with the assistance of a caregiver (Pit, Byles et al. 2008). As stated by 
Levy  (2003), the usefulness of any self-reported tool will always be limited by familiar 
and expected exclusion criteria included vision impairment, dementia, illiteracy or 
severe psychiatric conditions. This limitation highlights the necessity of obtaining the 
perceptions of informal caregivers of eligible non-recipients who care for individuals 
such as these. 
A strength of the thesis was that the perceptions of informal caregivers who care for 
the some of the most vulnerable members of the community were obtained.  Another 
strength was the systematic approach used to identify informal caregiver members of 
Carers, NSW who were actively involved in medication management tasks for an 
eligible non-recipient.  In addition to identifying respondents whose care-recipients 
were using multiple medicines, a previously developed screening tool (Travis, Bernard 
et al. 2003) was used to identify informal caregivers who were actively involved in 
medication management tasks and were not paid to provide caregiving tasks.   
7.5.2 Dealing with selection bias  
 
The literature review identified that the results from studies where the recruitment 
process involved pharmacists approaching their patients may have been influenced by 
selection bias (Section 1.4.3.1, page 16). A limitation of the thesis was that the 
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community pharmacy-based recruitment strategy used in Chapters Two, Three and 
Four meant that sampling bias could reduce the generalisablity of the findings. It is 
possible that pharmacists selectively recruited patients with known favourable attitudes 
towards HMRs or pharmacists’ services generally. Furthermore, only 29% of 
pharmacists who were contacted by the researchers agreed to recruit patients. It is 
possible that these pharmacists had favourable attitudes, and that their attitudes were 
reflected in the responses of respondents. Finally, it is also possible that the 
generalisablity may be reduced by social desirability bias. That is, because consumers 
had a prior relationship with the pharmacist, they may have provided responses which 
they thought would be viewed favourably. 
The findings of the thesis are strengthened by the fact that the views of consumers 
who were recruited anonymously were obtained.  Respondents were recruited by 
postal methods in the studies of Chapters Five and Six. For these studies, the sample 
was members of consumer organisations (COTA NSW and Carers NSW, 
respectively). These organisations were selected because their members (or the 
members’ care-recipients) were identified as having a good chance of being older 
persons who may therefore be using multiple medicines (Moen, Antonov et al. 2009).  
In these studies, the member’s name and postal address only was used by the 
member organisation to contact respondents. No other data regarding the members of 
the organisations was obtained.   
The process of obtaining data from various samples allowed for the measurement 
scales for positive outcome expectancy, communication efficacy and willingness to use 
HMR, to be validated and the relationships between these key variables to be 
analysed. Therefore, the potential for selection bias to confound interpretation of the 
relationships between the variables was minimised. The relationships between these 
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key variables were consistent across each of the studies which used structural 
equation modelling (Chapters Three, Five and Six).    
A limitation of the postal strategy was that members of the consumer organisations 
may be more interested in medication information than most eligible non-recipients. 
Dutta Bergman (2005) suggests that a person’s tendency to seek health information 
may be positively influenced by a person’s health consciousness. It is quite likely that 
members of consumer organisations have higher levels of health consciousness than 
members of the general public. It is uncertain how health consciousness may have 
influenced the relationships explored in this thesis.  
7.5.3 Information regarding HMR provided to respondents  
 
In order to study consumer perceptions of medication management services among 
those who have not yet experienced it, respondents must be presented with some 
information about the service. According to social cognitive theory, the content of this 
information could have an impact on respondents’ expectations of the outcome to be 
derived, their self-efficacy expectations and their future intentions (Bandura 1997).  In 
the literature review it was mentioned that many studies did not report the content of 
information regarding medication management services which was provided to 
respondents (Section 1.4.3.3, page 22). Furthermore, few studies provided a rationale 
for the content provided to respondents.  
A strength of the research conducted for this thesis was that respondents in all 
qualitative and quantitative studies were provided with the same validated message 
regarding HMR. Furthermore, within each of the manuscripts which make up the 
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thesis, the description of HMR provided to respondents was included as an Appendix. 
In addition, the rationale for the content was provided in each manuscript. The content 
was valid because it was adapted from a consumer-directed brochure provided by the 
Australian Government Department of Health with almost no alteration (Australian 
Government Depart of Heath and Ageing).  
Here it is noted that a limitation of the study was that only a single description of HMR 
was provided to respondents, yet as explained within the study of Appendix B, 
consumers may be exposed to an array of information available regarding HMR, 
particularly on the internet. Appendix B reports on a qualitative study using content 
analysis of relevant information available on websites at the time the data was 
collected for this study. Future studies may choose to vary the message provided to 
respondents in order to determine which attributes of HMR is the most likely to 
increase positive outcome expectancy and willingness. An extension of such research 
could use discreet choice experiments.   
7.5.4 Measurement issues  
 
Structural equation modelling using maximum likelihood estimation was used to 
explore the relationships between the constructs of the conceptual model in the 
studies of Chapter Three, Five and Six.  The findings of the thesis were strengthened 
by the fact that each of the studies broadly followed Schreiber’s (2008) core reporting 
practices for structural equation models. As is recommended, (Schreiber 2008)  
attention was paid to the distribution of the data. When the data were not normally 
distributed, as in Chapters Five and Six, maximum likelihood estimation with robust 
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errors was used (Bentler 2006). Estimates provided in this manner are generally free 
of bias, even in the presence of non-normal data (Curran, West et al. 1996). 
A strength of the research was that power analysis was performed to ensure an 
adequate sample size for structural equation modelling (Schreiber 2008).  Using the 
post-hoc method of Westland (2010), it was shown that there were an adequate 
number of responses for each of the studies to reliably estimate minimum effect sizes 
of approximately 0.20 .  
A limitation of the thesis however, was that each of the studies reported that the 
structural model data was a reasonable but not a good fit for the data. In the absence 
of other publications in the area of interest, the statistics chosen for reporting were 
those suggested (2008); Chi-square or Satorra - Bentler scaled Chi-square, 
Comparative fit index (CFI), Tucker-Lewis index (TLI) and Root mean square error of 
approximation (RMSEA) with 90% confidence intervals. In regard to the values of CFI, 
TLI, Schreiber suggested that the values of each of these should exceed 0.95 to 
indicate evidence of good fit (Schreiber 2008). Less stringent thresholds (CFI ≥ 0.90, 
TLI ≥ 0.90) have been advocated elsewhere as evidence of reasonable fit. (Holmes-
Smith, Cotte et al. 2006). In regard to RMSEA, values exceeding 0.06 with 90% 
confidence interval less than 0.08 indicate evidence of good fit (Schreiber 2008), 
whereas a threshold value of 0.08 has been advocated elsewhere as evidence of 
reasonable fit (Holmes-Smith, Cotte et al. 2006).  In each study, the Chi-square and 
the Satorra – Bentler scaled Chi–square was significant, but that was to be expected. 
In the studies of Chapters Three, Five and Six, CFI values ranged between 0.94 and 
0.96 and TLI values ranged between 0.92 and 0.94. In the studies of Chapter Three, 
Five and Six, the RMSEA with 90% confidence intervals were 0.065 [0.053 – 0.080], 
0.068 [0.059 – 0.083, and 0.057 [0.048 – 0.066] respectively.  
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One of the strengths of the research was that each study examined the measurement 
model (confirmatory factor analysis) before proceeding to structural equation 
modelling. Such an approach is recommended by Hair, Black et al. (2006) when the 
nature of the research is at a preliminary or development stage. Performing the 
confirmatory factor analysis prior to structural equation modelling allows for problems 
to be identified with measurement scales before hypothesis testing (Hair, Black et al. 
2006). Confirmatory factor analysis also provides the data to calculate and report the 
reliability of the measurement scales and perform tests of discriminant validity.   
A strength of the thesis was that, with the exception of the communication efficacy 
scale which is discussed below, all construct reliability values approached or exceed 
the 0.7 threshold (range 0.65 – 0.95) and the variance extracted approached or 
exceeded the 50% threshold (range 49% - 75%) (Hair, Black et al. 2006). Discriminant 
validity between each pair of constructs in Chapters Three, Five and Six was 
demonstrated.  
However, a limitation of the thesis was that there were problems with the 
measurement scales for communication efficacy in each of the studies. Items on this 
scale generally had relatively low to moderate factor loadings (range 0.40 – 0.70), low 
to moderate construct reliability (range 0.62 – 0.75) and the average variance 
extracted did not reach the 50% threshold (range 30 - 44%). Furthermore, it should be 
noted that the scale did not include any items to probe the communication efficacy 
required to ask the pharmacist for advice during the HMR interview. Items of this 
nature were not included because this communication barrier did not appear to limit 
willingness to ask for advice in previous qualitative research (White, Carter et al. 2011) 
and in Chapter Four. It is recommended that future research should attempt to improve 
the measurement of communication efficacy in the present context.  This could 
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possibly be achieved by using more items to tap more dimensions of communication 
efficacy or possibly re-wording of the items. 
Another limitation of research was the limited number of indicators for the negative 
outcome expectancy measurement scale. Based on a qualitative study (White, Carter 
et al. 2011), Chapter Three developed a measurement scale for negative outcome 
expectancy which included negative sentiments towards HMR. These included four 
items related to uncomfortable feelings about having a known or unknown pharmacist 
visit the home, feelings of compromised privacy and feelings of reduced personal 
capability. Exploratory factor analysis revealed that two of the four items did not load 
well onto the common factor. Subsequently, a two item scale was used which included 
two items related to uncomfortable feelings about having a known or unknown 
pharmacist visit the home. While this item had reasonable construct reliability (0.69) 
and acceptable variance extracted (0.53%), the scale does not fully explain all of the 
negative sentiments. It is recommended that future research should attempt to improve 
the measurement of negative outcome expectancy. This could possibly be achieved 
by using more items to tap more dimensions of negative outcome expectancy or 
possibly re-wording of the items.  
In Chapter Five, medication-problem worry was defined as the frequency with which a 
person worries. McCaul & Goetz (2010) have identified two dimensions of worry in 
relation to health behaviour - the intensity and the frequency. They suggest that there 
is no consensus about which is the most influential in modifying behaviour. Future 
research could develop a scale to probe the intensity of medication-problem worry 
experienced. Furthermore, only a single variable was used to measure medication-
problem worry. Future research could explore the elements or dimensions of this 
emotional response.  
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A strength of the research was the new finding that consumers’ medication-problem 
worry remained elevated for three months after changes to the medication regimen.  
Furthermore, caregivers’ knowledge hassles were also elevated during this time. A 
limitation of the study was that the presence of having had a recent medication 
regimen change was measured with a simple binary variable. Either an eligible non-
recipient had experienced a change within the previous three months or not. Future 
studies could explore in more detail the time-course of changes in negative affect 
associated with changing medication regimens. Furthermore, the nature of the 
regimen change may be significant. Future research in this area could record more 
details about the change in the medication regimen such as; the class of the new (or 
ceased) medication or ceased medication, whether the change was an increase or 
decrease in dose, or whether the change had been the result of an adverse event.  
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CHAPTER EIGHT 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
8.1 Conclusion 
 
The overall aim of this thesis was to determine the factors which influence consumers’ 
willingness to use HMR and caregivers’ willingness to assist their care-recipient to use 
HMR, prior to service provision.  
 
Overall recipients were very satisfied with, and willing to re-use HMR; they reported 
HMR provided them with increased medicines knowledge which helped them manage 
their medicines and reduce their medicine concerns. Eligible non-recipients were 
however, less willing to use HMR than recipients. The most obvious conclusion to 
draw from this finding is that the more HMR is performed throughout the community, 
the higher the overall level of willingness to use it will be. For the rest of the 
Conclusion, consumers refer to eligible non-recipients and caregivers refer to informal 
caregivers.  
 
It is encouraging that a clear majority of consumers were willing to ask their GP for an 
HMR, if they were concerned about their medicines. Similarly, caregivers were willing 
to ask their care-recipients’ GP for an HMR, if they were concerned about their care-
recipients medicines. These findings demonstrate that consumers and their caregivers 
have an important role in driving participation in medication management services.  
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For the first time it was shown that consumers who were aware of a medication 
management service were more willing to use the service than those who were not 
aware. This indicates that the more consumers know about HMR, the more likely it is 
that consumers will drive participation. While some consumers’ awareness of HMR 
had been generated by word-of-mouth and health promotion activities, the majority of 
awareness had arisen because HMR had been mentioned to them by GPs and 
pharmacists. These findings highlight the important role that health professionals have 
in persuading consumers to participate in health interventions. These findings are also 
encouraging because it is possible that other forms of exposure to the concept of HMR 
will improve consumer and caregiver participation.  
 
Consistent with previous research (White, Carter et al. 2011), the most concrete of 
consumers’ and caregivers’ expectations of the benefits of HMR (positive outcome 
expectancy) centred on learning about their (or their car-recipients’) medicines during 
the interview with the pharmacist. This positive outcome expectancy was the most 
important factor influencing consumers’ and caregivers’ willingness to participate in the 
HMR program. Overall however, consumers’ and caregivers’ positive outcome 
expectancy was not high. The major implication of this is that consumer-directed and 
caregiver-directed information about HMR should focus on it as an information 
resource that targets the needs of the individual.  At the same time, the choice of 
language and imagery used to describe HMR should ensure that the benefits of 
consumer education engender feelings of empowerment and autonomy. 
 
The results of this thesis indicate that for both consumers and caregivers, negative 
affect regarding the possibility of medication-related problems increased their 
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willingness to use, or willingness to assist a care-recipient to use, HMR respectively. In 
the case of consumers themselves, the negative affect measured was the worry a 
person feels when they consider them to be at risk of medication-related problems. In 
the case of caregivers of eligible non-recipients, the negative affect measured was 
knowledge hassles – daily stressors experienced whilst dealing with tasks which 
require knowledge about the safety and effectiveness of the care-recipients’ 
medicines.  In both cases, the level of negative affect was raised for three months after 
the eligible non-recipient had experienced a change in the medication regimen. 
Patients are at elevated risk of experiencing medication-related harm after having their 
medication regimen changed. Their level of negative affect (and the level of their 
caregivers’ negative affect) increases in response to these changes. Individuals from 
both groups will be more willing to want to participate in medication management 
services during this time. Health providers should ensure that wherever possible, 
multiple medicine-users and their caregivers are offered the opportunity to participate 
in medication management services when the medication regimen is altered.  
 
A common theme running through this thesis was that it was the oldest of consumers 
and caregivers, who experienced the least negative affect related to medication 
issues. Compared with younger persons, older persons are at greater risk of 
experiencing medication-related harm (Oladimeji, Farris et al. 2008). Older consumers 
and caregivers may require additional encouragement to use medication management 
services because they may not feel worried about being at risk of experiencing 
medication-related problems or feel hassled dealing with medication knowledge.  
 
Finally, the results of this study show that consumers’ willingness to use the 
collaborative HMR service depends on their perceptions of what the GP thinks of the 
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service. It is likely that the success of the HMR program depends on GPs active 
involvement in the promotion and delivery of the service.  
8.2 Future directions  
 
The research in this thesis presents a significant body of work which has provided 
substantial knowledge regarding consumers’ willingness to use medication 
management services. There are three main opportunities for future research in 
pharmacy services and in the broader area of information-seeking behaviour.  
 
First, the conceptual model developed and tested during this research could be 
adapted to investigate the willingness of consumers to use other medication 
management services, such as USAs’ Medication Therapy Management (MTM) or the 
UK’s Medicine Use Reviews (MUR). Locally, the Australian government has recently 
introduced a government funded service called MedsCheck (Australian Government 
Department of Human Services 2012)  MedsCheck provides an in-pharmacy review of 
a consumer’s medicines, focusing on education and self-management and aims to: 
• Identify problems that the consumer may be experiencing with their medicines;  
• Help the consumer learn more about their medicines including how medicines 
affect medical conditions;  
• Improve the effective use of medicines by consumers; and  
• Educate consumers about how to best use and store their medicines.  
 
Similar to the processes of UK’s MUR, community pharmacists are responsible for 
enrolling their patients into the MedsCheck program. Unlike HMR, the enrolment 
process for MedsCheck does not depend on a GP. Therefore, it would wise for 
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community pharmacists to learn more about the factors which influence consumers’ 
willingness to use MedsCheck and caregivers’ willingness to assist their care-recipient 
to use MedsCheck. The conceptual model could be applied to that situation with little 
need for change. Positive outcome expectancy would remain the virtually the same but 
other constructs such as communication efficacy and willingness would require minor 
adaptation. These adaptations could be achieved by conducting pilot studies using 
qualitative methods before proceeding to survey research. 
 
The second area ripe for research is for intervention studies to be conducted to 
determine the effect of increasing consumers’ expectations of pharmacy services. The 
thesis improved our understanding of consumers’ expectations of HMR and the factors 
which may influence these expectations. The thesis demonstrated that consumers 
have overall low expectations of medication management services in general, and 
specifically of HMR. The findings of the thesis could be used to guide the production of 
consumer-directed content aimed at increasing expectations. Intervention studies 
could be conducted to determine whether increasing consumers’ expectations of 
medication management services actually increases consumer participation. This 
could be achieved by providing groups of consumers with information with variable 
content regarding HMR and measuring their positive outcome expectancy and 
willingness to use the service. This could be followed by observation to see whether 
the content influenced participation.  
 
This thesis covered some patient-related factors which influenced willingness. Another 
area for research would to investigate which other factors may influence willingness. It 
was demonstrated that the consumer’s GP had an important role. Future research 
could determine whether for example, the communication skills of the consumer’s 
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GP’s influences willingness to use the service. Another possibility is that consumer’s 
regular pharmacist may have a role in influencing willingness.   
 
Finally, further research is warranted to understand the full potential of “knowledge 
hassles”. It has been known for some time that experiencing daily hassles is 
associated with the tendency to interpret events as threatening and with the tendency 
to seek out threat-relevant information. This research took a deeper look at this 
relationship. This is the first time that a relationship has been drawn between the 
specific feelings of being stressed about processing information on a health topic; and 
a willingness to seek information about that topic. These findings have important 
implications for pharmacotherapy and for the development of theory of information-
seeking behaviour. If confirmed in other contexts, the assessment of knowledge 
hassles could be a useful tool in health provider – client communication.  
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Abstract
Background: The Australian Home Medicines Review (HMR) is a free consumer service to assist
individuals living at home to maximize the beneﬁts of their medicine regimen and prevent medication-
related problems. It consists of a pharmacist reviewing a person’s medicines and collaborating with the
general practitioner to optimize the individual’s medicine management. The uptake of this service has
remained below the projected use, although the program has shown to successfully identify medication-
related problems and improve drug knowledge and adherence of the patient.
Objectives: This study investigates the perceived beneﬁts and barriers of the patients regarding the HMR
service who have used the service and who are eligible for it but have never used it.
Methods: Consumer perceptions were drawn from 14 semistructured focus groups, with patients and carers
belonging to the general HMR target population and consumer segments that have been postulated to be
underrepresented with regard to this service.
Results: The major beneﬁts reported were acquisition of medicine information, reassurance, feeling valued
and cared for, and willingness to advocate medication changes to the general practitioner. Perceived barriers
were concerns regarding upsetting the general practitioner, pride and independence, conﬁdence issues with an
unknownpharmacist, privacy and safety concerns regarding the home visit, and lackof information about the
program. Participants agreed that the potential beneﬁts of the service outweighed its potential barriers.
Conclusions: It is expected that direct-to-consumer promotion of HMRs would increase the uptake of this
valuable service. It would be necessary to ensure that the process and beneﬁts of the service are
communicated clearly and sensitively to eligible patients and their carers to obviate common consumer
misconceptions and/or barriers regarding the HMR service. Furthermore, any direct-to-consumer
promotion of the service must enable patient/carer self-identiﬁcation of eligibility.
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Introduction
In 2001, the Australian Government estab-
lished the Home Medicines Review (HMR)
Program to assist patients living at home to
maximize the beneﬁts of their medicines and
prevent medication-related problems.1 An HMR
is a free consumer service provided jointly by
doctors and pharmacists speciﬁcally for patients
who take multiple medicines each day; have re-
cently spent time in hospital; see multiple general
practitioners (GPs) and/or specialist doctors; or
are concerned, confused, or uncertain about their
medicines. The service is initiated by the patient’s
usual GP who generates a referral to the patient’s
local pharmacist. The latter organizes a specially
trained pharmacist to conduct an interview with
the patient, preferably in the patient’s home.
During the approximately 1-hour long visit, the
patients’ medicines are discussed and inspected.
The pharmacist summarizes his/her ﬁndings in
a report to the GP, who then discusses any
recommendations with the patient and may
make appropriate changes to their medication
regime.1 The involvement of a carer in this process
is optional and depends on the individual relation-
ship between the patient and carer.
The HMR and similar international programs
have been found in multiple studies to successfully
identify clinically signiﬁcant medication-related
problems, improve the drug knowledge and ad-
herence of the patient, improve patient health,
and potentially enhance the relationships between
the GP, pharmacist, and patient.1-7 It is, therefore,
in the public interest that this cognitive pharmacy
service is eﬀectively used by patients who are at
the highest risk of medication misadventure.
However, recent research conﬁrmed that those in
greatest need of an HMR are the least likely to
receive this service.8
Although numerous studies have investigated
the attitudes of pharmacists and GPs, the health
care providers involved in the HMR pro-
gram,1,8-10 and strategies have been proposed to
increase the uptake of the program by these stake-
holders, the literature on consumer perspectives is
relatively sparse. Only a few studies have investi-
gated the perceptions and/or satisfaction of
HMR patients,1,8,9,11 all resulting in the conclu-
sion that service recipients are generally very
pleased and well satisﬁed with the HMR service
and that they ‘‘recognize the beneﬁts arising
from the process.’’8,9 However, no speciﬁc data
exist on the perceived beneﬁts and barriers from
the perspective of HMR recipientsa versus those
of eligible nonrecipientsb, nor on the role of
carers, particularly informal carers, in the uptake
and provision of HMRs, who have been found
to attend approximately 34% of all HMR
interviews.9
Likewise, there is a lack of research on the
perceptions of speciﬁc consumer groups that are
underrepresented as HMR recipients, some of
which are believed to be at a higher risk of
experiencing medication problems than the gen-
eral HMR target groups. Based on a pharmacist
survey, Schwartzkoﬀ identiﬁed these underser-
viced groups to be older males, people of diverse
cultural and language backgrounds, those living
in remote or rural (isolated) areas, Aboriginal and
Torres Strait Islanders, young people with chronic
illnesses and/or other serious health problems,
and customers of smaller (eg, 1-pharmacist)
community pharmacies.9 Schwartzkoﬀ et al. 9
explained that older males are less willing to seek
and accept health care assistance and that ‘‘younger
patients.were rarely asked to consider having an
HMR,’’ it has been very diﬃcult for small (particu-
larly 1-pharmacist) pharmacies making HMR
home visits, community pharmacies in rural
locations often ﬁnd it diﬃcult to deal with HMR
referrals, and indigenous people and communities
of diverse cultural and language backgrounds are
‘‘consistently identiﬁed as disadvantaged in access
to health. services.’’9
A more recent study commissioned by the
Australian Government argues that certain pa-
tients in the period immediately after hospital
discharge, indigenous consumers, culturally and
linguistically diverse consumers, palliative care
patients, and noncompliant or nonadherent con-
sumers, all being at highest risk of medication
misadventure, appear to have rarely received an
HMR.8
This article examines and compares the per-
ceptions of HMR recipients toward the
HMR program with those of eligible nonreci-
pients and investigates the attitudinal diﬀerences
between the overall HMR target population and
the underrepresented segments identiﬁed by the
a Patients who have had an HMR in the recent past.
b Patients who have never had an HMR but would qualify for this service according to the Australian Government’s
eligibility criteria and risk factors.
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Schwartzkoﬀ study.c,d Additionally, attention is
given to the attitudes of carers of both HMR
recipients and eligible nonrecipients.
Methods
Data gathering
A total of 14 focus groups were conducted with
87 HMR-eligible patients and carers who were
recruited through voluntarily participating phar-
macists throughout Australia. The pharmacists
approached potential participants either while
dispensing medicines for them or on the occasion
of an HMR visit. In addition, carers were
recruited from a support group for family carers.
Assurances were given regarding anonymity and
conﬁdentiality. All participants agreed in writing
to the research content and process, including
audiotaping of the focus groups. Respondents
were given an A$50 reimbursement to cover their
costs and time for attending a focus group. Ethics
approval was obtained from the University of
Sydney Ethics Committee.
Semistructured focus group discussions were
chosen as the most appropriate method of data
collection. It has been shown that focus groups
oﬀer researchers a powerful investigative poten-
tial, especially in the areas of consumer behavior,
patient-provider collaboration, health literacy
research, and disease and medication manage-
ment.13 Speciﬁcally, the group discussion format
can stimulate the exchange of ideas, assist partic-
ipants to reﬁne their individual viewpoints by
comparing them with other people’s opinions,
help participants develop their thoughts and be-
liefs, and stimulate the articulation of attitudes.
Moreover, focus groups can provide a protecting
place that gives participants a sense of commu-
nity, which makes them more comfortable in
expressing their opinions. Participants are more
likely to bring up and discuss concerns and nega-
tive thoughts in focus groups than in other data
collection methods.13
Moderated by HMR-experienced pharmacist
researchers who were experienced in qualitative
research, the semistructured focus group sessions
were opened by a brief statement of the purpose of
the focus group and an invitation to discuss how
respondents obtain their medications, what kind of
medicine problems they tend to experience, and
how they manage these. The relationships of the
participating patients and carers to their pharma-
cists and GPs were then explored. After this
introductory discussion, the HMR program was
explained to eligible nonrecipient groups, and
participants were asked about their opinions
of this service and whether or under which circum-
stances they would consider using it. Themes
discussed were the character and qualiﬁcation
of the HMR pharmacist, the inﬂuence of the
HMR on the relationship with the patients’ local
community pharmacist and GP, the potential
eﬀects of theHMRon the patients’ currentmedica-
tion management, the disclosure of the patients’
medical records to the reviewing pharmacist,
privacy and safety issues in relation to the home
visit, and the participants’ ideas regarding HMR
follow-up activities as well as their overall thoughts
and feelings concerning this service.
In addition to the above points, the HMR
recipient groups were also asked about their
expectations and potential concerns regarding the
HMR service during the initiation phase of the
HMR(before theHMRvisit) andwhether andhow
these attitudes changed during and after the HMR
interview. In addition, the HMR recipient groups
were encouraged to talk about any actual changes
resulting from the HMR visit and subjective out-
comes, such as health and quality-of-life changes.
They were asked about their overall satisfaction
with the service, about any suggestions they could
thinkof for improving the service, andwhether they
would have another HMR in the future and/or
recommend it to friends and family.
In all groups, it was investigated whether
participants would actively ask their GP for an
HMR referral. The focus group sessions were
concluded with a facilitator’s summary of the
discussion and the respondents thanked for their
time and involvement. Each focus group took
between 30 and 70 minutes, depending on the
number of participants and their level of interest
in the topic.
Participants
In total, 87 consumers participated in 14 focus
group discussions held in 4 states of Australia
c This article does not include the Aboriginal and Torres Strait Islander and ethnic consumer groups. Because of their
distinctly diﬀerent circumstances, the attitudes of these consumer segments are discussed in a separate article.
d Statistics on the use of the HMR service by speciﬁc consumer groups, except for sex- and age-related statistics, were
not available from the Australian Government.
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(New South Wales, Victoria, Queensland, and
South Australia). The groups included 69 patients
and 18 carers as well as 8 respondents who
identiﬁed as both patients and carers. Of the
14 focus groups, 8 consisted of eligible non-
recipients (patients and carers) and 5 consisted
of HMR recipients (patients and carers). In
addition, there was 1 carer-only focus group
consisting of 2 carers of HMR recipients and
4 carers of eligible nonrecipients.
For the purpose of this study, patients were
deﬁned as persons who had had an HMR in the
past 6 months (HMR recipients) and those who
had never had an HMR but were eligible for this
service according to the Australian Government’s
eligibility criteria and risk factors for HMRse
(eligible nonrecipients). Carers were deﬁned as
persons who provide support to someone with
a disability, mental health problem, chronic con-
dition, or who is frail aged. They could be family
members, friends, or employees who care for the
patient for between a few hours a week or all
day every day.
The average number of participants per focus
group was 6, with a range of 3-10. The age of the
participants ranged from 33 to 91 years. Forty-
ﬁve percent were male, and 55% were female. A
deﬁnition of each consumer segment and the
number of focus groups conducted for each are
listed in Table 1. Carers and patients participated
in 12 of 14 focus groups with an approximate
carer-to-patient ratio of 1:3. No speciﬁc focus
group was held with younger chronically ill
HMR recipients because of a lack of suitable
and interested patients.
Analysis
All focus group discussions were audiotaped
and transcribed verbatim with tracking of indi-
vidual speakers. In addition, the moderators’
assistantsmadedetailed sessionnotes on seatingor-
der, body language, and indications of group
mood. Each focus group session was debriefed by
the involved research team members, with the im-
pressions of agreement and controversy discussed
and the ﬁndings summarized in an abridged report.
Thematic analysis was used to analyze the data in-
volving a 3-step process14: (1) UsingNVivo 8 (QSR
International [Americas] Inc., Cambridge, MA,
USA), codes were generated and collated into ten-
tative themes, which were checked back across the
entire data set; (2) the codes were connected into
categories and subcategories and relationships
established between categories to ﬁnd themes; and
(3) the themes weremapped and deﬁned and names
for each theme generated. Discrepancies between
researchers were resolved in team discussions
involving the chief investigator and the 2
coresearchers.
Results
The beneﬁts and barriers ofHMRs perceived by
recipients and eligible nonrecipients of the investi-
gated consumer groups are described in the follow-
ing sections.Manyof the attitudes are shared by the
various respondent groups (recipients/eligible non-
recipients, patients/carers, andgeneralHMRtarget
groups/low-use segments). The results, therefore,
cover the common views, and where disparate
perceptionswere raised by speciﬁc subgroups, these
are noted. A summary of the perceived HMR
beneﬁts and barriers including additional partici-
pants’ quotes are depicted in Table 2.
Perceived beneﬁts of HMRs
Participants identiﬁed 4 key beneﬁts of having
an HMR: acquisition of personalized information
and advice regarding medications; reassurance
regarding medications and coordination of their
care; feeling valued and cared for by a health care
provider; and enhancing the patient-provider and
pharmacist-GP relationships. Sorting out the
medicines cabinet and ensuring that the medical
e HMR eligibility requirements as set out by the Australian Government (http://www.health.gov.au/internet/main/
publishing.nsf/Content/ppsac-hmr):Patients who may beneﬁt from a HMR include those:
 taking 5 or more regular medications;
 who are confused or worried about their medicines (or forget to take their medicines);
 taking more than 12 doses of medication per day;
 who have had a signiﬁcant change to their medication regime;
 with literacy or language difﬁculties, dexterity problems, impaired sight, or those with cognitive difﬁculties such as
dementia;
 seeing a number of different doctors, including GPs and specialists;
 recently discharged from hospital.
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records of the GP are up-to-date were reported
as secondary beneﬁts. The following sections
describe each of these attitudes in detail.
Information acquisition
The ﬁrst unprompted beneﬁt raised by partic-
ipants in every focus group was the opportunity to
acquire personalized information and advice re-
garding medications. Most respondents reported
that the medication instructions that they received
from their health care providers (doctors and
pharmacists) were sometimes vague and/or in-
adequate. Printed medicine information sheets
distributed by pharmacists were largely seen as
being too general, confusing, and ‘‘fear monger-
ing,’’ rather than being a valuable source of
information. Other sources of medicine informa-
tion such as the Internet and organizations such as
the National Prescribing Service were mentioned
as being helpful but were not considered to be
suﬃciently speciﬁc to the individual’s health cir-
cumstances. Therefore, participants regarded the
HMR as an ideal opportunity to better under-
stand the correct dosage and administration
method and the eﬀects of each prescribed medi-
cine in relation to their individual disease states
as well as to dispel any confusion, such as that
caused by brand substitution. A need for more
information about possible medication interac-
tions and side eﬀects was also raised, and thus,
overall, the respondents saw a need to identify
inappropriate or detrimental medication therapy.
HMR recipient (general): When I started taking
tablets, I had no idea what I was taking or what
for. I’ve had my home review and I’ve just asked
about side eﬀects to some of the medication that
I’ve been taking and [the HMR-pharmacist]
explained that to me, which was good.
However, some respondents, particularly cus-
tomers from smaller pharmacies, mentioned that
they already received extensive and satisfactory
medication advice from their local pharmacist.
When [the pharmacist] is giving you the [medica-
tions] they go through it, even though you’ve got
the stuﬀ . time after time, they will still go
through it with you.
[In response to the facilitator’s question if they
worried about the interactions between medica-
tions]: Well, I don’t because that’s where I leave
it to the pharmacist.
Reassurance and coordination of care
HMR recipients reported that the HMR visit
gave them a strong sense of ‘‘peace of mind’’ that
their drug regimen was adequate, coordinated,
and up-to-date. A lack of reassurance from
prescribing doctors and dispensing community
pharmacists and an awareness of increasing (usu-
ally age related) cognitive diﬃculties coping with
the prescribed medication regimen were described.
Having [the HMR-pharmacist] check on me [was
important] because I’m getting a bit old.
Likewise, eligible nonrecipients of all consumer
segments considered ‘‘reassurance’’ to be a key
beneﬁt of an HMR. This was often driven by
Table 1
Deﬁnition of consumer segments and number of focus groups per segment
Consumer segment Deﬁnition of consumer segment Number of
HMR recipient
focus groups
Number of eligible
nonrecipient
focus groups
Older males Male patients aged 75y and older 1 1
Younger patients Patients younger than 65y, who have a chronic illness
and/or other serious health problems
0 2
People living in remote
and rural areas
of Australia
Patients and carers who belong to the PHARIAa
categories 2-6. Pharmacies located in these areas
are eligible for the Rural Pharmacy Maintenance
Allowance
1 1
Customers of smaller
pharmacies
Patients and carers whose regular community
pharmacy usually has only 1 pharmacist on duty
at any one time
1 1
General HMR
target population
Patients and carers who are not included
in any of the above segments
2 3
Plus 1 mixed carer-only group
aPHARIA: Pharmacy Accessibility/Remoteness Index of Australia; available at: www.gisca.adelaide.edu.au/
projects/pharia_0708/PhARIA_info.html#cat, accessed: June 2008.
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Table 2
Perceived beneﬁts and barriers of the HMRdparticipants’ voices
Beneﬁt/Barrier HMR recipients or their carer Eligible nonrecipients or their carer
Beneﬁts
Information
acquisition
I actually had my medicines in the
wrong spot at one time and [the
HMR-pharmacist] just said .
put them in the wardrobe in
a cooler spot. (General).
The pharmacist gave us a lot of
information and it was fantastic.
(Remote and rural)
Well, youdat least you’d learn what you’re
actually taking and what it is for. (General)
You would get a more thorough evaluation of
what type of, what you’re taking and . what
other things might be interacting with what
you’re taking maybe. (Younger chronically ill)
Excellent idea [the HMR], yes. Especially
taking a few tablets, you might be taking them at
the wrong time. They can clash with each other.
(General)
Reassurance and
coordination of care
[The HMR gives us] a little bit
more conﬁdence in
taking our medication. Before we
were a bit apprehensive taking it
because of not knowing if [the
medicines] counteract each other.
I thought it [the HMR] was very
interesting because it had
always worried me about the
amount of pills and things.
Each specialist you go to only treats what he treats
and he might give you a medication which will
interact in a bad way with another drug from
another specialist. They very rarely contact each
other, the specialists. In the end you have all
these doctors and you need someone like the
pharmacist to tie it all together. (General)
[I was] going to the diabetes center., and they
changed blood pressure medication. And as soon
as I went back to the other doctor, he says no, we
won’t do that . So I go to the specialist center
and then he decides no, we’ll do something else.
You go back up in and say well why did he
change it? I said, well, I don’t know . and
you’re caught in sort of a war of doctors
sometimes. (Younger chronically ill)
Feeling valued
and cared for
[The reviewing pharmacist] came
in, not judging whatever
medication you’re on. She was
there just to help you, to make
sure that you were happy with
your medication, to make sure
you knew everything about
[them]. (General)
I think it [the HMR] gives you a sense overall of
knowing that there’s somebody out there that
really gives a damn. (General)
Enhancing
communication
and relationships
[The HMR-pharmacist] didn’t
think the two [medications]
together were quite right so when
we went to the doctor, she
changed her medication around
because the chemist had sent her
a note . I think that’s a really
good idea. (Older Male) Even
after the tablet review [HMR],
he’ll [the pharmacist] always ask
you is there anything perhaps that
he could put down to alert the
doctor to. (General) Well, I felt I
knew my new doctor better [after
the HMR] because he got
a [medication review] report
from the pharmacist. (Remote
and rural)
It’s opening up the communication between the
pharmacist and yourself, and the doctor so that
if there are any complications arising from the
prescribed medicines, that you’re taking you can
pass it on to your pharmacist who then passes it
on to your doctor. (General)
(Continued)
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a fear of taking too many or too much medication
and, thus, experiencing side eﬀects. Additionally,
eligible nonrecipients from the various segments
hoped that the HMR would help them coordinate
an overall picture of their medications when
seeing multiple GPs and specialists and using
diﬀerent pharmacies.
Carers appreciated that the HMR would help
them share their responsibility for the patient’s
medicines, hence relieving some of the carer’s
emotional stress.
Carer of HMR recipient: We have feed in from all
the doctors and because I know a little bit I do just
correlate [the information] . [but the HMR is]
just taking all that more pressure oﬀ me.
Feeling valued and cared for
Many respondents were extremely keen about
(eligible nonrecipients) and pleased with (HMR
recipients) the opportunity to receive undivided
attention from a health care provider and spend
a relatively long time talkingwith a pharmacistwho
would listen nonjudgmentally and address their
questions and concerns. The concept that a health
careprofessionalwouldhelp themthroughavariety
of highly personal, often worrying health and
medication issues was immensely powerful and
engenderedparticipants’ emotions of feeling valued
and cared for. Interestingly, the older male HMR
recipients placed a high value on the reviewing
pharmacist’s professional and interpersonal skills.
I think [the reviewing pharmacist] would need to
be more experienced. A senior. They would need
to understand people as well as the eﬀects of the
medications.
Enhancing communication and relationships
A perception of the respondents’ strengthened
relationships with the local pharmacist and GP,
and between the pharmacist and GP, was another
Table 2 (Continued )
Beneﬁt/Barrier HMR recipients or their carer Eligible nonrecipients or their carer
Barriers
Concern of
upsetting the GP
But [the doctor] might [say], well,
I’m the doctor; I know what’s best
for the patient. (General)
I’d be frightened the doctor might say ‘oh no, this is
checking up on me’. I’ve got a lot of faith in him.
(Carer) The doctor might get upset . (Older
male) You don’t want to oﬀend the doctor.
(Older male)
Pride and independence I thought he’s [the HMR
pharmacist] checking up
to see if I’m doing the right thing,
and I knew I was doing the right
thing. (Remote and rural)
I’ve got everything under control at the moment,
that’s right, yes. (Carer) But then, there could be
some people who mightn’t be as alert as they
were when they were 75 and they’re hitting 90,
and they would be quite happy to concede that
they are a bit muddily. And often at the end of
the day there’s tablets left and will I take them
all at once or whatever. And, so, yes, I wouldn’t
mind a visit. (General)
Unknown pharmacist Dealing with somebody that you’ve
known for many, many years,
having someone come from
another pharmacy is still quite
acceptable but not as friendly or
as intimate. (General)
I think when they come to your house, it becomes
a very personal sort of a thing, and you prefer
someone that you’ve had dealings with rather
than a stranger. (Customer of a smaller
pharmacy) I think that [the HMR] would be
more thorough if it was done in the home, but I
would feel more uncomfortable having it done in
the home, but that’s my personal choice.
(Younger chronically ill)
Home privacy and
safety concerns
No concern
Desire for more
information and for
inclusion in the process
as a carer
Well, if they’re going to write things
[in a report] I’d be interested. I
really didn’t know anything
about the report. (General)
There might be ethical problems or whatever, but
it’d be interesting to see the original report
rather than have it ﬁltered through the doctor.
(Younger chronically ill) (On being prompted
if they were interested in a written HMR-
report): Let’s say [the patient] decides to be a bit
antsy and hide her report and I still don’t know
what’s going on and I’m still caring for her.
(Carer)
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core beneﬁt, speciﬁcally, but not solely identiﬁed by
HMR recipients. Although a few respondents
stated that their doctor and pharmacist had always
collaboratedwell, the common view prior to having
anHMRwas that the relationship betweenGP and
pharmacist was superﬁcial or virtually nonexistent:
Carer: I don’t think the doctor has communication
with the pharmacy.What I’m saying is that once
your doctor gives you the prescription you can go
to any pharmacist so the doctor is not aware where
you’re going.
Carer: I think the doctor and the pharmacist, each
of them are trying to protect their patch and .
I don’t know whether they’re going to sort of
happily interact with one another.
The HMR was perceived as a conduit to
improving these relationships.
Other beneﬁts
Secondary perceived HMR beneﬁts were the
practical advantages of sorting out the patient’s
medicines on hand, disposing of unnecessary or
expired medications, and keeping the doctor’s re-
cords of the patient’s medications up-to-date. The
identiﬁcation of prescribing and other errors was
very rarely mentioned spontaneously as a per-
ceived beneﬁt of an HMR and even when raised
by the facilitator, there was little support for this
because of the extremely high levels of trust in
both the GP and the pharmacist. Even on prompt-
ing, the possible advantage of saving money was
not seen as a beneﬁt of HMRs. On prompting,
the possibility of an HMR leading to greater inde-
pendent living was considered valid by only 2
groups (older males and remote and rural HMR
recipients).
Perceived barriers to HMRs
Among those who never had an HMR (eligible
nonrecipients), possible barriers that would deter
them from having an HMR were noted. Concerns
focused (in decreasing order of frequency) on the
fear that the HMR could cause deterioration in
their relationship with their GP, the belief that
they do not need an HMR, having the HMR with
an unknown pharmacist, and privacy issues. In
addition, eligible nonrecipients regretted that lack
of HMR knowledge had prevented them from
receiving this valuable service.
Concern about upsetting the GP
A signiﬁcant proportion of respondents felt
that GPs ranked higher than pharmacists in the
health care hierarchy. They believed that GPs
might, therefore, be reluctant to accept medica-
tion recommendations made by pharmacists and
become upset with the patient for having or
asking for an HMR.
HMR recipient A (general): I don’t think the GP
would like suggestions from the pharmacist. HMR
recipient B: Most doctors will take, uh . HMR
recipient A: They take oﬀence.
Some customers of smaller pharmacies per-
ceived the pharmacist to be in a good position to
conduct the HMR and give the GP formal
feedback because they were seen to have more
up-to-date and specialized medication knowledge
and be less inﬂuenced by drug companies than
GPs. Participants from the general HMR target
group were split about their trust in the pharma-
cist’s ability and authority to give the GP medica-
tion feedback.
Respondents from several consumer segments
highlighted that better promotion of the HMR
program to GPs could help alleviate negative
attitudes that GPs might have toward the service,
thus enhancing the likelihood of the HMR being
oﬀered to patients at risk. One respondent even
suggested that the HMR service was so beneﬁcial
that it should be compulsory for doctors to oﬀer
them to their patients. Another patient summa-
rized the core role that GPs play in the HMR
program by stating: We need to work on the
doctors and get the doctor to (promote HMRs)
(HMR recipient, customer of small pharmacy).
Pride and independence
Respondents who perceived that they had no
need for an HMR believed that they knew enough
about their medications and are in control of
them but would be open to have an HMR in the
future, particularly if their cognitive abilities
deteriorated.
Eligible non-recipient (younger chronically ill):
Some people might see [having an HMR] as an
admission that they’re getting more dependent, so
the younger age groups don’t want to do it, but
the older age groups have learned to live with
that feeling of maybe slightly more dependency,
and it’s not an issue for them.
One carer of an HMR recipient was careful not
to tell friends or family about the HMR experi-
ence in order that she and her husband whom she
cared for were not seen as dependent or inferior.
I haven’t told any relatives or any friends of my
husband’s peccadilloes because I’m frightened
they will see him as a devalued person.
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However, most other HMR recipients were
pleased to discuss the service with others without
reservations.
Unknown pharmacist
Discussing the scenario of an unknown
pharmacist conducting the HMR, several eligible
nonrecipients perceived this as a barrier to a sat-
isfactory HMR. These respondents felt less
comfortable with the thought of an unfamiliar
pharmacist conducting the HMR and would not
as readily entrust personal information to them as
they would to their regular pharmacist. Some also
thought that an unknown pharmacist would be
less credible to the patient’s doctor.
Eligible non-recipient (older male): Well, there
would be a barrier between you and the chemist
if you don’t know them.
Other eligible nonrecipients and HMR recipi-
ents, on the other hand, regarded an external
pharmacist as a welcome opportunity to gain
a second opinion to check on any medication
problems that their local pharmacist or GP did
not pick up and to steer clear from a potential
conﬂict of ﬁnancial interest that their local com-
munity pharmacist might have.
Eligible non-recipient (younger chronically ill):
Even if you had two qualiﬁed people, having a sec-
ond person looked at, it might be a beneﬁt to pick
up one thing that someone else couldn’t see.
Carer: Well, I think they [unknown pharmacists]
are objective and I see it as a check on the [local]
pharmacist and the doctor in case, you know, they
overlook something.
Home privacy and safety concerns
Particularly some younger chronically ill pa-
tients expressed concerns regarding the HMR
being conducted in the patient’s home. They felt
more comfortable having the HMR in a neutral
place, conceding that the review would be more
thorough if it was done in the patient’s home.
Older males, participants from the general target
groups, and customers from smaller pharmacies
were only apprehensive of allowing the HMR
pharmacist into their home if the pharmacist
was not previously known to them. In such cases,
identiﬁcation, such as a prior phone call to an-
nounce their arrival at a particular date and
time and a uniform or badge, would alleviate their
safety concerns.
Most eligible nonrecipients, however, seemed
to feel at ease with the home visit and perceived
that the medicines review was best conducted in
the patient’s usual living environment.
Eligible non-recipient (general): I’d rather have
[the HMR] in the home. I wouldn’t want anyone
else to see my big bag of goodies!
Interestingly, none of the HMR recipients had
any home privacy concerns. They found the pa-
tient’s home to be an ideal venue because it made
them feel comfortable without time restraints.
HMR-recipient (remote and rural): You feel more
comfortable in your own home. . it’s more
personal. You’re also not time-limited either,
whereas in the pharmacy you can see all the people
lining up.
HMR-recipient (general): Being at home is a dif-
ferent atmosphere ‘cause if you go to the chemist
and you’re asking [questions], there’s people
around you and listening, there’s not the same
feeling.
Carers of HMR recipients valued the home
visit because of the physical diﬃculties of trans-
porting elderly sick patients to diﬀerent places.
Desire for more information before and subsequent
to the HMR
A number of HMR recipients wished they had
been better informed about the HMR process
before having the HMR. Some, for example,
thought a nurse would conduct the HMR; an-
other person was upset to learn that the HMR
pharmacist was informed about her medical
diagnoses without her consent. Others were
confused about the role of the HMR pharmacist,
speculating that they were merely monitoring the
patient’s medication adherence.
When [the pharmacist] came, I thought ‘I wish
I knew she was going to say this, I would’ve like
prepared diﬀerently’.
Likewise, many HMR recipients did not know
that the HMR pharmacist issued a post-HMR
report to the GP. Several respondents were
disappointed that they were not informed of this
and wanted to receive a copy of the report to
understand the pharmacist’s recommended ac-
tions, to feel in control of the HMR outcomes,
to be able to refer back to it for future reference,
and/or to be informed about the content of the
communication between pharmacist and GP. Par-
ticipants from the younger age groups particularly
wanted to ensure that the post-HMR advice from
their GP was consistent with the pharmacist’s
recommendations.
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Eligible non-recipient (younger chronically ill):
It’d be interesting to see the original report rather
than have it ﬁltered through the doctor. Because
the doctor might ﬁlter what he reads and even
subconsciously, so you can say, well, what did he
mean when he said this and whatever, put him on
the spot.
Furthermore, the need for an up-to-date med-
ication list of what to take as well as when and
how was repeatedly raised by participants of
various consumer segments.
Eligible non-recipient (general): I actually pre-
sumed there was going to be a written. statement
to say, you know, if you’re taking something in the
morning you should be taking at night, he [the
HMR-pharmacist] can just write down: ‘make
sure you take such and such at night’, just in simple
one-syllable words and you’re there, and your fam-
ily can see that too when they come.
Most participating eligible nonrecipients
regretted that they had not known about the
existence of the HMR program before participat-
ing in this study and suggested that this valuable
service should be promoted more widely.
Some carers of HMR recipients felt completely
excluded from the HMR process. They regretted
that they were not invited, hence were not present
at the medication review, and that they did not
receive any feedback on the HMR results, which
compromised their ongoing care for the patient.
[The patient] told [the pharmacist] that [the
carer] didn’t care for her properly. I didn’t know
what had been written about us [the carer] .
[as the pharmacist] said ‘‘due to privacy I can’t
show you that form’’ . But then the thing what
upset me was, what if what she said was true.
What if I wasn’t looking after her properly?
Nobody followed it up.
Overall, it was observed that HMR recipients,
although some of them had hadmajor reservations
prior to having their ﬁrst HMR, were highly satis-
ﬁed with their HMR experience and desirous of
having another HMR if appropriate. Eligible non-
recipients were split between those who wanted an
HMRorwould be happy to have one if their GP re-
quested it for them and those who did not see a per-
sonal need for having anHMR(at the present time)
in spite of recognizing the beneﬁts that the HMR
service provides and perceiving it as a valuable ser-
vice for others.No respondent perceived the service
to be of no value. The congruence of attitudes to-
ward the HMR between eligible nonrecipients
and HMR recipients before receiving the service
demonstrates that there is no evident diﬀerence be-
tween the groupswith respect to their willingness to
participate in an HMR.
Discussion
Although this study’s ﬁnding of the high con-
sumer satisfaction levels with the HMR is consis-
tent with the results from earlier studies,1,8,9 the
insights that this study gained into speciﬁc prob-
lems that patients and carers perceived regarding
accepting or asking for an HMR are new. These
concerns need close examination because they
could inﬂuence whether the service is taken up
by high-risk patients or refused with the resultant
risk of the patients experiencing adverse drug
events.
The most prominent concern voiced by all
types of participants was the worry that their
participation in an HMR could upset the GP,
which meant that there was the possibility of
patients rejecting having an HMR even before
discussing this with their doctor. The role of the
GP as being the gatekeeper to the uptake of
HMRs has been identiﬁed in several studies, one
of which suggested, ‘‘the HMR referral is GP
generated rather than led by patient demand.’’15
Similarly, it has been argued that the HMR up-
take will remain low without a change in the level
of support for the program by GPs.8 In addition
to these ﬁndings, this study reveals the direct
link that exists between the consumer awareness
of the GP’s power position and its negative impli-
cations for the HMR uptake in the patients’
minds, speciﬁcally in situations where the HMR
was suggested to the patient by someone other
than the GP.
Another concern that could impede the uptake
of the HMR was the reported lack of trans-
parency about the HMR process, which points
to an absence of a thorough patient education
process regarding the purpose, beneﬁts, and pro-
cedural steps of the HMR at the time of its
initiation. The implications of underinformed
consumers who may hold incorrect assumptions
regarding a health service that they can choose to
accept or reject are concerning. As Fogg12 notes:
‘‘What a person thinks is the purpose of a medica-
tion review is likely to inﬂuence their perception of
its appropriateness and usefulness.’’ It is thus sug-
gested that adequately addressing the service ben-
eﬁts and potential recipient concerns at the time of
the service initiation could not only help patients
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to have a clear and positive picture of what to ex-
pect but also obviate any reservations related to
issues of pride and independence, an unknown
pharmacist, and/or domestic privacy.
Another concern that emerged from this study
is the perception held by some carers of being left
out of the medication review process and, related
to that, the carers’ uncertainty about their care re-
cipient’s medication issues. Similar problems have
been identiﬁed by Smith et al16 who found that
approximately 5% of the carers who participated
in their study wanted more information on rou-
tine medication details. Although the carers in
the study by Smith et al16 reported problems of
not being informed about their care recipients’
medication changes, they were at the same time
aware of the prescribers’ dilemma in juggling in-
formation disclosure to carers with the care recip-
ients’ right to privacy. Other studies found that
managing medication contributed to the stress of
caring,17 carers generally expressed stronger infor-
mation needs and required diﬀerent types of infor-
mation than patients,18 and the provision of
speciﬁc information to carers was vital in the pro-
cess of developing competency as a carer.19,20 The
undermet information need of carers has shown to
cause widespread dissatisfaction of the carers 21-23
and added to the carers’ diﬃculty in deﬁning their
caring position in relation to the care recipient
and their health care professionals.21 In light of
this existing research, our study ﬁndings are
a timely reminder that it is necessary to review
the role and status of carers in the provision of
HMRs to care recipients.
The disinclination of older male eligible non-
recipients to seek medication advice and their
skepticism about how they could beneﬁt from an
HMR is another noteworthy issue. An integrative
literature review that critically analyzed 124 stud-
ies on help-seeking behavior in the context of sex
supports the assumption that masculinity beliefs
of white middle-class men are signiﬁcant variables
inﬂuencing their health risk appraisal and help-
seeking behavior. The review reported that men
were poor attendees for preventative medicine,
consistently ignored symptoms of ill health, and
avoided or delayed seeking professional help from
the health services for fear of ‘‘appearing weak,
hypochondriacal (sic), or lacking in masculin-
ity.’’24 Such sex-speciﬁc ideologies could be an im-
portant factor in a man’s decision to accept or
seek an HMR, but further research is required
to investigate the variations between men of dif-
fering socioeconomic status, age, and ethnicity.24
It is critical that any promotional messages for
the HMR service emphasize that having an
HMR is not an admission of inferiority or lack
of independence.
Finally, inferences can be drawn from the
perceptions of customers of smaller pharmacies,
who appeared better informed about their medi-
cations and exhibited relatively higher levels of
self-conﬁdence with managing their medicines,
higher awareness levels of the HMR program,
and better relationships with their local pharma-
cist than other groups. Although this ﬁnding
needs to be veriﬁed through further research, it
highlights the value and importance of the
day-to-day consulting and advisory role of
community pharmacists, particularly with regard
to patients who would beneﬁt from enhanced
medication advice but do not belong to the most
at-risk HMR target groups.
In summary, it is expected that direct-
to-consumer promotion of the HMR program
could greatly increase the uptake of this valuable
service. Care must be taken that any promotional
messages clearly communicate details about the
HMR purpose, process, and beneﬁts as well as the
patient eligibility criteria to obviate misconcep-
tions and/or barriers regarding the service and
prevent the misuse of the service by those who are
not at (highest) risk of medication misuse.
Study limitations
There are several limitations of this study. First,
the participants of the carer-only focus group were
recruited from a carer support group. Consumers
attending support groups are likely to be more
highly educated, desire more information, and/or
use more adaptive coping strategies.25 It might,
therefore, be possible that the views of the carer-
only group were more sophisticated or detailed
than those of the average carer or that any concerns
that more aware and/or maturated carers might
have already processed remained unreported.How-
ever, the comments from the mixed patient-carer
focus groups, where the carers were not recruited
through a carer support group, are largely congru-
ent with the comments of the carer-only group.
Second, studies based on focus group research
are limited by the social contexts in which they are
situated, potentially causing problematic silences
and/or exaggerated speech.26 However, such po-
tential drawbacks may have been outweighed by
the opportunities that the group sessions oﬀered.
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Speciﬁcally, the unfolding group dynamics helped
participants to explore and clarify their own per-
spectives, stimulated the exchange of experience
in a relaxed atmosphere fostering mutual disclo-
sure, and highlighted the values shared by patients
who are at risk of medication misadventure.27
Third, patients who were oﬀered but refused to
have an HMR were not speciﬁcally recruited for
this study, and neither did the study include
patients who are housebound because of their
physical inability to attend a focus group. How-
ever, it is assumed that housebound patients
would usually have a carer, and the inclusion of
carers in this study could have, therefore, to some
extent mitigated the exclusion of housebound
patients. The perceptions of patients who refused
an HMR would be a valuable addition to this
research. Furthermore, research with larger pa-
tient samples and quantitative research would be
beneﬁcial to verify correlations, for example,
between patients’ attitudes toward HMRs and
their relationships with doctors and pharmacists.
Conclusion
Although individuals who had experienced the
HMRwere overall highly satisﬁed with the service,
a number of barriers to the use of the HMR
program were identiﬁed regarding that might be
addressed by means of direct-to-consumer pro-
motion. Care must be taken that in any such
promotional messages, the purpose of the HMR,
its procedural steps, and its beneﬁts are clearly
communicated to the public to prevent the occur-
rence of common misconceptions and/or barriers
regarding the service. Attention has to be given not
to exclude carers ofHMR-eligible patients from the
medication review process and to address older
male patients in a sex-sensitive manner. Addition-
ally, it is of utmost importance that any marketing
strategies include a precise and easily understand-
able deﬁnition of the HMR eligibility criteria to
capture the most at-risk HMR target population
and decrease the probability of noneligible patients
requesting an HMR from their GP.
Acknowledgment
This project was funded by the Australian
Government Department of Health and Ageing
as part of the Fourth Community Pharmacy
Agreement Research and Development Program
managed by the Pharmacy Guild of Australia.
References
1. Bennett A, Smith C, Chen T, Johnsen S, Hurst R.
A comparative study of two collaborative
models for the provision of domiciliary medication
review: St George Canterbury Medico/Pharmacy
Projectdexecutive report. Available at: http://www.
guild.org.au/mmr/content.asp?id¼406. Accessed
November 2009.
2. Castelino RL, Bajorek BV, Chen TF. Targeting
suboptimal prescribing in the elderly: a review of
the impact of pharmacy services. Ann Pharmacother
2009;43:1096–1106.
3. Holland R, Desborough J, Goodyer L, Hall S,
Wright D, Loke YK. Does pharmacist-led medica-
tion review help to reduce hospital admissions and
deaths in older people? A systematic review and
meta-analysis. Br J Clin Pharmacol 2008;65:303–316.
4. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J.
Eﬀects of a medicine review and education
programme for older people in general practice. Br
J Clin Pharmacol 2000;50:172–175.
5. Sorensen L, Stokes JA, Purdie DM, Woodward M,
Elliott R, Roberts MS. Medication reviews in the
community: results of a randomized, controlled eﬀec-
tiveness trial. Br J Clin Pharmacol 2004;58:648–664.
6. YuK,NguyenA, Shakib S, et al. Enhancing continu-
ity of care in therapeutics: development of a post-
discharge home medicines review model. J Pharm
Pract Res 2007;37:22–26.
7. Quirke J, Wheatland B, Gilles M, Howden A,
Larson A. Home medicines reviews: do they change
prescribing and patient/pharmacist acceptance?
Aust Fam Physician 2006;35:266–267.
8. Campbell Research & Consulting. Home Medicines
Review Program, Qualitative Research Project, Final
Report. Department of Health and Aging; 2008.
http://www.guild.org.au/mmr/content.asp?id=406.
Accessed November 2009.
9. Schwartzkoﬀ J, et al for Urbis, Keys, Young. Evalu-
ation of the Home Medicines Review Programd
Pharmacy Component, Investigator Initiated Guild
Government Grant 2004-526. The Pharmacy Guild
of Australia; 2005. Canberra BC ACT 2610, Avail-
able at: http://www.guild.org.au/research/project_
display.asp?id=277. Accessed November 2009.
10. Roberts A, Benrimoj C, Chen T, Williams K,
Aslani P. Quantiﬁcation of Facilitators to Accelerate
Uptake of Cognitive Pharmaceutical Services (CPS)
in Community Pharmacy, Investigator Initiated
Guild Government Grant 2003-007. The Pharmacy
Guild of Australia; 2004. The University of Sydney,
Sydney, NSW 2006; Available at: http://www.guild.
org.au/research/project_display.asp?id=263. Accessed
November 2009.
11. Chen T, Larkin C. Consumer attitudes toward
and experiences of domiciliary visits by commu-
nity pharmacists. Aust Pharm 2002;21:682–684,
686–688.
15White et al./Research in Social and Administrative Pharmacy 8 (2012) 4–16
APPENDIX A 190
12. Fogg S. Consumer Evaluation of Domiciliary Medica-
tion Management Reviews. Consumers’ Health
Forum; 2001.
13. Huston SA, Hobson EH. Using focus groups to
inform pharmacy research. Res Social Adm Pharm
2008;4:186–205.
14. Liamputtong P. Qualitative data analysis: concep-
tual and practical considerations. Health Promot
J Austr 2009;20:133–139.
15. Roughead E, Pratt N, Peck R, Gilbert A. Improving
medication safety: inﬂuence of a patient-speciﬁc
prescriber feedback program on rate of medication
reviews performed by Australian general medical
practitioners. Pharmacoepidemiol Drug Saf 2007;16:
797–803.
16. Smith F, Francis S-A, Gray N, Denham M,
Graﬀy J. A multi-centre survey among informal
carers who manage medication for older care
recipients: problems experienced and development
of services. Health Soc Care Community 2003;11:
138–145.
17. Ranelli PL, Hansen RW. Medication-Related
Stressors and the Family Caregiver: A Qualitative
Analysis. Res Sociol Health Care 1997;14:233–248.
18. Harrison J, Haddad P, Maguire P. The impact of
cancer on key relatives: a comparison of relative and
patient concerns. Eur J Cancer 1995;31:1736–1740.
19. Brown M-A, Stetz K. The labor of caregiving: a the-
oretical model of caregiving during potentially fatal
illness. Qual Health Res 1999;9:182–197.
20. Grahn G, Danielson M. Coping with the cancer
experience. II. Evaluating an education and support
programme for cancer patients and their signiﬁcant
others. Eur J Cancer Care (Engl) 1996;5:182–187.
21. Morris SM, Thomas C. The need to know: informal
carers and information. Eur J Cancer Care (Engl)
2002;11:183–187.
22. Walker E, Dewar BJ. How do we facilitate carers’
involvement in decision making? J Adv Nurs 2001;
34:329–337.
23. Winstanley S, Thompson B, Harper A, Hudson E.
Users and carers views about health services. J Com-
munity Nurs 2004;18:4.
24. Galdas PM, Cheater F, Marshall P. Men and health
help-seeking behaviour: literature review. J Adv Nurs
2005;49:616–623.
25. Grande GE, Myers LB, Sutton SR. How do
patients who participate in cancer support groups
diﬀer from those who do not? Psychooncology
2006;15:321–334.
26. Hollander JA. The social context of focus groups.
J Contemp Ethnogr 2004;33:602–637.
27. Kitzinger J. Introducing focus groups. BMJ 1995;
311:299.
16 White et al./Research in Social and Administrative Pharmacy 8 (2012) 4–16
APPENDIX A 191
 
192 
 APPENDIX B – WEBSITE INFORMATION AVAILABLE ABOUT HMR 
APPENDIX B 
 
 
 
 
HOME MEDICINES REVIEW WEBSITE INFORMATION: 
CONSISTENCY OR CONFUSION? 
 
 
 
 
 
 
 
 
 
 
 
 
SR Carter 
L White 
Australian Pharmacist  2010;  
29(10); 882-888 
 
Vo
l. 
29
 –
 O
ct
ob
er
 #
10
882
Home Medicines Review 
website information: 
consistency or confusion?
research
Abstract
Introduction: Since consumer 
awareness and understanding is a 
significant component of the success 
of the Home Medicine Review 
(HMR) program, the publicly available 
information regarding the benefits 
and eligibility criteria is of interest. 
The objective of this study was to 
compare and contrast the information 
regarding HMRs made available for 
consumers from a variety of sources, 
using the most easily accessible 
channel, the internet. 
Methods: A thorough internet search 
of health professional and consumer 
directed information about HMRs 
was conducted. A content analysis 
of all information relevant to HMRs 
on two health professional sites and 
five consumer‑directed sites was 
performed and comparisons were 
made.
Results: Four themes were derived 
from the analysis: 1) Rationale for 
HMR, 2) HMR objectives, 3) Patient 
counselling, and 4) The use of 
medication risk factors in statements 
about eligibility criteria. Comparing 
a variety of professional and 
consumer resources about HMRs, 
the present study found a lack of 
consistency between resources in 
HMR information in three main areas: 
1) the medication risk factors, which 
are used to define those persons 
who may receive benefit from and 
be eligible for HMRs, 2) the use 
of subjective patient perceptions 
of negative experiences with, or 
emotions about medicines, which, if 
used, could empower consumers to 
self‑identify for the program, and 3) 
the description of positive elements 
of communication during the HMR 
interview, such as the extended length 
of the interview with the pharmacist 
and the opportunity to have questions 
answered by the pharmacist.
Conclusions: Consumer‑directed 
resources may lack salience because 
medication‑related problems, the 
resolution of which underpins the 
program, are conceptually vague and 
the various descriptions of the need for 
HMRs omit specific details about the 
nature of the problems such as timing 
of administration, drug interactions, or 
that prescribed medications may, for a 
variety of reasons, be inappropriate. In 
order to improve message consistency 
and salience for consumers, future 
research and discussion is needed 
in order to optimally describe HMR 
benefits through the use of objective 
risk factors, subjective or perceptual 
factors, descriptions of medication‑
related problems and communication 
opportunities afforded. 
Introduction
With the objectives of improving 
medication management, maximising 
therapeutic benefit of medicines 
and reducing adverse events, 
Home Medicines Reviews (HMRs) are 
provided by general practitioners and 
pharmacists for patients who are at risk 
of medication misadventure. Growing 
steadily since 2001, the HMR program 
provides approximately 4,000 services 
per month throughout Australia.1 The 
service is expected to grow, as funding 
for the HMR program as been allocated 
by the Fifth Community Pharmacy 
Agreement; however, in order to ensure 
that the program is cost effective, 
HMRs should only be provided to 
the consumers for whom benefit is 
most likely.
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research
industry to manage participant 
selection by providing health 
professionals with a list of risk factors 
for medication misadventure within 
descriptions of service benefit and 
consumer eligibility guidelines. 
Eligibility for an HMR is constructed 
on the premise that the patient is at 
risk of harm because of a medicines 
management issue, rather than the 
patient being at risk because of a 
demographic factor, the presence of 
a particular disease state or overall 
health status. The Department has 
recently refined health professional 
information regarding HMRs, and 
this will be referred to in this paper; 
however, between 2001 and 2009, 
the following examples of risk factors 
were provided:2
1. Currently taking 5 or more regular 
medications; 
2. Taking more than 12 doses of 
medication/day; 
3. Significant changes made to the 
medication regimen in the last 
3 months; 
4. Medication with a narrow 
therapeutic index or medications 
requiring therapeutic monitoring; 
5. Symptoms suggestive of an 
adverse drug reaction; 
6. Sub‑therapeutic response to 
treatment with medicines; 
7. Suspected non‑compliance or 
inability to manage medication 
related therapeutic devices; 
8. Patients having difficulty managing 
their own medicines because of 
literacy or language difficulties, 
dexterity problems or impaired 
sight, confusion/dementia or other 
cognitive difficulties; 
9. Patients attending a number of 
different doctors, both general 
practitioners and specialists; 
and/or 
10. Recent discharge from a facility/
hospital (in the last 4 weeks). 
Inclusion of most of these risk 
factors was evidence‑based in that 
experimental studies demonstrated a 
relationship between the risk factor 
and adverse events, for example 
unplanned hospital admission. Whilst a 
detailed description of the origin of 
each risk factor is beyond the scope 
of this paper, risk factors 1,2,3,4,7, 
and 9 appear to have been adapted 
from the study by Koecheler.3 There is 
considerable evidence that physical or 
cognitive problems (risk factor 8) and 
hospital discharge (risk factor 10) are 
associated with medication‑related 
problems. Having symptoms 
suggestive of an adverse reaction 
(risk factor 5) and sub‑therapeutic 
response (risk factor 6), by definition, 
indicate that medication misadventure 
is present. 
The issue of whether or not HMRs 
have been successfully targeted to 
those most in need was discussed 
in a recent Australian government‑
commissioned qualitative evaluation 
of the HMR program.4 The authors 
suggested that there was an 
inconsistent uptake of the service 
across the community among those 
patients most ‘at risk’ of medication 
misadventure and concluded that 
HMRs should be targeted to those 
‘at risk’ of medication misadventure, 
including Indigenous consumers, 
culturally and linguistically diverse 
consumers and palliative care patients. 
The concept that a demographic 
characteristic or particular disease 
state was a predisposing risk factor 
that could be used to target HMRs is 
innovative in that apart from functional 
and cognitive disabilities, disease 
and/or demographic descriptors 
were not previously mentioned. 
Also excluded from consideration was 
the presence of coexisting multiple 
diseases, that is, multimorbidity,5 
despite this being a risk factor 
demonstrated in Koecheler and 
colleagues’ study.3
Since consumer awareness and 
understanding is a significant 
component of the success of the 
HMR program, the publicly‑available 
information regarding the benefits 
and eligibility criteria is of interest. 
The objective of this study was 
therefore to compare the information 
regarding HMRs made available for 
consumers from a variety of sources, 
using the most easily accessible 
channel, the internet.
Method
A thorough internet search was 
conducted during May 2010. 
Firstly, health professional‑
directed information was sought 
in two key Australian Government 
websites, those of the Australian 
Government Department of Health 
and Ageing (the Department),a 
the department responsible for 
Community Pharmacy Agreement 
services and Medicare Australia 
(Medicare),b the agency responsible 
for remunerating GPs and pharmacists 
to perform the service, using the 
search term ‘Home Medicines 
Review’. Secondly, a search for 
consumer‑directed information about 
HMRs was conducted. In order to 
replicate how a consumer would 
search for information concerning 
HMRs, the government websites 
above were investigated, searching 
in consumer sections. In addition, 
a simple internet ‘Google’ search with 
the term ‘Home Medicines Review’ 
was conducted. Within the first 
seven sites to appear in the ‘Google’ 
results, information intended for heath 
professionals was discarded and 
links to consumer information were 
investigated. All information pertaining 
to HMRs was saved as text files and 
a content analysis of information, 
available at the time of access, was 
conducted using themes derived from 
the data. Preliminary codes resulted 
from discussions between the authors. 
Subsequent analysis was performed 
independently by the two authors who 
met regularly to discuss and resolve 
differences to reach consensus and a 
final coding structure.
Results
In addition to the two government 
websites which provided information 
to health professionals which were 
freely accessible to the public, five 
websites with consumer‑directed 
information regarding HMRs were 
identified. The consumer‑directed 
material included the Australian 
Government Department of Health and 
Ageing brochure (Publication Approval 
Number 2927,c also available in 
hardcopy), the Department’s consumer 
website Help with Health – Medication 
Management.d The Pharmacy Guild 
of Australia’s consumer website,e the 
NPS’s consumer website,f and Seniors.
gov website.g
Content analysis revealed four 
themes: 1) Rationale for HMR, 2) HMR 
objectives, 3) Patient counselling, and 
4) The use of medication risk factors in 
statements about eligibility criteria.
Theme 1. Rationale for HMR
With the exception of one consumer 
site, each resource mentioned or 
implied that the need for an HMR 
was premised on the existence of 
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medication problems which lead to 
adverse events, for example: 
If medicines aren’t used properly, 
or if the wrong ones are used 
together, the results can be serious. 
Each year more than 140,000 
Australians have to go to hospital with 
problems caused by their medicine. 
(NPS consumer website). 
The Department’s consumer site 
had a message that ‘medicines can 
occasionally make you sicker’. In most 
consumer‑directed material, there was 
little detail about what actually goes 
wrong with medicines or how that 
happens, for example the quotation 
above does not specify whether 
the issue of medication‑related 
problems may be the result of the 
prescriber’s choice of medicines or 
the consumer’s (mis)use. The most 
thorough explanation of how these 
problems may occur was found on 
the Department’s consumer website, 
Help with Health – Medication 
Management, which introduced 
the concept of age‑related changes 
causing changes in sensitivity 
to medicines:
Age-related changes in the body can 
also increase older people’s sensitivity 
to the effects of medication. 
(Department’s consumer website).
Theme 2. HMR objectives 
There was a high degree of 
consistency in information regarding 
the objectives of the program. 
On most sites, there were statements 
suggesting or implying that HMRs 
aimed to detect problems, prevent 
adverse events and increase potential 
benefits of medicines, for example:
It has been shown that, in up to 
69% of these cases, the problem 
[adverse events] can be avoided. 
(Pharmacy Guild consumer website).
The Medicare site for health 
professionals and the NPS consumer‑
directed site provided the most 
detailed information regarding 
benefits of the program. In all 
documents, a statement was made 
that HMRs ‘assist people of any age 
to manage their medicines better 
while they are living at home.’
Theme 3. Patient counselling
Whilst most information resources 
discussed the potential for 
information transfer between patient 
and health professionals, there was 
a high level of inconsistency in the 
descriptive detail of what patient 
counselling occurred during an 
HMR. For example, the Medicare 
site provided almost no detail about 
the extent of patient counselling, 
although the provision of counselling 
may be inferred. With regard to the 
consumer‑directed information, the 
only resource that mentioned that 
a pharmacist provides information 
about medicines, and gave the 
patient an opportunity to ask 
questions, was the Department’s 
consumer‑directed site. 
The pharmacist will talk to you 
about how you take them and 
any difficulties or uncertainties 
that you may have. (Department’s 
consumer website).
The Pharmacy Guild and the NPS 
sites mentioned that the GP 
would discuss medications, and 
the NPS site provided significant 
detail, but these resources did 
not specifically state that the 
pharmacist provided an opportunity 
for counselling, and neither did they 
suggest that the HMR provided a 
chance to ask questions of either 
health professional. 
The GP will discuss any 
recommendations with you and may 
make appropriate changes to your 
medication regimen. (Pharmacy Guild 
consumer website). 
Two resources, the Medicare 
consumer site and the Seniors site 
did not specifically mention that 
an HMR provided patients with 
information.
Theme 4. Eligibility criteria
In all documents, risk factors for 
medication misadventure were used 
to either guide health professionals 
and regarding patient eligibility or to 
guide consumers as to whether they 
may expect to receive a benefit as a 
result of an HMR. Table 1 presents a 
summary of the information contained 
within each document pertaining 
to medication risk factors. In each 
document, the use of risk factors is 
prefaced and the preceding statement 
is also included in the table. 
Multiple medications
The risk associated with polypharmacy 
was broached by each information 
resource, yet there was inconsistency 
regarding the representation 
of polypharmacy. Within health 
professional information, polypharmacy 
was represented by the patient taking 
five or more medications daily or taking 
greater than twelve doses daily. Some 
consumer sites used non‑numerical 
approaches including ‘a number of 
medicines’ and ‘multiple medications’, 
and others used ‘taking more than 
five medicines daily’. No consumer 
site referred to taking more than 
12 doses daily.
Discharge from hospital
All sites, except the 
Department’s consumer site, 
referred to hospital discharge. 
Memory, cognition and 
management ability 
The Department’s health 
professional site included 
references to non‑compliance as 
a result of forgetfulness and there 
was a separate entry for dementia. 
However, neither forgetfulness 
nor dementia was mentioned by 
Medicare. All consumer‑directed 
information either mentioned 
forgetfulness directly or mentioned 
problems in terms of difficulty 
managing medicines. Patient 
management difficulties may be 
caused by limited health literacy, sight 
and language and the Department’s 
health professional and Medicare 
sites explicitly mentioned these 
factors, whilst the consumer‑directed 
sites did not. The Department 
also specifically included manual 
dexterity, but this was not mentioned 
elsewhere. No information resource 
dealt with the issue of intentional 
non‑adherence. 
Multiple prescribers 
Both the health professional‑directed 
information resources referred to 
having multiple regular prescribing 
doctors however this was referred 
to in only one consumer‑directed 
resource, the Pharmacy Guild 
consumer site.
Significant changes in 
medication regimen
Both the health professional‑directed 
information resources referred 
to having a significant change in 
medication regimen, yet this was 
not referred to in any consumer‑
directed information. 
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Table 1. Information contained within each resource pertaining to risk factors for 
medication misadventure 
Medicareb Department 
of Health and 
Ageinga
Department’s 
consumer 
brochure. 
Publication 
Approval 
Number 2927c
Department’s 
consumer 
website – Help 
with health 
– Medication 
managementd
Pharmacy Guild 
Consumere
NPSf Seniorsg
Preface A general 
practitioner must 
assess that a 
review of a patient 
living at home is 
clinically necessary 
to ensure the 
quality use of 
medicines or to 
address a patient’s 
needs. Examples 
of risk factors 
include patients:
Patients who may 
benefit from a 
HMR include those
You might 
benefit from a 
home medicines 
review if:
It is important that 
medicine is used 
safely and wisely. 
If: [   ] you may 
benefit from a 
service known as 
a Home Medicines 
Review.
You could benefit 
from a HMR if:
The HMR is 
particularly useful 
for people who:
Home Medicines 
Reviews assist 
people of any age 
to manage their 
medicines better. 
If you are: 
Risk 
Factors
currently 
taking five or 
more regular 
medications 
taking 5 or 
more regular 
medications
You take a number 
of medicines
you take a number 
of medicines
you take more than 
five medicines in 
a day
take more than five 
medicines per day 
using multiple 
medications
taking more 
than 12 doses of 
medication per day 
taking more 
than 12 doses of 
medication per day
as above as above as above
recent discharge 
from hospital 
recently discharged 
from hospital
You have recently 
been discharged 
from hospital or 
from care
You have recently 
spent time in 
hospital
have recently spent 
time in hospital
have been recently 
discharged from 
hospital or other 
care facility
taking medication 
with a narrow 
therapeutic 
index or require 
therapeutic 
monitoring
with symptoms 
suggestive of 
an adverse drug 
reaction
forget to take their 
medicines 
Do you always 
remember to take 
your medicines? 
[Orientation 
message] 
sometimes forget 
to take your 
medicines
do not always 
remember to take 
their medicines
those with 
cognitive 
difficulties such as 
dementia 
You are having 
difficulty with your 
medicines
you are having 
difficulty managing 
them
having difficulty 
managing your 
medication
having difficulty 
managing their 
own medicines 
because of literacy 
or language 
difficulties, 
impaired sight 
with literacy 
or language 
difficulties, 
dexterity problems, 
impaired sight, 
You are having 
difficulty with your 
medicines 
you are having 
difficulty managing 
them
having difficulty 
managing your 
medication
attending a 
number of 
different doctors, 
both general 
practitioners and 
specialists
seeing a number of 
different doctors, 
including GPs and 
specialists
see more than one 
GP or specialist
with significant 
changes to their 
medication 
regimen in the last 
three months,
have had a 
significant change 
in their medication 
regimen
Confusion Confused about 
their medicines
are confused 
… about your 
medicines
are confused about 
their medicines
Worry worried about their 
medicines
are worried about 
your medicines
are concerned 
about their 
medicines
a,b,c,d,e,f and g refer to websites which are provided at the end of the reference list.
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Symptoms suggestive of an 
adverse reaction
Only the Medicare website 
referred to symptoms suggestive 
of an adverse reaction.
Medicines with a narrow 
therapeutic index or which 
require therapeutic monitoring
Only the Medicare site referred 
to medicines with a narrow 
therapeutic index or requiring 
therapeutic monitoring. 
Emotional factors – 
confusion and worry
The Department’s health professional 
site referred to patient confusion 
and worry about medicines whereas 
the Medicare site does not. Of the 
consumer‑directed material, both 
the Pharmacy Guild and the NPS 
referred to confusion and these sites 
also mentioned negative emotional 
states, in terms of worries and 
concerns respectively.
Discussion
A significant problem for consumer‑
directed information resource 
development is the description of 
patient benefit of the HMR program, 
since in order to increase the personal 
relevancy of many disease specific 
information resources, it is traditional 
to provide background statements 
regarding one’s personal risk of 
experiencing the disease. However, 
in the situation of encouraging 
participation in HMRs, it is not 
appropriate to provide information 
about disease‑specific risk, rather 
treatment‑specific risk is the relevant 
issue, and the method by which this 
information is disseminated requires 
sensitivity. Whilst it would be wise 
to inform consumers of potential 
problems so that they would ask about 
the service, conversely it is important 
not to unnecessarily increase patients’ 
concerns about medicines or to 
undermine confidence in the health‑
care system. It should be noted that 
increasing patient concerns about 
medicines may increase intentional 
non‑adherence.6–10
It was found that most consumer‑
directed HMR resources stated 
that some patients are at risk of 
medication misadventure. These 
statements appeared however to 
have been treated so sensitively that 
they possibly lack salience for the 
lay person. Overall, there was a lack 
of description about the preventable 
practical problems which may lead 
to medicines misadventure. With the 
exception of one resource, there 
was no reference to dose issues, 
timing issues, appropriateness11,12 or 
age‑related changes in sensitivity,13 
such that consumers may not 
understand how problems occur 
during the management of complex 
medication regimens.
Analogous to the provision of risk 
factors for diseases within disease‑
specific information resources, most 
HMR resources presented a range 
of treatment risk factors pertaining 
to medicines misadventure, in order 
to assist the reader to personally 
identify with the message. In addition, 
some professional and consumer‑
directed HMR resources suggested 
that either the health practitioner 
or consumer may rely on a range of 
subjective experiences regarding 
medication consumption in order to 
determine whether the service would 
be beneficial. With regard to the 
provision of risk factors, four types of 
objective risk factors were identified: 
polypharmacy, recent regimen change, 
having multiple regular prescribers and 
medicines with a narrow therapeutic 
window which require monitoring. 
We found that there was a lack of 
consistency in the presentation of 
objective risk factors for medication 
misadventure in statements regarding 
patient eligibility for the program. 
Each of these types of risk factors 
warrant inclusion in consumer 
information resources and ideally, 
these risk factors would be used 
consistently throughout all resources. 
Whilst comment about all classes 
of risk factors may be useful, the 
remainder of the discussion focuses 
on the use of polypharmacy, regimen 
change and subjective factors.
Polypharmacy
The most frequently included risk 
factor in the information resources 
studied was polypharmacy, yet this 
was promoted to consumers in a 
subjective manner. The objective, 
evidence‑based risk factor is taking 
five or more medicines daily or 
more than 12 doses per day.3 Most 
consumer‑directed resources avoided 
the use of numbers, using vague 
terminology such as ‘multiple’ or ‘a 
number’ of medicines. A significant 
issue for policy in this area is that 
increasing age is associated with an 
increase in the average number of 
medicines taken,14 and furthermore 
consumer expectations about whether 
the number of medications that a 
person took would be described 
as multiple also increases with 
age.15 Further work is required to 
consistently define polypharmacy or 
multiple medication use as a valuable 
criterion for HMR eligibility
Regimen change 
Introducing new medicines adds 
to the complexity of a medication 
regime, and this contributes to 
overall patient concerns15 and 
dissatisfaction with professional 
services.16 Not surprisingly, many 
patients become non‑adherent to 
medicines early in the course of 
treatment,17 and for the consumer of 
multiple medicines, regimen changes 
occur routinely. Koechler, et al.3 
published an association between 
having frequent changes in medication 
regimen (four times during the 
preceding 12 months) and medication 
misadventure. This risk factor was 
adapted for use in HMR material 
by requiring there to have been a 
significant change in medication 
regimen within the preceding three 
months. Regimen change or new 
medicines, however, did not appear in 
any consumer‑directed material. Since 
this risk factor would be relatively 
easy for consumers to understand, it 
is suggested that it be considered for 
immediate inclusion in all resources.
Medication regimen change is a 
common feature of hospitalisation for 
people who take multiple medications 
and the resultant potential for 
confusion may contribute to a high 
rate of medication‑related problems.18 
It is therefore not surprising that 
being discharged from hospital within 
the last month is a recognised risk 
factor for medication misadventure.19 
Hospital discharge was utilised 
in most resources, albeit with 
consumer‑directed material referring 
to the time period as ‘recent’ rather 
than as one month. 
Subjective factors
There is a need for policy‑makers 
to address the high degree of 
inconsistency in both health 
research
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professional and consumer‑
directed resources with regard to 
the inclusion of subjective patient 
perceptions of negative experiences 
with, or emotions about, medicines. 
These factors included statements 
regarding patients’ medicines 
management capability, memory, 
cognition and worry about medicines 
and symptoms suggestive of 
adverse effects. 
The inclusion of these subjective 
factors in consumer‑directed 
information would appear to engage 
patients and carers to utilise gained 
expertise with medication.20 This 
paper proposes that subjective 
factors deserve mention in all 
consumer and health professional 
material. Encouraging consumers 
to examine their own thoughts and 
feelings in order to self‑identify 
for the service would assist them 
to exercise some level of control 
over medication‑taking. Provided 
consumers believe that the HMR 
service would be beneficial, this 
encouragement would reduce 
any feelings of abandonment by 
health professionals in the move 
towards self‑care management of 
chronic disorders.21
Benefit 
A clear and consistently stated 
benefit of the HMR program, 
contained in all resources, was that 
HMRs improve patients’ ability to 
effectively manage their medicines. 
There was however, much variation 
in the content and level of detail 
which describes the communication 
opportunity provided by an 
extended consultation with a 
pharmacist. Some consumer‑
directed information suggested that 
the patient will receive information 
about how best to manage their 
medicines, yet only one of the 
resources reviewed suggested that 
the pharmacist’s visit is where the 
information is obtained, whereas 
two sites suggested that the GP 
would provide this information 
after the pharmacist’s visit. Only 
one consumer‑directed resource 
stated that the patient would have 
an opportunity to ask questions 
at any stage of the process. This 
is a significant oversight because 
one of the objectives of HMRs is 
to prevent misadventure resulting 
from poor adherence and in order 
for adherence to be optimised and 
concordance achieved, two‑way 
communication is necessary.22 
No information resource quoted 
the expected length of time 
available for discussion during the 
pharmacist’s visit or compared that 
with the time available for most 
general practice and community 
pharmacist consultations. Given 
that many patients report that 
GP consultations are too short to 
discuss their medicine concerns,15,23 
there is an opportunity for 
descriptive messages about HMRs 
to promote the pharmacists role 
in addressing patients’ concerns 
during the relatively long HMR 
pharmacist consultation. 
The authors acknowledge that the 
content of website information is 
continuously updated and that the 
present findings and conclusions 
pertain to the information available 
at the time of the study.
Conclusion
In order to improve message 
consistency and salience for 
consumers, future research and 
discussion is needed in order to 
optimally define HMR benefit 
through the use of objective risk 
factors, subjective or experiential 
factors and descriptions of 
medication‑related problems and 
communication opportunities. 
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DESCRIPTION OF JOURNALS 
 
International Journal of Pharmacy Practice (IJPP) 
The International Journal of Pharmacy Practice (IJPP) is the official journal of the 
Royal Pharmaceutical Society which is the professional body for pharmacists and 
pharmacy in England, Scotland and Wales. It is a peer reviewed, international journal. 
It is one of the leading journals publishing health services research in the context of 
pharmacy, pharmaceutical care, medicines and medicines management. It has been 
published since 1991. Currently it does not have an impact factor.  
 
Research in Social and Administrative Pharmacy (RSAP) 
Research in Social and Administrative Pharmacy (RSAP) is a peer-reviewed pharmacy 
practice journal which publishes original scientific reports and comprehensive review 
articles in the social and administrative pharmaceutical sciences. It has been 
published since 2005 and the current impact factor is 2.35. 
 
International Journal of Clinical Pharmacy (IJCP) 
International Journal of Clinical Pharmacy (IJCP) provides a medium for the 
publication of articles on clinical pharmacy and related practice-oriented subjects in the 
pharmaceutical sciences. The scope of the journal is clinical pharmacy, its research 
and its application in pharmaceutical care. It has been published since 1979 and up 
until 2010 was known as Pharmacy World Science. The current impact factor is 1.036. 
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Health Expectations 
Health Expectations is peer-reviewed journal publishing original research, review 
articles and critical commentaries on all aspects of public participation in health care 
and health policy. The Journal provides a multi-disciplinary and international forum in 
which researchers from a variety of backgrounds can present their work to other 
researchers, policy makers, health care professionals, managers and consumer 
advocates. It has been published since 1998 and the current impact factor is 2.315. 
 
 
Australian Pharmacist 
Australian Pharmacist is the official journal of the Pharmaceutical Society of Australia. 
It is primarily a professional journal for practicing pharmacists. It contains pharmacy 
education and practice features, peer-reviewed research papers, health and pharmacy 
news and information about PSA activities, as well as paid advertising and promotional 
material. It has been published since 1981 and it currently does not have an impact 
factor.  
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